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Abstract
Abstract
The lumen of the gastrointestinal tract has a variety of potentially harmful constituents
ranging from the various bacteria and their by-products, pharmacological agents or
nutrients ingested to the numeroussecretions. These are separated from the underlying
tissue by an epithelial monolayer which if absent would allow luminal contents to exert
noxious or inflammatory effects on the tissue below. The monolayer exists as a sheet
thrown into manyfolds and ridges knownascrypts and villi. Intestinal epithelial cells (IECs)
Originate in the crypts and migrate to thevillus tips from whence they are shed. There are
a myriad of mechanisms knownto close defects which result in the monolayer however the
process of shedding must create transient breaks in the monolayer whereits barrier
function is potentially compromised. Previous work performed by my supervisor (Professor
A.J. Watson) has demonstrated that the barrier functionis still maintained in the majority
of instances and the defectisfilled with a non-cellular material.
In contrast to previous work which had been performed on murine models we chose to
examine human tissue to investigate the process of shedding in the gastrointestinal tract.
Weidentified the optimum method of tissue preservation, documented the frequency of
shedding events in the small and large intestine, the method of epithelial restitution
following shedding, the relationship of shedding with apoptosis and its association with
cellular components of the sub-mucosa. Our data supports Potten’s hypothesised rate of
epithelial cell loss in the intestine of 1400 cells per day. We found noassociation of
shedding events with other cell types found in the villus (macrophage, endothelial and
leucocyte) and our data supports a purse-string mechanism of restitution following IEC
shedding.
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Introduction
1.1. The history behindthe investigation of epithelial cell shedding
The equipment required to determine the microscopic structure of the mammalian
intestine and consequently study the process of shedding took centuries to develop. In
1590 the Dutch father and son Zacharias and Han Janssen developed a tube with two
lenses to magnify objects (the precursor of the microscope and telescope) which Galileo
Galilei (1609) subsequently improved by the addition of a focus. Overhalf a century later,
two landmarks were when Robert Hookefirst used the term ‘cell’ while describing cork in
his book ‘micrographia’ (1667) and Anton Van Leeuwenhoekdescribed bacteria, yeast and
teaminglife in a droplet of water.
Two hundred years later fixatives such as Clark’s alcohol-acetic and Muller’s solutions
(1850’s) were developed and subsequently superseded by formaldehyde (discovered 1859,
formalin devised by Hoffman in 1868 and advocated by Blum 1892). At the same time
dyes which had beenin existence for millennia and newly developed stains were being
used on tissue for the first time. Cermine was used by Joseph Gerlach in 1858 and
Waldeyer developed haematoxylin in 1863. Haematoxylin was not popular until Ehrlich
(1886) added eosin as an effective counter stain. In the same decade microtomes became
available for the first time (1880) and superseded the cutting of tissue by sharp knives.
Despite microscopes having been invented three hundred years earlier it was the
equipment,fixatives and stains associated with routine histology today that had not been
developed until the 1880’s. In 1888 Heidenhain described the cells lining the small
intestine and Paneth demonstrated they have the same embryological origin (Heidenhain
1888; Paneth 1888). In 1892 Bizzozero reasoned thatthe dividing crypt cells are pushed on
13
Introduction
to the villi and Friedman (half a century later) used irradiation to make cells oedematous
and track the movement of goblet cells from crypt to villus but made no commentas to
their fate (Bizzozero 1892; Friedman 1945). Leblond and Stevens in 1948 described
extrusion zonesatthe villus tip and attributed them to cell shedding (described previously
by Palzelt, Vossler and others butattributedto fixation artefacts). Cells were thought to be
damaged during the course of digestion and the crypt progenyreplacedthis loss (Bizzozero
1892; Vossler 1900; Ramond 1904; Patzelt 1936; Friedman 1945; Leblond and Stevens
1948; Leblond, Stevens et al. 1948). In a second paper from the same year Leblond and
colleagues used the recently developed technique of performing a ‘radioactive autograph’
with P® to corroborate Friedman’s work on IEC migration from crypt base to villus tip
(Leblond, Stevens et al. 1948). Similar results were observed with other radioisotopes;
methionine-S*’, adenine-C™ and tritium (H’) labelled thymidine (Belanger 1956; Pelc and
Howard 1956; Leblond, Everett et al. 1957; Leblond and Messier 1958; Walker and Leblond
1958).
Other discoveries of note were when von Mollendorff in 1925 (followed by Maximowin
1927) commentedfor the first time on lamina propria macrophages congregating at the
tips of intestinal villi in the guinea pig (Mollendorff 1925; Maximow 1927). Theyincorrectly
assumed that macrophages took substances from the lumen. Sawicki et al. recognised that
the cells phagocytosed migrating cells but incorrectly concluded these werefibroblasts or
intra-epithelial lymphocytes (Mollendorff 1925; Maximow 1927; Sawicki, Kucharczyk etal.
1977). Creameret al. used a dissecting microscope on anaesthetised dogs to view for the
first time IECs being shed in a live animal (Creamer, Shorter et al. 1961). Potten and Allen
produced electron micrographs of shedding IECs, described the movementof an effete cell
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upwards comparedto its neighbours prior to shedding (rather than phagocytosis) and were
the first to associate elongated microvilli with effete IECs (Potten and Allen 1977).
1.2. Models of cell shedding
Various models of cell shedding within the mammalian intestine have been proposed
howeverthere is relatively little documentation regarding shedding within the human
intestine which may be duetodifficulties in obtaining, retrieving or preserving tissue
(Shibahara, Sato et al. 1995; Gibson 2004; Bullen, Forrest et al. 2006). A great leap in our
knowledge regarding the mechanism which operates in the human intestine has occurred
due to the newly available confocal endoscope which allows observation of human small
intestinal cell shedding in real time (Watson, Chu et al. 2005). The majority of historical
data focuses on other mammals and a wealth of authors have documented the process of
shedding in a numberofdifferent animals which not surprisingly has given quite different
results.
Simply put, the mechanism by whicheffete IEC can be shedis either whole or in fragments
and the tight junction (TJ) will reform at the apical, middle or basal aspects of the
neighbouring cells. There are five models which have been described to accountfor effete
cell loss in the mammalian intestine; cells are either normal sized, shrunken, swollen or
phagocytose. An effete IEC shrinks secondary to apoptosis and either detaches from the
basement membraneorits neighbours (Han, lwanagaet al. 1993; Han, lwanagaet al. 1993;
Iwanaga, Han et al. 1993; Iwanaga, Han et al. 1994; lwanaga, Han et al. 1994; Ilwanaga,
Hoshi et al. 1994; lwanaga, Hoshi et al. 1994; Iwanaga 1995; Mayhew, Myklebust etal.
1999; Watson, Chuet al. 2005). If an effete IEC swells through a process similar to necrosis
it will either rupture its membraneor break the adhesive molecules holding it in place. The
most recently proposed model is by Watson and demonstrates normal-sized cells being
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shed (Watson, Chu et al. 2005). Four of the above models provide a complete barrier
during the loss of effete IEC’s whereas the modelinvolving cell swelling would allow
transfer of substances between lumen and submucosa (Mayhew, Myklebust et al. 1999;
Watson,Chuetal. 2005).
Shedding is a four dimensional event (x, y, z and time) and thus capturing these
phenomena occurring in human intestine is difficult. The evidence for some models of
shedding is from other species due to accessibility of tissue and the ability to perform
procedures which are impossible in a live human. Unfortunately these may not directly
correspond to human physiology. Human specimens weretraditionally examined with
conventional microscopy which is limited to two dimensions or scanning electron
microscopy which allows visualisation of three dimensions but does not allow a four
dimensional reconstruction. Specimen retrieval is difficult for human tissue given they are
resected surgically. Trauma and ischaemia during specimen retrieval, processing and
fixation are potential sources of inaccuracy documenting the quantity and nature of IEC
loss. Excessive cell loss may make shedding appear more frequentofif IECs are completely
lost less frequently than actually occurs. Trauma may create defects in the epithelial
monolayer and cell shrinkage may be dueto artefact or the geometry of the section rather
than apoptosis.
The optimum method to examine shedding in animal models is confocal microscopy which
allows real time visualisation of shedding events. This technique involves placing an
anaesthetised animal on a custom built stage of a multi-photon microscope with a
circulating water bath maintaining a temperature of 37°C. The abdomenis opened and the
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intestine incised along the anti-mesenteric border followed by application of fluorescent
stains. This technique was not available for use in humanintestine at the time this work
was Carried out. However the subsequent development of confocal endomicroscopy has
expanded our knowledge of shedding in the humanintestine and is currently the best
modality to observe shedding. Although confocal endomicroscopyis a leap forward in our
ability to observe shedding in the human intestineit is limited in terms of the magnification
possible and the reagentsavailable for staining. The model described by Watsonis the only
model to utilise data obtained from both confocal microscopy and endomicroscopy
(Watson, Chuet al. 2005; Kiesslich, Goetz et al. 2007).
1.2.1. Models involving extrusion of entire cells
Three modelsof effete cell loss from the mammalian intestine exist during which complete
cells are shed. The historical model of shedding involves loss of whole cells, Madara
modified the mechanism of tight junction complex (TJC) restitution during cell loss which
he describes as ‘zipper-like’ (discussed below) (Madara 1990; Han, Iwanaga et al. 1993;
Han, Ilwanagaet al. 1993; Ilwanaga, Han et al. 1994; Ilwanaga, Hoshi et al. 1994; Ilwanaga
1995; Shibahara, Sato et al. 1995). The most recent model has been proposed by Watson
and will be discussed in more detail at the end of this section (1.2.5.). Their studies used
live in-vivo data and demonstrate serial images of whole cell shedding in real time (figure
1.8) (Watson, Chu et al. 2005). The remaining model of entire cell extrusion is covered in
section 1.2.2.3; the morphology of the cells lost appears different (cells are swollen) and
they follow twodifferent routes of shedding either whole orin fragments which potentially
allow defects in the monolayer.
Creamer demonstrated in-vivo shedding of IECs from villi of anaesthetised dogs but the
imageslack significant detail and scanning electron microscopy (SEM) images of the murine
17
Introduction
small intestine by Potten and Allen demonstrate the loss of intact cells but it is impossible
to discern which modelof whole cell shedding occurs (Creamer, Shorteret al. 1961; Potten
and Allen 1977).
1.2.1.1. Extrusionof entire cells with basal extensionof lamellipodia
This is probably the simplest modelof IEC shedding; the cell detaches from the basal lamina
and is lost to the lumen. Simultaneously with IEC detachment, the TJs bordering the effete
cell migrate apically just below the apical brush border of neighbouring cells (Mayhew,
Myklebustet al. 1999). Lamellipodia extend from neighbouring cells to form a TJC beneath
the extrudingcell whilst the apical TJCsarestill intact and thus a second barrier formsprior
to the detachmentof the older TJs (figure 1.1-part 2) (Mayhew, Myklebust et al. 1999).
Gradually the new, basal TJCs migrates apically but once the new complex has formed the
cell breaks contact with its neighbours and is shed into the lumen (figure 1.1-part 3). The
TJC lies at the height of its neighbours and the neighbouring epithelial cells havefilled the
defect (figure 1.1-part 4). The luminal cells are nucleated with signs of apoptosis (Han,
lwanagaet al. 1993; Mayhew, Myklebust et al. 1999).
This model of shedding is thought to occur in the dog, hamster, human, mouse and rat
small intestines with limited evidence it may occurin the rat colon (Baron and Miller 1990;
Han, lwanagaet al. 1993; Ilwanaga, Hanet al. 1993; lwanaga, Hoshiet al. 1994; IlwanagaT.
1994; Iwanaga 1995; Shibahara, Sato et al. 1995; Myklebust and Mayhew 1998; Mayhew,
Myklebust et al. 1999).
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Figure 1.1 Model of the extrusion of whole intestinal epithelial cells during shedding
with basal extension of lamellipodia and subsequenttight junction complex formation.
o.50
1. Effete epithelial cell begins to 2. Lamellipodia extend from neighbours
detach from the basal lamina. Tight beneath detached cell to form a tight
junctions migrate apically. junction.
3. Tight junction migrates up the 4. Tight junctions have migrated to thelateral plasma membrane asthe height of their neighbours and cell is
cell is shed. completely detached.
® Tight junction complex i Effete cell
1.2.1.2. Extrusion of entire cells with the production of an impermeable
substance
Watson proposes morphologically normal IECs are shed from theapical portion of thevillus
and that a substance is produced below theeffete cells that provides a temporary barrier
whilst the cell is shed and the TJs subsequently reform (Watson, Chu et al. 2005). In
contrast to the previous model the TJs are thought to form apically rather than basally
(Bullen, Forrest et al. 2006). This will be discussed in more detail in section 1.2.5.
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Figure 1.2 Modelof the extrusion of entire cells with the production of an impermeable
basal substance.
Oomso-00
1. Effete epithelial cell begins to detach 2. Cell has been shed with gapleft in the
from the basal lamina. Substance forms epithelial monolayer.
beneath sheddingcell.
ech} (eles)
3. Whilst the tight junction closes apically 4. Whenthetight junctions have reformed the
the basal substance acts a temporary plug plug is absorbed.
@ Tight junction complex a Effete cell al Impermeable cellular substance
1.2.2. Models involving extrusion ofcell fragments
Three models exist where cells are lost as fragments. The first model shows phagocytosis
of effete IECs by macrophageswith loss of apical fragments only and the second model
restores the TJC by lamellipodia extending through the middle portion of the effete cell so
the apical half of the cell is lost (Han, Ilwanaga et al. 1993; Han, Ilwanaga et al. 1993;
Iwanaga, Han et al. 1993; Iwanaga 1995; Myklebust and Mayhew 1998; Mayhew,
Myklebust et al. 1999). The third model involves necrosis of cells which may be shed as
entire cells and or fragments andis discussed in section 1.2.2.3.
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1.2.2.1. Phagocytosis ofeffete epithelial cells
In the first model intra-epithelial lymphocytes(IELs) target effete IECs (Figure 1.3. Part-1)
and induce subsequent phagocytosis by macrophages but leave the TJs intact (Figure 1.3.
Part 2) (Iwanaga, Hanet al. 1993). Lamellipodia extend from neighbours to form a new TJC
belowthestill intact apical fragment of the membrane(Figure 1.3. Part 3) (Iwanaga, Han et
al. 1993). Following formation of the new complex the apical fragment detaches andis
lost into the intestinal lumen (Iwanaga, Han et al. 1993). The late loss of TJs is a major
difference to the other models of shedding in which they are lost early in the process. .
Figure 1.3 Extrusion of apical cell fragments with prior phagocytosis by macrophagesBe)
1. Effete epithelial cell targeted by IEL. 2. Lamina propria macrophage
phagocytoses basal portion of cell
leaving tight junction complexesintact.
 
@
9 6mt
3. Lamellipodia extend from 4. Tight junctions have migrated to the
neighbouring cells forming tight height of their neighbours and cell is
junction complexes. completely detached.
® Tight junction complex a Effete cell (@) IEL he00290
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There is insufficient evidence to say whether apoptosis occurs in the phagocytosed basal
fragments butinterestingly lwanaga has demonstratedin the guinea pig that this is specific
to epithelial cells; no cellular components of other cell types were found in the
macrophages(Iwanaga, Hanet al. 1993; Mayhew, Myklebust et al. 1999). This mechanism
of shedding is thought to occur in the guinea pig, horse, monkey and reindeer (Han,
Ilwanagaet al. 1993; Han, Ilwanaga et al. 1993; lwanaga, Hanet al. 1993; lwanaga, Han etal.
1994; Iwanaga 1995; Takahashi-lwanaga, Iwanaga et al. 1995; Suzuki, Mori et al. 1997;
Myklebust and Mayhew 1998; Mayhew, Myklebustet al. 1999)
1.2.2.2. Shrinkage of effete epithelial cells
This modelinvolves retention of the apical membrane dueto the effete cell shrinking; a
waist forms round thecell (figure 1.4. part 1) which eventually obliterates and allows
lamellipodia to meet. A new TJ forms beneaththestill intact apical membrane (Mayhew,
Myklebust et al. 1998; Myklebust and Mayhew 1998). Once the new TJ has formed and
migrated apically the residual membrane is released. The basal portion of the cell is
phagocytosed by macrophages (Mayhew, Myklebust et al. 1998; Myklebust and Mayhew
1998). Myklebust and Mayhewobserved this model of shedding occurring in the reindeer
and seal; they describe weakening of intercellular contact between adjacent cells at the
sites of lateral membraneinter-digitations (Mayhew, Myklebust et al. 1998; Myklebust and
Mayhew 1998). The basal portion of the cell when separated disintegrates into pockets
which contain large organelles and the apical remnants are shed into the lumen (Myklebust
and Mayhew 1998). It is not known what becomesof the basal remnants that lie between
the neighbouring cells but it is presumed that the lamina propria macrophages
subsequently phagocytose them (Myklebust and Mayhew 1998). There is evidence that this
potentially occurs in the human colon; Barkla examined colonic biopsies from essentially
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normal colon and demonstrated apoptotic cells passing through fenestrations in the
basement membraneona ‘currentoffluid’ (Barkla and Gibson 1999).
Figure 1.4. Extrusionofapical cell fragments with effete cell shrinkage
 
1. Effete epithelial cell shrinks and the 2. The thin middle region breaks down
middle of the cell thins. Lamellipodia and a tight junction forms The basal
extend from neighbours. remnantis phagocytosed by macrophages.
cA
 
3. Thetight junction migrates apically 4. Tight junctions have migrated to the
and the neighbouring cells bridge the height of their neighbours and cell is
gap. completely detached.
® Tight junction complex a Effete cell aMacrophage
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1.2.2.3. Shedding resulting in breaches of epithelial continuity
Allen and Potten first documented holes on the surface of murine intestinal villi which
could have been goblet cells that had recently released their contents but previous and
subsequenthistological and transmission electron microscopy (TEM) imagesin chicken, pig,
rat, reindeer and seal have provided further evidence to corroborate the model (Holman J.
1975; Potten and Allen 1977; Shibahara, Sato et al. 1995; Watson 1995; Mayhew,
Myklebustet al. 1998; Myklebust and Mayhew 1998; Mayhew, Myklebustet al. 1999).
Figure 1.5. Effete cells swell and are shed breaching the epithelial barrier
Effete epithelial cell swells similar
to necrosis.  oleh)
The degradedcell remnants leak into the The degrading cell loses contact with
lumen through defects in the cell neighbouringcells.
membrane.
e Tight junction complex
ae Effete cell
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Effete IECs are thought to undergo a process similar to necrosis, the cell swells and
becomes less electron dense (Watson 1995; Myklebust and Mayhew 1998; Mayhew,
Myklebust et al. 1999). The morphology of the cells is discussed later but in brief the
organelles are swollen; the integrity of the cell disrupted and the microvilli lost but there
are no morphological features of apoptosis (Mayhew, Myklebust et al. 1999).
Subsequently the cell either splits and releases the cells contents into the intestinal lumen
or loses contact with the neighbouring cells and is shed completely leaving a defect in the
epithelial monolayer. IELs are believed to target the effete cells which when shed result in
defects in the epithelial barrier (Mayhew, Myklebustet al. 1999).
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1.2.3. The role of non-epithelial cells in effete cell loss
Some models of effete epithelial cell loss from the mammalian intestine utilise different
non-epithelial cells in a variety of roles. As might be expected theseroles are similar in a
number of models and some models do not require any additional help other than that
provided by the epithelia themselves. Thefirst models involved extrusion of whole cells
which did not directly involve intra-epithelial lymphocytes or macrophagesand differ from
the latter three models. However Watson’s model utilises an impermeable plug, the
producerof whichis not discussed and mayinvolvefibroblastic activity.
1.2.3.1. Intra-epithelial lymphocytes
These are one of the most abundantcells in the intestine and a wealth ofliterature exists
regarding their role and involvementin cell shedding. The majority of lymphocytesin the
intestine are T-cells and consist of two distinct populations: the intra-epithelial lymphocyte
(IEL) and lamina propria lymphocytes (LPLs). Lymphocytes are segregated according to
their T-cell receptors (TCRs) which are either y6 or af. The proportion of lymphocytes of
each TCR vary betweenthespecies and type of lymphocyte such that 33% of IELs in the
human intestine are y6 compared with 5% of LPLs. Howeverin the murineintestine T cells
have equal numbersof yé and af (Nanno,Shiohara et al. 2007). Different subgroups of the
yd TCR are tissue specific (y7 in the intestine) and have been postulated to allow targeting
of tissue specific antigens and may serve a role in identification of effete epithelia (Nanno,
Shiohara et al. 2007). The epithelial monolayer, in addition to functioning as a barrier, also
acts as antigen presenting cells to intra-epithelial lymphocytes and communication has
already been demonstrated whereby IELs alter the barrier function or epithelial
differentiation state (Dahan, Roth-Walteret al. 2007).
The proportion of IELs to IECs vary according to species, region of intestine and position on
the villus (Mayhew, Myklebust et al. 1999). The apical portion of the villus is the optimum
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site to sample luminal contents and this is thought to be the reason whythere are greater
numbersof IELs present. Howeverthe full effect of their function as antigen presenting
cells at this site and the combined effect of the luminal constituents they are exposed to
are not known and mayinduce effete cells to be shed. Howeverit seemslogical that IELs
which induce effete cell loss (figure 1.6) must have a specific stimulus since they are
frequently presentat the villus tip (in the murine epithelial monolayerat a rate of 1 IEL/3-5
IEC and in the humanup to 40 IELs/100 IECs in the jejunum and 20-25 IELs/100 IECs in the
ileum) and specificity of acting on a single cell would imply a local origin. (Chang, Mahadeva
et al. 2005; Macdonald and Monteleone 2005).
Figure 1.6. Humanintra-epithelial lymphocytes (green arrows) original magnification
x40; A. Haematoxylin and Eosin stain, B Immuno-histochemistry with antibody against
CD45 (human leucocyte antigen) with lymphocyte located below cell in the process of
being shed (yellow arrow). Bar 15m.
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1.2.3.1.1. Human
The cavities below shedding cells are frequently occupied by IELs. However as discussed
previously these IELs are frequently present at the tip of the villus; they do not appear to
have granules and hence appearto lack perforin or granzyme (Shibahara, Sato et al. 1995).
ThusIELs are thought unlikely to be solely responsible for effete cell loss (Shibahara, Sato et
al. 1995). Diseases which cause an influx of IELs in to the mucosa result in abnormal villus
architecture and blunting (presumed secondary to increased epithelial shedding); the
commonest cause ofa rise in IEL numbersis following an acuteviral illness (temporary) but
coeliac disease, food protein intolerance, tropical sprue and Crohn’s disease cause more
prolonged elevations (Chang, Mahadevaet al. 2005).
1.2.3.1.2. Rat
Thereis little data regarding IEL association with shedding in the rat intestine. The rat
extrudes whole cells and the IELs are perforin negative and have short cell processes which
are not thought to have a direct role in cell shedding (Iwanaga, Han et al. 1994; lwanaga,
Hoshi et al. 1994).
1.2.3.1.3. Guinea Pig
NumerousIELs are presentin thevillus tips in greater numbers compared to the rest of the
villus and their Golgi apparatus is more developed in the perinuclear region but there is
relatively less rough endoplasmic reticulum (Han, lwanaga et al. 1993). They extend
processes that interdigitate with IECs and macrophages (Han, Iwanaga et al. 1993). The
interaction with macrophages and epithelial cells and the more developed Golgi apparatus
implies IELs have a keyrole in cell shedding in this species.
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1.2.3.1.4. Reindeerandseal
The effete reindeer and seal IECs are shed following cell shrinkage, thought to be targeted
in a mechanism similar to the guinea pig by IELs and the residual material following cell
shrinkage phagocytosed by macrophages howeverthere are relatively few macrophagesin
these animals compared to the guinea pig (Mayhew, Myklebust et al. 1998) (Myklebust and
Mayhew 1998). The IELs have also been shownto contact both effete and healthy IECs
(Myklebust and Mayhew 1998).
1.2.3.2. Lamina propria macrophages
Thesecells are able to remove particles smaller than 2um (not cleared by physiochemical
mechanisms) by phagocytosis and act as antigen presenting cells (Nanno, Shiohara etal.
2007). Their number, size and location differ in the intestine between species which will in
part be due to the method and frequency of cell shedding; models requiring cell
phagocytosis obviously require more macrophages(Holman J. 1975; Sawicki, Kucharczyk et
al. 1977; lwanaga, Hanet al. 1994; Ilwanaga, Hoshi et al. 1994; Shibahara, Sato et al. 1995;
Suzuki, Mori et al. 1997). Han demonstrated in the guinea pig more and larger
macrophages; located in the sub-epithelial layer (as opposed to the lateral sides of the
central lacteal) in the upperthird of the villus, in addition to stronger acid phosphatase and
cathepsin B reactivities (Han, lwanaga et al. 1993). They are arranged tightly together with
a polygonal appearance and epithelioid arrangement, extending pseudopodia deep to the
epithelial layer and occasionally actually located between IECs (Han, Ilwanagaetal. 1993).
The cytoplasm has numerous lysosomes, phagosomes and residual bodies which Han
demonstrates (using 5-bromodeoxy-uridine) are of epithelial origin by performing serial
histological sections and following the life course of an IEC which by day 4 was
phagocytosed (Han, Ilwanagaet al. 1993).
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There are greater numbers, size and activity of macrophages in the lamina propria of
guinea pigs (effete cells are known to be phagocytosed) compared to human or mouse
which seldom have macrophages seen associated with shedding events (Sawicki,
Kucharczyk et al. 1977; lwanaga, Han et al. 1994; lwanaga, Hoshi et al. 1994; Shibahara,
Sato et al. 1995). Yet there is evidence that macrophages remove effete human colonic
IECs. Hall demonstrates apoptotic bodies being removed from the colon by macrophages
and similarly in melanosis coli; a condition of where macrophages become laden with
lipofuscin (a pigment secondary to phagocytosis of effete cells) following excessive laxative
use, commonly anthraquinolones (Hall, Coates et al. 1994; Barkla and Gibson 1999). Rat
macrophagesare relatively less active in terms of phagocytosis compared with the guinea
pig (Ilwanaga, Han et al. 1994; lwanaga, Hoshiet al. 1994). Lamina propria macrophages
have also been demonstrated to phagocytosefibroblasts, IELs but most commonly IECs
(Sawicki, Kucharczyk et al. 1977; Han, lwanaga et al. 1993).
1.2.3.3. Neutrophils
These cells are predominantly involved in wound healing as opposed to cell shedding. They
are sometimes perceived as detrimental but are useful in sterilising epithelial breaches
contaminated with bacteria, secrete prostaglandins and have negative feedback with
endothelial and tissue cells (Blikslager, Moeser et al. 2007). They also supply AMP which
liberates adenosine and in turn results in chloride secretion from IECs (IEC flush- important
for TJ repair) (Blikslager, Moeser et al. 2007). Adenosine also binds the Az, receptor on
neutrophils reducing migration, degranulation and production of O, reactive intermediates
(negative feedback) (Blikslager, Moeser et al. 2007). Even when dead they continue to help
when their phagocytosis by macrophages produces resolvins and proteins reducing
neutrophil accumulation (Blikslager, Moeseret al. 2007).
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1.2.4. Morphology of sheddingcells
Prior to cells being shed they have been reported to have a variety of morphologies
depending on the mechanism ofeffete cell loss.
1.2.4.1. Extrusion of entire cells
Potten and Allen (1977) described the surface morphology of effete cells at an early stage
of shedding in the murine small intestine as having a micro-vesicular appearance amongst
and within the micro-villi (Potten and Allen 1977). Electron microscopic images
demonstrated these cells having longer micro-villi than their neighbours and describe the
‘closing ranks’ of neighbours around theeffete cell (Potten and Allen 1977). Further TEM
studies have shownthat IECs near the tip lack basal cytoplasm and contain numerousclear
and autophagic (dense material/membranous structures) vacuoles in the cytoplasm
(Shibahara, Sato et al. 1995). The cell extends thin cytoplasmic processes into the basal
lamina but no blebbing structures are seen at the basolateral or intercellular spaces and
the nucleus appears intact (but irregular/round with dispersed chromatin) (Shibahara, Sato
et al. 1995). As extruding cells become increasingly apoptotic they initially become convex
and then polyp like with splayed microvilli, during which the cell may show morphological
signs of apoptosis (nuclear chromatin and cytoplasmic condensation) which have been
absent to this point (Potten and Allen 1977; Madara 1990; Shibahara, Sato et al. 1995;
Mayhew, Myklebust et al. 1999; Watson, Chu et al. 2005; Bullen, Forrest et al. 2006).
Contact is maintained with adjacent cells through TJCstill late in the process of shedding
(Shibahara, Sato et al. 1995). Neighbouring cells are seen extending processes beneath the
sheddingcell (Shibahara, Sato et al. 1995). Cells at the late stage of shedding are extremely
fragile and easily lost with the minimal trauma produced by washing a specimen which may
account for the gaps seen in Potten and Allen’s micrographs (Potten and Allen 1977;
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Shibahara, Sato et al. 1995; Bullen, Forrest et al. 2006). Examination of small intestinal
washings found 85% of exfoliated cells were epithelial (Hall, Coates et al. 1994).
1.2.4.2. Extrusion of apical cell fragments secondary to phagocytosis of effete
cells
The fragmented cells retrieved from the guinea-pig intestinal lumen have microvilli twice
the length of unshedcells, consistent with findings in other models prior to shedding (Han,
lwanagaet al. 1993). In this modelit is only the apical membrane remnantsthat are shed.
1.2.4.3. Extrusion of apical cell fragments with effete cell shrinkage
Effete cells are thinner with dense nuclei and later develop thicker microvilli of variable
lengths often longer and matted togetheror occasionally no microvilli at all (Myklebust and
Mayhew 1998). The apical cell membraneis concave secondaryto cell shrinkage and the
cellular adhesion from lateral membraneinter-digitations is weakened by the expanded
processes of neighbouring cells (Myklebust and Mayhew 1998). The cell develops an hour-
glass shape which subsequently appears mushroom-shaped as the middle portion of the
cell splits to allow the neighbouring cells lamellipodia to make contact and the apical
remnantis held in place by TJCs (Myklebust and Mayhew 1998).
1.2.4.4. Cell swelling prior to loss
In the swollen effete epithelial cell model the microvillus morphology changes at an early
stage with a disrupted and vesiculated brush border (Myklebust and Mayhew 1998;
Mayhew, Myklebust et al. 1999). The apical cell border is convex with the distendedcell
bulging towards the lumen (Myklebust and Mayhew 1998). Finally cells have lost their
microvilli, organelles swell and disintegrate, nuclei become thinner with less electron dense
and more granular heterochromatin culminating in a breakdown in cellular integrity
(Myklebust and Mayhew 1998). The cell apex may detach allowing its content to flow into
the intestinal lumen with a defect resulting (Myklebust and Mayhew 1998). The majority of
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cells affected are individual but occasionally small groups of 2-3 cells are affected (Watson
1995; Myklebust and Mayhew 1998). If the apex of the cell fails to detach the whole cell
may be lost (Myklebust and Mayhew 1998).
1.2.5. Previous departmental work regarding the extrusion of entire
cells with the production of an impermeable substance
Previous studies performed in our department demonstrated defects (termed gaps) in the
murine intestinal epithelial monolayer associated with shedding. They were published in
Gastroenterology (Watson A.J., et al., Epithelial barrier function in vivo is sustained despite
gaps in epithelial layers. Gastroenterology, 2005. 129(3): p. 902-12.) and are discussed
below (images are used with the authors’ permission). Mice were examined using confocal
microscopy, a modification of an established procedure. Anaesthetized mice underwenta
laparotomy and exteriorization of a segment of small bowel opened along the anti-
mesenteric border. The live animal was placed in a custom built chamberwith a circulating
water bath at 37°C on a two photon microscope. This apparatus allowed imaging of the
luminal surface of the intestine using a combination of confocal and two photon
microscopy at depths from 20-50um below thevillus tip.
1.2.5.1. The epithelial monolayer contains discontinuities
Figure 1.7 showsthetip of a murinevillus with IECs fluorescing (due to cytosolic NADPH)in
response to two photon excitation except in two areas marked by arrows in image A.
Image B demonstrates that the defects in the monolayer reflect 720 nm laser-light,
indicating they are filled with a reflective substance and image C is an overlay- cytosol
autofluorescenceis green andreflected laser light red.
1.2.5.2. Gaps in the monolayerdo not contain cellular material.
Intra-peritoneal injection of Hoechst 33258 allowed visualisation of the nuclei of IECs
(figure 1.7 image D). —Bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein acetoxymethy!
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ester (BCECF) application (figure 1.7 image E) directly to the mucosal surface allowed
identification of cytosol. Figure 1.7 images D and E demonstrate the monolayer with an
area devoid of nuclei and cytosol the size of a single IEC (yellow arrow). Confocal
reflectance (Image F) shows the defect to contain reflected material highlighted by the
overlay (image G) where nuclei are blue, cytosol green andreflectedlight red.
Figure 1.7 A. Autofluorescence of intestinal epithelial cytosol, B. confocal reflectance of
intestinal epithelial cells, C. Overlay of images A and B. D. Nuclear fluorescence with
Hoechst DNAstain, E. Cytosolic BCECF fluorescence, F. Confocal reflectance, G. Overlay of
images D, E and F. Bar = 20pm (from Watson A.J., et al., Epithelial barrier function in vivo
is sustained despite gapsin epithelial layers. Gastroenterology, 2005. 129(3): p. 902-12.)
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Transgenic mice with an endogenous fluorescent protein (YC3.0 transgenic calcium
chameleon mice) have a similar appearance. Nuclei are seen to fluoresce in response to
Hoechst (figure 1.8 image H) and cytosol fluoresces (figure 1.8 image I). However
discontinuities exist in the epithelial monolayerthe size of a single cell (arrow), filled with a
reflective material (figure 1.8 image J). The overlay (figure 1.8 image K) with nuclei blue,
cytosol green and reflected material red best shows the defect with an absence ofcellular
material.
Figure 1.8 images L to O show another gap (yellow arrow) in the monolayer. Application of
a nuclear stain (Hoechst 33258) shows the gap to be devoid of nuclear material (figure 1.8
image L) and application to the mucosal surface of 1,1’-dilinoleyl-3,3,3’,3’,-
tetramethylindocarbocyanine, 4-chlorobenzenesulfonate (Dil)-a dye specific to the cell
membrane(figure 1.8 image M) demonstrates that membraneis absent at these sites. The
defect is again filled with a reflective material which is shown on image N. The overview
(figure 1.8 image O) with nuclei staining blue, cytosol green and reflective material red,
emphasises the gap (arrow) has a lack of cellular constituents but is filled with a reflective
substance.
In summary Watsonet al demonstrate discontinuities in the murine epithelial monolayer
which are devoid of nuclear, cytoplasmic and membranous material and therefore are not
cellular. Howevertheyare filled with a reflective material.
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Figure 1.8. Images from transgenic YC3.0 calcium chameleon mice; H. nuclear
fluorescence, |. cytosolic CFP fluorescence, J. Confocal reflectance and K overlay of H, |
and K. L Nuclear fluorescence with Hoechst, M. membraneDil fluorescence, N. confocal
reflectance, O. Overview. Bar = 204m (from Watson A.J., et al., Epithelial barrier function
in vivo is sustained despite gaps in epithelial layers. Gastroenterology, 2005. 129(3): p.
902-12.)
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1.2.5.3. Quantification of Gaps in the Monolayer
Image A in figure 1.9 gives a 3 dimensional view of the villus tip (from above and views
from two sides at right angles to each other). The cross hairs are centred on a gap
(identified by the lack of a nucleus, cytosol and size of approximately 10um).
The graphin figure 1.9 image B showsthe percentage of gaps in the monolayer(as defined
previously) compared to the number of IECs present. Watson et al show the average
length of a murine small intestinal villus is 350m + 22um. Hence the uppermost 20% was
assessed and within this region 3% of the cell positions have gaps withlittle variability over
the 70um studies.
Figure 1.9 image C is an overlay image from YC3.0 transgenic calcium chameleon mice;
cytosolic auto-fluorescence is green and reflected light red. Gaps are highlighted by the
yellow arrows and indicate a variety of sized and shaped discontinuities in the monolayer.
Concerned that goblet cells might have been mistaken for the gaps in the monolayer,
formalin fixed sections were stained with a mixture of two mucin stains (alcian blue and
periodic acid Schiff). Goblet cells stained positively (red arrows). However the
discontinuities (yellow arrows) did not.
In summary Watsonet al identified a constant rate (3%) of gaps in the apical 20% of the
villus of varying sizes and shapes. The frequency of these gapsis less than that of goblet
cells and the absence of mucin staining indicates they are not incorrectly identified goblet
cells.
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Figure 1.9 A. Chameleon transgenic mouse stained with Hoechst 33258, nuclei blue and
cytosol fluorescence green. View from above shownin the crosshairs and confirmed two
vertical views at right angles (green and red axes) are shownin green and red boxes.B.
Percentage of epithelial cell positions lacking cells, as a function of distance from villus
tip. Serial optical sections at 1-um intervals 0-70 um from villus tip with cell positions
visualized by nuclear staining and confocal reflectance. Gaps defined as a region ~10 pm
in diameterin the x, y and z axis with absent nucleus (Hoechst 33258 stain) and cytosol
(assayed by cytosolic BCECF, autofluorescence, or CFP). Thirty-twovilli counted from 10
mice. C. View from above of villus cells of chameleon transgenic mouse; demonstrates
variability in diameters and angularity of the margin ofcell-free zones (yellow arrows)vs.
epithelial cells (green: fluorescent protein; red: reflectance). (D) Formalin-fixed sections
of mouse tissue. ABPAS mucins stain positively distinguishes goblet cells (red arrows)
from gaps (yellow arrow). (from Watson A.J., et al., Epithelial barrier function in vivo is
sustained despite gapsin epithelial layers. Gastroenterology, 2005. 129(3): p. 902-12.)
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1.2.5.4, Permeability associated with gaps in the monolayer
To assess if these defects in the monolayer resulted in areas of permeability, villi were
bathed in an impermeable dye, Lucifer Yellow (figure 1.10 images A and E). Discontinuities
wereidentified by the use of Hoechst to locate absent nuclei (figure 1.10 images C and F)
and confocal reflectance was assessed to ensure defects contained the reflective material
(images figure 1.10 B and G). The majority of nuclear gaps (97%) did not allow Lucifer
yellow to permeate as indicated in image A by the yellow arrow. Howeverin 3% of cases
Lucifer yellow permeated (figure 1.10 image A, yellow arrow head) but never beyond the
lower limit of adjacent nuclei.
Watsonetal also identified cells with a nucleus located moreapically than its neighbours
(figure 1.10 image G-arrow head); these appearto becells in the process of being shed.
The monolayer appearedpartially compromised at the shedding events as Lucifer Yellow
permeated beneath the sheddingcell (figure 1.10 image G) although not beyond thelevel
of neighbouring nuclei. 45% (5/11) of regions with Lucifer Yellow permeation were
associated with shedding events. The absence of permeation deeper than neighbouring
nuclei is assumedto indicate the reflective material is performing a role as a barrier.
In summary gaps are generally not associted with permeable regions of the monolayer.In
a minority (3%) dye permeates a short distance. However a material within the defect
prevents further passage of dye. The areas of increased permeation are associated with
shedding events in 45% ofcases.
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Figure 1.10 Images of the murine villus with the addition of luminal Lucifer Yellow
{images A and E), confocal reflectance (B and F), addition of Hoechst 33258 (images C and
G) and overlay (images D and H). Bar = 20m (from Watson A.J., et al., Epithelial barrier
function in vivo is sustained despite gaps in epithelial layers. Gastroenterology, 2005.
129(3): p. 902-12.)
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1.2.5.5. Gaps in the monolayerprevent movementof extracellular fluid
Intravenous injection of a fluorescent dextran allowed visualisation of the extracellular
spaces upto thetight junctions (figure 1.11 images A, C, D, E) and wheninjected in mice
expressing a cytosolic fluorescent protein (YC3.0 transgenic calcium chameleon mice)
allowed the identification of discontinuities in the monolayer. The overlay image (figure
1.11 images B, F, G and H) clearly shows extra-cellular fluid (red) and the cytosol (green).
The gaps (asterix) in the monolayer are devoid of colour having neither extracellular fluid
nor cellular components. The extra-cellular fluid in neighbouring cells is seen to flow up to
the presumedsite of the tight junctions located apically. However at the gap the fluid up
to the height of neighbouring nuclei but no further. This demonstrates that although gaps
appear not to contain anything on these images, the contents of the gap must prevent
movement from submucosa to lumen and when viewed in conjunction with figure 1.10
prevent movement from lumen to submucosa.
1.2.5.6. Rate of cell shedding in the murine small intestine
Using Hoechst stained villi Watson et al took serial time-lapsed images (1-3 mins) in
anaesthetized mice (figure 1.12 image A). Cells were shed (figure 1.12 image B upper
graph) at a speed of 0.83 + 0.06um/minute (n=53 cells) but this occurred at apparently
random times. The resulting defects in the monolayer were not completely filled by
neighbouring cells for up to 60 minutes. The lower graph measures nuclear intensity (a
function of apoptosis; greater nuclear condensation results in higher DNA intensity) of
shedding cells. The shedding cells did not appear to have significant nuclear condensation
comparedwith luminal cells. Haematoxylin and eosin (H&E) staining of fixed tissue concurs
with this as cells in late stages of shedding have nuclear condensation or fragmentation
(figure 1.12 images C-E).
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Figure 1.11 YC3.0 calcium chameleon mice injected with intravenous fluorescent dextran
distributed to extra-cellular fluid. Images A, C, D, E dextran fluorescence and imagesB,
F,G, H overlay with dextran red and CFP fluorescence green. An astrix indicates a
discontinuity in the epithelium, an arrowhead indicated the basal pole and an arrow
indicates the apical pole. (from Watson A.J., et al., Epithelial barrier function in vivo is
sustained despite gapsin epithelial layers. Gastroenterology, 2005. 129(3): p. 902-12.)
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Figure 1.12 A. Time lapsed images of a Hoechststained cell being shed (arrow). B. Upper
graphis the inter-nuclear distance between cells in the process of shedding and their
static neighbours. Lower graph showsthe nuclear fluorescence intensity over the same
time course. Formalin fixed murine intestinal epithelial cells being shed from the villus
stained with H&E (C), mucin stain (D) and humanintestinal epithelium stained with H&E
(E). The inset image in D indicates a positively staining goblet cell (red arrow). Bar =
20um. (from Watson A.J., et al., Epithelial barrier function in vivo is sustained despite
gapsin epithelial layers. Gastroenterology, 2005. 129(3): p. 902-12.)
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1.2.5.7. Whatis the relationship of apoptosis with cell shedding?
PhiPhiLux (PPL), a fluorogenic substrate for caspase-3 like activities allows the detection of
active caspase-3 (a downstream activator of apoptosis) in live cells. Watson et al assessed
the relationship of cytosolic caspase-3 activity with cell shedding using PPL. Figure 1.13
shows villi immersed in PPL which confirmed shed cells (arrow head) had nuclear
condensation (bright with Hoechst-image A’) and caspase-3 activity (bright with PPL-image
A’); PPL was noted to be fluorescent hence backgroundactivity. The majority of cells
(10/12) in the process of shedding (arrow)failed to show caspase-3 activity. A minority of
cells (2/12) demonstrated caspase-3 activity and nuclear condensation(figure 1.13 images
D-G) which is interpreted as being due to caspase-3 activity being late in the apoptotic
pathway and consequently rarely expressed prior to shedding.
In summary caspase-3 is a late product in apoptotic cascades and appears chronologically
to occur at a similar time period to chromatin condensation and nuclear fragmentation.
The majority of shedding cells appear not to show evidenceofits activation whilst in the
process of being shed. However shed luminal cells stain for caspase-3 activity and have
condensed chromatin.
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Figure 1.13 Time course studies of tissues stained with Hoechst 33258 and exposed to
10pmol/L PhiPhiLux in the luminal fluid. A” PhiPhiLux fluorescence; A’ nuclear
fluorescence of Hoechst 33258-stained DNA; An overlay of images A” and A’. Nuclei with
condensed chromatin (A’, arrowhead) are in the lumen, surrounded by brighter
PhiPhiLux (A”). (B and C) Overlay images collected 2 and 5 minutes later. The arrow
indicates a cell being shed but remaining PhiPhiLux negative (A—C). (D-G) Time course of
shedding for 1 cell (at arrow) with PhiPhiLux-positive cytoplasm. (from Watson A.J., et
al., Epithelial barrier function in vivo is sustained despite gaps in epithelial layers.
Gastroenterology, 2005. 129(3): p. 902-12.)
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1.3. Crypt-Villus Homeostasis
The epithelial monolayeris a sheetof cells linked at their apical borders by tight junctions
and movesslowly from crypt baseto villus tip. New cells arise in the lower third of each
crypt as a productofdivision of stem cells or of the transit cell population. These join the
monolayer to be lost near the villus tip (Heath 1996). The small intestine contains an
estimated 1.1 million crypts, each of which contain approximately 250 cells and of these
150 are rapidly dividing (Hermiston, Wong et al. 1996). Four to eight crypts supply each
villus with an estimated 2000-8000 cells (depending on site in the small intestine); crypt
transit times have been estimated at 3.1 days in the duodenum,3.8 days in the jejunum
and 3.2 daysin the ileum crypts (Cheng and Leblond 1974; Hermiston, Wongetal. 1996).
The migration time from crypt mouthtovillus tip reduces from 41 hours in the duodenum
to 31 hours mid intestine and 16 hours in the terminal ileum (Leblond, Clermont et al.
1967).
1.3.1. Stem Cells
Crypt length is a balance of proliferation and migration (Carriere 1966). The crypts of the
small intestine were previously thought to contain 4-16 actual stem cells located at the
4/5" position (from the bottom of the crypt). However recent studies by Barker et al have
identified a Wnt targeting gene product Lgr5 (leucine-rich-repeat-containing G-protein-
coupled receptor 5) which found that stem cells lie at the crypt base in the small intestine
and colon; a concept first proposed by Bjerknes and Cheng (Bjerknes and Cheng 1981;
Potten and Loeffler 1990; Barker, van Es et al. 2007).
A variety of authors report great variability between species with from 0.4% to 60% of the
crypt being termed stem cells (variability being dependent on the criteria used to define
‘stemness’: the more stringent the criteria the less cells found). The previously accepted
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theory (described by Potten) was of 4-8 stem cells in each small intestinal crypt with a
single stem cell’s progeny supplying the crypt and associated villus with cells of four
lineages. A transit population exists in the crypt consisting of progressively more
differentiated cells; a group of these cells (30-40) remain in a state of quiescence but
should the normal mechanism ofcell production become disturbed they can take on the
role of stem cells (Bjerknes and Cheng 1981; Potten and Loeffler 1990; Kirkwood 2004;
Sancho, Batlle et al. 2004; Leedham,Brittan et al. 2005; Radtke and Clevers 2005; Barker,
van Es et al. 2007).
Division occurs in greater numbersvertically than transversely such that the daughters of
dividing cells rise up the crypt (Potten and Loeffler 1987). Stem cells are preserved near
the crypt base (but still undergo approximately 1000 cell divisions in the mouse and in
excess of 30 000 in the human). Their daughter cells rise up the crypt and enterthe ‘transit
population’ which is thought to numberfour generations with each successive generation
rising higher up the crypt; being more differentiated and less likely to divide (Kirkwood
2004; Leedham,Brittan et al. 2005). As cells reach the cryptvillus axis they are mature IECs
and no longer divide (Kirkwood 2004; Leedham,Brittan et al. 2005).
Of the 250 cells in each small intestinal crypt, approximately, 2/3 (150-160) pass rapidly
through the cell cycle and result in the villus claiming 300 cells per day (Bjerknes and Cheng
1981; Potten and Loeffler 1990). Potten calculated that cells exit the crypt at a rate of 0.75
positions/hr, given the crypt diameteris around 16 cells, this equates to 12 cells per hour
or 288 cells per day (Potten and Loeffler 1990). From this data he also estimated that
approximately 1400 cells supply each villus per day (given 6-10 crypts supply each villus)
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(Potten and Loeffler 1990). The turnover time (time to replace the populationofcells) is
estimated to be 2.1-3.3 days in the duodenum and 2.4- 4.4 days in the jejunum with
maximal mitosis occurring in the mid crypt positions (Cheng and Leblond 1974).
Cell Cycle: The total length of the cell cycle in human IECsis reported between 12 hours and
2 days. S-phase is about 10 hours (15-20% of IECs are believed to be involved in DNA
synthesis at any one time), G2 1-6 hours and M phase about 1 hour (Eastwood 1977)
(Sancho,Batlle et al. 2004) . Potten describes 10% of IECs being in S-phase (220 cells) and
0.4% in mitosis (9 cells) (Potten, Kellett et al. 1992).
IEC proliferation is reduced by adrenalectomy, uraemia, irradiation, methotrexate, B
adrenergic stimulation, sympathectomy, cAMP (through inhibition of DNA synthesis),
exclusion from alimentation, fasting, marasmus and kwashikor, hydrocortisone and
ethanol. Ulcers show lower rates of renewal (this may be a consequence rather than an
effect) and absence of y5 T cells (may be due to reduced lamina propria cellularity or
related to Vy7" y6 IELs/lymphocytes) (Chang 1971; Eastwood 1977; Nanno,Shioharaetal.
2007).
The cell cycle is shortened according to the site of the intestine (shorter in distal small
intestine than proximal and proximal shorter than distal colon), the age of the individual
(increases with age), following intestinal resection, with low doses of serotonin (inhibitory
in high doses), excess growth hormone, thyroxine, testosterone, a adrenergic stimulation
or B blockade and diseases such as coeliac disease (cell renewal cycle % the normal
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duration and increased proliferation) or gastroenteritis (Carriere 1966; Eastwood 1977;
Leblond 1981; Kirkwood 2004).
1.3.2. Intestinal Epithelial Cell Migration
Migration from crypt to villus tip occurs over 5-6 days in the proximal humanintestine and
3 days in the distal ileum. The velocity of cell movement decreaseswith heightin the crypt
and typically migrate 1-2 cell positions per hour (a few cells have been demonstrated to
persist for a few weeks) or at an estimated 5-10 pum/h (Heath 1996; Gordon, Hooperetal.
1997).
With a wealth of information regarding transit times on the crypt andvillus it is surprising
that so little is known regarding the mechanism of this migration. Does the same method
occur in thecryptasin the villus? Puromycin (a protein synthesis inhibitor) stops migration
of crypt cells but only slightly inhibits villus cell migration (Heath 1996). There are four
potential methods of migration consisting of basement membrane (BM) flow, mitotic
pressure, active movement and a co-operative model (Heath 1996).
1.3.2.1. Basement membraneflow
The possibility that the BM or basal lamina moves passively upwards displacing the
overlying epithelium seems unlikely given the lamina is thin (50-100nm) and frequently
punctured by IEC protrusions, dendritic cells and leucocytes (Heath 1996). The lamina
seemsunlikely to be strong enoughto pull the IECs. However the lamina may have the
almost opposite role, as a lubricant to enable cells to slide if pressure is present from cells
lower down the crypt-villus axis. The use of anti-laminin antibodies to follow BM
movement clearly demonstrated no gross movement (Heath 1996). The impact
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myofibroblasts have on IEC migration is not known but noradrenaline (a potent inhibitor of
smooth muscle contraction) prevents movementofvillus IECs (Heath 1996).
1.3.2.2. Mitotic pressure
The effect of mitosis on migration is unclear. Logic suggests that in the crypt the rapidly
dividing cells exert pressure on their compatriots and if the crypt shape is maintained
would result in a greater proportion of the pressure being transmitted upward. The crypt
shape is maintained by the pericryptal sheath but is this secondary to proteinaceous
material or myofibroblast contracture? Transit times are also quicker in the villus; which
many crypts supply but may not have the same amountof pressure. The argument for
mitotic pressure playing a pivotal role is strengthened by the migration rate being identical
to the rate of cell division in the crypt (Heath 1996). Howeveragainst mitosis being the
driving force for cell movementis that following irradiation movement occurs by shrinkage
of the crypt size and inhibitors of protein synthesis and protein glycosylation inhibit cell
movement(Potten and Loeffler 1987).
1.3.2.3. Active movement
Other cells within the body are known to moveutilising the actin cytoskeleton such as
fibroblast, keratinocytes and neutrophils. Fibroblasts use pseudopodia (lamellipodia and
filopodia), extensions of the cell margin driven by the polymerisation of actin subunits onto
existing long actin filaments or meshwork of short F-actin. Adhesions at sites of contact
with lamellipodia and substratum allow tension to develop on actin meshwork and hence
contractureresults in cell movement (Heath 1996).
The tight junctions present at the apical margins of IECs regularly contract in response to
defects in the epithelial monolayer and cell shedding (Heath 1996). The pursestring
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contracture is thought to be responsible for many of the changesin the rapidly developing
embryo (Heath 1996). Howeverthe tension created by their contracture could dissipate
quickly through surrounding cells. However there is some evidence from cell culture
models that this may occur (Heath 1996). These models demonstrate that IECs at a wound
edge closely resemble fibroblasts in their pattern of adhesions and cytoskeletal
organisation (Heath 1996). Gastric, small intestinal and colonic epithelial cells are seen
becomingflatter and extending lamellipodia at areas of denudation in both crypt andvillus
(Heath 1996).
1.3.2.4. The co-operative model
This model is as the name suggests combinesall three potential methods of epithelial
migration described above. It utilises IEC division, the strength of the bonds joining the
monolayer in addition to the effects of the basal and apical cytoskeleton plus the
mesenchymal cells (Heath 1996).
1.3.3. Rates of cell shedding
Various authors have attempted to estimate the rates of intestinal epithelial cells shed
from a villus. Potten estimated 1400 cells migrate to each villus per day and was thefirst to
use a computer modelof stem andtransit cell division. He assumedsix crypts supply each
villus with a constant supply of 250 cells per day (Potten and Loeffler 1990). Hall has
comparedthis to his own data which estimated 960-1200 apoptotic bodies per day. He
implied from that figure approximately 1000 cells per day was an accurate approximation
but assumed the majority if not all cells entering the villus undergo apoptosis (Hall, Coates
et al. 1994). Hall found 8 apoptotic bodies per crypt per hour and compared them to the
documented 2.7-8.8 cells produced in each crypt per hour (Hall, Coates et al. 1994).
Shibahara commented on 6.8+4.5 cells (mean +standard deviation) protruding from the
villus on SEM (non-rinsed) (Shibahara, Sato et al. 1995). Using other modalities such as
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TUNEL staining, apoptotic cells occur not only at the villus tip but also near the tip; the
incidence of which was 28.9+14.3 (mean +standard deviation) cells. Some of these
positively staining cells had no morphological evidence of apoptosis (Shibahara, Satoetal.
1995). Intestinal epithelial cell shedding is no doubt a frequent event. All the authors
mentioned above had the difficulty of viewing a three dimensional event in fixed tissue.
The unknownduration and relationship of apoptosis with shedding in the humanintestine
increases the difficulty observing and quantifying this four dimensional event. This may
only be resolved with the timelyarrival of confocal endoscopy.
1.4. The fate of effete cells
The destiny of aging cells is not a random, chaotic process as was once thought but an
ordered event. Theintestinal villi are a careful balance of proliferation and loss. There is a
constantinflux of cells from crypts; cell loss must be precisely controlled to avoid dramatic
changesin villus length (Hall, Coates et al. 1994; Watson 1995). IECs at the endoftheir life
are potentially removed via a number of mechanisms; they either undergo apoptosis,
necrosis, phagocytosis or are shed and these mechanism are not necessarily mutually
exclusive (Strater, Koretz et al. 1995). Necrosis is a passive event but phagocytosis and
apoptosis are energy dependentprocesses (Watson 1995). The fate of these senescent IECs
is a source of controversy which is centred around the chronological order of detachment
of the IEC from the basement membrane and their subsequent modality of demise.
1.4.1. Necrosis
Necrosis is characterised morphologically by dilatation of organelles (mitochondria and
endoplasmic reticulum), flocculation of chromatin and cellular swelling which eventually
results in rupture of the various componentsofthe cell including its membrane (Watson
1995). Necrosis occurs in response to toxins, cytolysins, hypoxia, ischaemia or dramatic
temperature changes (Watson 1995). Reactive oxygen metabolites are a particularly well
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documented causeof necrosis and knownto causeelevated cytosolic calcium, cytoskeletal
destabilisation, peroxidation of membranelipids, proteolysis, increased cell volume and
membrane damage (Watson 1995). As described earlier, apoptosis is energy dependant
and necrosis is independent; in fact depletion of ATP is a major feature of necrosis (Watson
1995). There is scanty evidence for necrosis occurring in the large intestine. A single
author commented on IEC necrosis in the colonic crypts (basal third) but the majority of
authors reported apoptosis not necrosis occured in the intestine (Barkla and Gibson 1999).
1.4.2. Apoptosis
Also termed ‘programmed cell death’, this normal physiological process of cell self-
destruction may be initiated by the presence or removal of stimuli/supressors and is
utilised by the organism to remove excess or un-required cells during embryogenesis or
phasesof tissue growth (Kerr, Wyllie et al. 1972). Potentially harmful cells with damaged
DNAandthosein excess or with potentially deleterious effects (immune cells without self-
tolerance) are removed (Liang and Fesik 1997; Watson 2004). Distinct morphological
changes characterizing apoptosis were recognized as early as the nineteenth century.
Sequential changes occur within the cell: discrete clumping and condensation of the
chromatin, margination of condensed chromatin at the nuclear membrane (crescent
formation), dissolution of the nuclear membrane, cytoskeletal disruption, membrane
blebbing, cell shrinkage with loss of mitochondrial function (described as pyknotic or
chromatolytic), loss of cohesion with neighboring cells and breaking apart of the highly
condensed nucleus into fragments surrounded by a small rim of cytoplasm and plasma
membrane, the so-called apoptotic bodies (Watson 1995; Liang and Fesik 1997;
Stadelmann and Lassmann 2000; Watson 2004). The process of apoptosis is active and in
the later stages unstoppable, resulting in nuclear and structural degradation in estimated
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times varying from one to four hours (Hall, Coates et al. 1994; Strater, Koretz et al. 1995;
Thornberry and Lazebnik 1998).
A leap in the understanding of this process was the discovery that the nematode worm
Caenorhabditis elegans required activation of the genes ced-3 and ced-4 for apoptosis to
proceed and that ced-9 prevented cell death (Shaham and Horvitz 1996; Thornberry and
Lazebnik 1998; Watson 2004). Ced-3 is a homologue of mammalian proteases-the caspase
family discussed below. Thefinal phase of apoptosis, destruction of the cellular remnants
has been termed ‘secondary necrosis’ but is unrelated to necrosis.
1.4.2.1. Caspases
These are a family of cysteine proteases homologous in structure to interleukin-1B-
converting enzyme,classified from 1 to 10 andutilising a cysteine neucleophile to cleave
aspartate motifs (necessary for DNA repair and cell integrity) (Liang and Fesik 1997;
Grossmann, Maxsonetal. 1998; Thornberry and Lazebnik 1998; Watson 2004). Members
of the caspase family are important in apoptosis and are classified according to their
function: the apoptosis initiators (caspase 2, 8, 9, and 10) and the apoptosis executioners
(caspase 3, 6, and 7) (Grossmann, Maxsonet al. 1998; Watson 2004). Caspase1 and 11
function predominantly as cytokine processors (Grossmann, Maxsonet al. 1998).
The effector or executioner caspases (caspase 3, 6 and 7) are produced in inactive
zymogens which mustbeactivated to function. They are activated byinitiator caspases
(caspase 8 and 10), the initiator caspases mayalso activate themselves (Watson 2004). The
effector caspases produce the morphological effects of apoptosis but there is a
considerable delay between caspase activation and visible apoptosis (Watson 1995;
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Watson 2004). Caspase 3 is formed by cleavage of pro-caspase 3 by caspase (extrinsinic)
or caspase 9 (intrinsic-discussed later) (Grossmann, Maxson et al. 1998; Thornberry and
Lazebnik 1998; Watson 2004). Caspases produce their effects by removing proteins which
prevent harm tothecell; for example inhibitor of caspase-activated deoxyribonuclease (I?
)/DFF45 prevents DNA fragmentation by caspase-activated deoxyribonuclease (CAD) by
complexing with it (Thornberry and Lazebnik 1998; Watson 2004). In its active form,
caspase 3 plays a role in the proteolytic cleavage of many key proteins, such as the nuclear
DNArepair enzyme poly (ADP-ribose) polymerase and |“? which promotestheactivation of
DNA-cleaving CAD thus allowing DNA fragmentation (Grossmann, Maxsonet al. 1998;
Thornberry and Lazebnik 1998; Watson 2004). Caspases cleave structural regulator
proteins to produce continual activity (Thornberry and Lazebnik 1998; Watson 2004). The
Bcl-2 family of proteins consist of both pro and anti-apoptotic (discussed later). The anti-
apoptotic members are survival promoting proteins which are attacked by caspases
(discussedlater).
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Figure 1.14. A schematic of the internal and external apoptotic pathways; red arrows
indicate the death ligand receptor pathway and green arrows indicate the cytolytic
effector cell pathway. The death ligand receptor pathwayinvolvesactivation by ligands
of the Tumour Necrosis Factor (TNF) family or Fas which induce intermediate proteins to
bind to the Fas associated Death Domain (FADD). FADD recruits pro-caspase 8 which
when activated either directly activates caspase 3 or indirectly activates it through
activation of caspase 9. Caspase 9 activation amplifies the response to caspase 3 which
once activated is irreversible. Caspase 3 cleaves the inhibitor of caspase-activated
deoxyribonuclease (ICAD) resulting in unrestricted deoxyribonuclease activity and DNA
fragmentation. The intrinsic pathway utilizes Bax or Bak to create permeability in the
mitochondrial membraneallowing cytochromeC to escape and activate the apoptosome-
APAF-1 complex which results in caspase 9 activation. Caspase 9 activation then follows
the commonpathwaydescribed above.
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1.4.2.2. The Extrinsic Pathway
On the cell membraneare a series of receptors which can be activated by ligands such as
Apo2/TRAIL and CD95/FAS-L. Activation of the death receptor Fas (APO-1/CD95) and other
members of the tumour necrosis factor (TNF) receptor family induce a series of
intermediate proteins (including FADD/Mort1 and RIP) which bind to the death receptor
(Fas-associated death domain-FADD) (Liang and Fesik 1997; Grossmann, Maxsonetal.
1998; Stadelmann and Lassmann 2000; Watson 2004). The domain does not act as an
enzyme but brings aboutits activity through protein-protein interaction (Liang and Fesik
1997). In addition to the death domain, FADD also contains a death effector domain,
whichis essential for the induction of apoptosis (Liang and Fesik 1997). Termed the death
inducing signaling complex, procaspase 8 is recruited and autocatalytically activated.
Caspase 8 in association with caspase 10 (can also autocatalytically activate) cleave and
thereby activate the effector caspases 3, 6 and 7. At which point the extrinsic pathway
converges on theintrinsic pathway (Wang, Chunetal. 2001).
Cells which utilize the extrinsic pathway are divided into two groupsthose in which Bcl-2
does not prevent Fas-induced apoptosis (eg. thymocytes) and those in which bcl-2 blocks
Fas-induced apoptosis (eg. hepatocytes).
The additional activation of the mitochondrial (intrinsic) pathway acts to create an
amplification loop, important because caspase is not able to activate effector caspases to
the extent that they kill the cell solely due to its efforts (Watson 2004). Apoptosis and
proliferation are activated by the TNF receptor with the predominant effect being
secondary to the amount of nuclear factor kB (NFkB) activation (Micheau and Tschopp
2003). Beyond a requisite amount of NFkBtranscriptional activity, the inhibitory protein c-
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FLIP is transactivated and this inhibits caspase 8 thus allowing cell survival but inadequate
NFkB activation leads to caspase 8 mediated apoptosis (Micheau and Tschopp 2003).
1.4.2.3. The Bcl-2 gene family
The Bcl-2 gene wasinitially identified as an oncogene, over-expressed in human B-cell
lymphomaasa result of chromosomal translocations (Liang and Fesik 1997). It suppresses
apoptosis but other membersofits family induce apoptosis and they may antagonize each
other(Liang and Fesik 1997). This family of proteins controls release of cytochrome C from
mitochondria (part of the intrinsic pathway) (Watson 2004). The membersof the Bcl family
have four potential Bcl homologous (BH) domains whichare essential for their function.
1.4.2.3.1._ The anti-apoptotic members:Bcl-2, bcl-XL, and bcl-w have four BH domains
each (Liang and Fesik 1997; Watson 2004). Bcl-2 and Bcl-XL inhibit apoptosis primarily,
although not exclusively, by sequestering BH-3 molecules, thereby preventing activation of
Bax and Bak (Watson 2004). This arrangement of molecules is the same as in C elegans
where the BH3 homologueegl-1 serves to inhibit the multidomain ced-9 molecule (Watson
2004). Other inhibitors outside the bcl-2 family are mcl-1, the family of inhibitors of
apoptosis protein (IAP) and apoptosis suppressors e.g. neuronal inhibitor of apoptosis
protein, X-linked inhibitor of apoptosis protein, survivin, c-IAP1, c-IAP2, viral anti-apoptotic
proteins, p35 and heat shock protein 70 (Stadelmann and Lassmann 2000). Bcl-2 is
expressed in large quantities at the colonic crypt base but is undetectable at the luminal
surface and noneis expressed in the small intestine of man or mouse (Grossmann, Maxson
et al. 1998).
1.4,2.3.2._ The pro-apoptotic members: Bad, bid and bim contain only the BH-3 domain
(Stadelmann and Lassmann 2000; Watson 2004). Bax and Bak contain multiple BH domains
and act as gatewaysto theintrinsic pathway (Watson 2004). Bax moves from cytosol to
the mitochondrial outer membranein responseto death signals and bak is activated where
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it resides on the mitochondrial membrane (Watson 2004). In unison their activation results
in cytochrome C being released from the inter-membrane space of the mitochondria. Bak
has the inverse relationship to bc/-2 being present on the colonic luminal surface epithelial
cells in large quantities and has been proposed as a stimulus for effete cell loss
(Grossmann, Maxsonetal. 1998; Pritchard, Potten et al. 1999; Duckworth and Pritchard
2009).
1.4.2.4. The intrinsic Pathway
The genes of the Bcl-2 pathway comprise the functional stages of what is known as the
intrinsic or mitochondrial apoptotic pathway in mammals (Grossmann, Maxsonetal. 1998;
Pritchard, Potten et al. 1999; Watson 2004). This is activated in response to damaging
processes within the cell; either from stress, DNA damage, hypoxia, loss of survival factors,
detachment from the basement membraneoranerror of the cell cycle and as described
above is mediated by the mitochondria. In the healthy state the mitochondria is an even
balance of pro-apoptotic and anti-apoptotic actions of the Bcl-2 family. However when
stressed too severely Bax or Bak create permeability in the mitochondrial membrane
allowing cytochrome C or SMAC/DIABLOto escape and activate a protein complex called
the apoptosome-APAF-1 which in turn activates caspase 9. The apoptosomeis formed by
the union of APAF-1 with procaspase 9 and cytochrome c (Acehan,Jiang et al. 2002;
Watson 2004). The union occurs through binding of caspase recruitment domains in both
APAF-1 and caspase 9 (Acehan, Jiang et al. 2002; Watson 2004). Caspase 9 then activates
the commonpathwaycaspases3, 6 and 7 (Grossmann, Maxsonetal. 1998; Watson 2004).
1.4.2.5 Anoikis
Anoikis is a form of apoptosis induced by detachment of anchorage-dependentcells from
their basement membrane. Effete IECs undergo either apoptosis or necrosis as presented
in the models earlier but this is not a question of one or the other occurring in a specific
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species; both have been witnessed in the same specimens (Proskuryakov, Konoplyannikov
et al. 2003). Apoptosis occurs within minutes of mesenteric ischaemia and detachmentof
cells from the basement membrane (BM) induces apoptosis (anoikis) (do Vale, Costa-
Ramoset al. 2007). The debate is whether in the normal intestine apoptosis is induced by
or induces detachment from the BM. The twoare linked and chronologically very close
together which meansit is hard to discern which pre-empts the other. The length of delay
between apoptotic enzyme activation and morphological features appearing is not known
but the delay is short. Late apoptotic cells are identified with the TUNEL technique and are
thought to be positive for less than 60 minutes. The majority of cells retrieved from a
normal human duodenal lumen are morphologically apoptotic and positive on TUNEL
staining. However someare negative, consistent with anoikis (Shibahara, Sato et al. 1995).
It has been proposed surface colonic IECs break their loose attachments to the BM prior to
apoptosis secondary to pressure from dividing cells below (Barkla and Gibson 1999; Gibson
2004). Howeverin-situ apoptosis is thought to result from chromosomal mutations (these
are episodic within the crypt). Luminal agents are knownto betoxic such as bile acids and
haem which reduce IEC lifespan. Luminal constituents are toxic themselves: the short chain
fatty acid butyrate is a strong inhibitor of the histone deacetylase family of enzymes
(luminal concentration of butyrate 20mM or greater) (Lapre, De Vries et al. 1993; Sesink,
Termontet al. 1999)Lapre, De Vries et al. 1993; Sesink, Termontet al. 1999).
There are few studies which demonstrate anoikis occurring in-vivo but those that do have
the problem that agents causing the cells to detach may also cause apoptosis. Do Vale
assessed anoikis in vivo using pasturellosis in fish (the sea bass and sea bream IECs
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resemble those of mammals) as the agent to inducecell loss. Howeverthis pathogenalso
induces apoptosis of macrophages and neutrophils (due to the apoptogenic exotoxin
AIP56). Consequently the detached cells may have been apoptotic prior to detachment
(do Vale, Costa-Ramos et al. 2007). In late acute pasteurellosis large numbers of IECs
detached from the BM apparently secondary to exotoxin release rather than direct
infection (do Vale, Costa-Ramos et al. 2007). Some of the detached cells display
morphological features of apoptosis (shrunken, roundedcells with chromatin condensation
and nuclear fragmentation) but others appeared healthy (do Vale, Costa-Ramos etal.
2007). SomeIECs were lost in sheets and initially broke contact with their neighbours (over
10-20 mins); followed by rounding, the length of their brush borders increased (up to 4.5
times normal) and eventually became disorganised (do Vale, Costa-Ramos et al. 2007).
Whilst still in sheets, nuclear condensation and fragmentation occurred in a minority but
passage throughto secondary necrosis wasrelatively rapid (20-30min from separation) (do
Vale, Costa-Ramoset al. 2007). Interestingly do Vale commentsthat an early feature was
swelling of mitochondria with rupture of the outer membranein a minority and cristal
reduction (size and number) prior to other morphological features. Hence there may be
someconfusion morphologically between necrosis and apoptosis (do Vale, Costa-Ramoset
al. 2007).
1.4.3. Phagocytosis
Wehavealready discussed the two models of effete cell loss which involve phagocytosis
popularised by lwanaga and also Myklebust and Mayhew(see 1.2.2.2.1-2) (Iwanaga, Han et
al. 1993; lwanaga, Han et al. 1994; lwanaga, Han et al. 1994; lwanaga, Hoshiet al. 1994;
Iwanaga, Hoshiet al. 1994; lwanaga 1995; Myklebust and Mayhew 1998). Strater describes
two formsof cell death in colonic mucosa. The colonic epithelial cells undergo apoptosis
but are either extruded from the monolayer or phagocytosed by neighbouring epithelial
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cells (Strater, Koretz et al. 1995). The second methodofeffete IEC loss was observed in the
human colon. Howeverhis observation that apoptotic bodies were within adjacent IECs
seems potentially flawed because apoptotic bodies adjacent to a cell membrane in the
plane of section would appear to be within the cell. Strater hypothesised that the rapid
clearance of apoptotic cells though phagocytosis, their uptake by adjacentcells, the erratic
nature of apoptosis and the short duration of the process (a few hours) are reasons why
relatively small numbers of apoptotic IECs are seen (Strater, Koretz et al. 1995; Stadelmann
and Lassmann 2000).
The most convincing paper to show evidence of phagocytosis within the human colon was
by Barkla (using immunohistochemmistry and electron microscopy) who observed
apoptotic bodies, flowing ‘on a current of fluid’ through the lamina propria, to be
phagocytosed by macrophages(Barkla and Gibson 1999). However he comments that his
technique used minimal trauma to obtain specimens but they were colonic biopsies and
Our personal experience with duodenal biopsies is that they sustain considerable trauma.
Hence this declaration that no shedding cells were seen in the specimens begs the
question: had helost all shedding cells with trauma? Additionally he is the only author to
report necrosis occurring in the colon which might be a result of a poor technique of
specimencollection. In summarylittle evidence exists for phagocytosis occurring to a large
degree in the human intestine butit is certainly a vital componentofeffete cell loss in the
guinea pig, horse, monkey and reindeer (Han, Ilwanaga et al. 1993; Han, Ilwanagaetal.
1993; Iwanaga, Han et al. 1993; Ilwanaga, Han et al. 1994; lwanaga 1995; Takahashi-
Iwanaga, Iwanaga et al. 1995; Suzuki, Mori et al. 1997; Myklebust and Mayhew 1998;
Mayhew, Myklebust et al. 1999)
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1.4.4. Morphology of Effete Intestinal Epithelial Cells
Colonic IECs close to crypt mouths are observedas regular,flat cells whereas those distant
to the mouth(possibly effete) are rounded and irregular (Barkla and Gibson 1999). Cells on
the tips of villi have been demonstrated to exhibit fragmentation of their DNA which
implies apoptotic mechanismsare initiated prior to detachment from their neighbours.
Howeverlate morphological features of apoptosis are seldom seen in the monolayer
(Strater, Koretz et al. 1995). An important morphological feature of effete IECs is
elongation of microvilli which has been documented across species (guinea pig, sea bass,
mouse and human); lwanaga assessed guinea pig IECs and found theincrease in length
associated with imminent loss of 1513 nm + 89nm compared to normal lengths of 920 +
46nm andin luminal fragments of 1784 + 89 nm (Iwanaga, Hanet al. 1993) (Potten and
Allen 1977; Bullen, Forrest et al. 2006; do Vale, Costa-Ramoset al. 2007). Apoptotic bodies
are frequently found in or below the BM and between enterocytes of the stomach, small
intestine and colon (some of which were within macrophages) (Hall, Coates et al. 1994).
The frequencyin the small intestinal monolayer of apoptotic bodies was reported by Hall as
0.905 per villus and in the lamina propria adjacent to the BM at a frequency of 0.213 per
villus (both are more frequent towardsthe villus tip) (Hall, Coates et al. 1994). In the colon
apoptotic bodies occurred in the monolayer at a frequency of 0.74 per crypt and in the
lamina propria at 0.245 per crypt (Hall, Coates et al. 1994).
1.5. The Epithelial Barrier
The IEC monolayer forms the first of many barriers that maintain a relatively stable
environment by separating the vast ocean of imbibed food, drink, pharmacological agents
and commensal and pathogenic bacteria (10°"-10"* bacteria per gram of stool) from the
lamina propria containing legions of lymphocytes (Abreu, Fukata et al. 2005; Macdonald
and Monteleone 2005; Mumy and McCormick 2005; Siccardi, Turner et al. 2005). The
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monolayeris a wall of IECs connected to each otherby tight junctions with dendritic cells
and lymphocytes episodically projecting through to sample luminal contents without
creating breaches in the monolayer (Macdonald and Monteleone 2005;Siccardi, Turner et
al. 2005). If luminal organisms were to provoke a response the result would be perpetual
inflammation (Mumy and McCormick 2005).
Beyond the monolayeris a layer of glycoprotein knownasthe glycocalyx. It covers the IEC
microvilli and performs numerous proteolytic activities, forming a biochemical barrier at
the luminal surface of the intestine which degrades proteins and peptides (Siccardi, Turner
et al. 2005). The glycocalyx is covered by a mucus layer derived from goblet cells and
composed of mucin glycoproteins that provide a second physical barrier to the movement
of proteins and peptides (Siccardi, Turner et al. 2005).
The description above implies the monolayer is an impermeable, fixed structure. This is
not the case; relatively large molecules such as food proteins have been found in plasma
and intestinal bacteria in mesenteric lymph nodes of healthy animals (Macdonald and
Monteleone 2005). This is speculated to occur at points of cell shedding,follicle associated
epithelium or Peyer’s patches (Macdonald and Monteleone 2005; Siccardi, Turner et al.
2005). The monolayer interacts basally with the basement membrane and IECs move
apically from the crypt base, analogous to a chain of people holding hands; impenetrable
but malleable. The barrier is thought to be regulated jointly by IECs, dendritic cells and M
cells (all have the ability to present antigens to lymphocytes within the lamina propria)
(Abreu, Fukata et al. 2005; Mumy and McCormick 2005; Siccardi, Turner et al. 2005; Dahan,
Roth-Walteret al. 2007).
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1.5.1. Cell Junctions
The monolayer is similar to a highly selective sieve; able to change permeability with
location and physiological need. This is achieved through the intercellular junctions
(desmosomes, tight and adherens junctions). The most important is the tight junction
(Ivanov, Nusrat et al. 2004). The difficulty in assessing mucosal permeability following
effete cell loss is that the majority of mechanismsofcell injury result in inflammation but
normal physiological mechanisms such as cell shedding do not result in inflammation.
Consequently true information regarding sheddingis limited.
1.5.1.1.Tight Junctions (TJ)
Historically the TJ was thought to create a completely impermeable barrier. However
Duffy first demonstrated regulation of TJCs in the gall bladder by cAMP andtheassociation
of their reorganization results in barrier permeability (Duffey, Hainau et al. 1981).
The TJ is located at the IECs apical lateral border, just sub-apical to the brush border and
joins neighboring IECs. In addition to their role in the regulation of solute and
macromolecule diffusion (gate function) they polarise the epithelial cells into apical and
basal regions (Blikslager, Moeser et al. 2007). The IECs make continuous contact with cells
around their periphery resulting in a belt of TJCs surrounding the IEC. The TJC is composed
of integral proteins attached to cytoplasmic plaque proteins (Ivanov, Nusrat et al. 2004;
Blikslager, Moeser et al. 2007). The integral-membrane proteins (Claudins, Occludin and
Junctional Adhesion Molecules) interact with cytoplasmic plaque proteins (Zonula
Occludens-1,-2,-3, symplekin, lymphocytic leukaemia fusion-6 and cingulin) through their
cytoplasmic tails at specific domains (Bojarski, Weiske et al. 2004; Ivanov, Nusrat et al.
2004; Siccardi, Turner et al. 2005; Blikslager, Moeser et al. 2007). The claudins and
occludins N and C terminals are cytoplasmic and each has four transmembrane domains,
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resulting in two extracellular loops (Bojarski, Weiske et al. 2004). Claudins are involved in
the selective permeability (according to charge and size) of the TJ (Clayburgh, Shenetal.
2004). Of the 20 proteins in this group claudins 3 and 5 are expressed in both the rat
intestinal crypts andvilli but claudin 2 is limited to expression in the crypts and claudin 4
the villi (Blikslager, Moeseret al. 2007).
Figure 1.15. Tight junction formation between neighbouring intestinal epithelial cells.
      Basementmembrane     
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TJ modulation allows selective passage of substances. The only well documented model of
TJ permeability in normal physiology is that of binding glucose and Na* to SGLT-1 on the
apical membrane resulting in their flow through the TJ (Blikslager, Moeser et al. 2007).
Sodium-glucose co-transport has been demonstrated to occur via the TJ when the
transporter becomes saturated (Clayburgh, Shen et al. 2004). In rodent mucosa it is
associated with condensation of microfilaments within the peri-junctional actinomyosin
ring, suggesting actinomyosin contraction and driven by myosin light chain kinase (MLCK)
phosphorylation of myosin II regulatory light chain (Clayburgh, Shen et al. 2004). The
movement available to TJs occurs through contractile events involving MLCK mediated
contraction of the actinomysin peri-junctional ring interacts with claudin and occludin
proteins (TJ elements that establish the paracellular barrier) through a series of scaffolding
structures (Siccardi, Turner et al. 2005). Regulatory proteins have been localised to the TJ
that play active roles in formation, stabilization and down-regulation of functional TJ
structures (Siccardi, Turner et al. 2005).
A fluorescent construct of TJC proteins has demonstrated caveolae-mediated endocytosis
of occludin in response to TJ disruption (secondary to actin depolymerisation) indicating
occludin likely has a significant role in TJ homeostasis (Shen and Turner 2005).
1.5.1.2. The AdherensJunction (AJ)
In addition to TJ’s providing a barrier the AJ maintainscell-cell contact (Ivanov, Nusratet al.
2004). Similar to TJ’s the AJ has integral (E-cadherin) and cytoplasmic components(Ivanov,
Nusrat et al. 2004). E-cadherin binds calcium ions which results in a conformational
change.
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1.5.2. The Paracellular Space
This is a tortuous channel between neighbouring IECs which extends from the TJ apically to
the lamina propria basally. The most sensitive measure of barrier function is trans-
epithelial electrical resistance (TER). The TERis the flow of ions across the monolayer. The
TER accounts for resistance from the combination of IECs and the paracellular space
(Blikslager, Moeseret al. 2007). The largest componentof the TERis the paracellular route
(75-94% of total passive ion flow) and is best assessed by substances which only travel via
the paracellular route e.g. mannitol (Blikslager, Moeser et al. 2007). Type Il desmosomes
are attached to the membrane,their location and shape changes due to fluctuation of
membrane tone. The change in the desmosome’s location or shape thus alters TER
(Blikslager, Moeser et al. 2007). If the paracellular space exceeds the maximum width of
the tight junction the contribution of the intercellular space to paracellular resistance is
almost nothing (Blikslager, Moeseret al. 2007).
The paracellular space contributes 20-30% of TER compared to the TJs in normal tissues
(Blikslager, Moeser et al. 2007). Increased anion secretion results in increased TER and
collapse of lateral intercellular space in healthy and acutely injured tissues (Blikslager,
Moeser et al. 2007). The TJ and paracellular permeability are modulated by external
factors such as prostaglandins (PGs) which modulate ion transport and the short circuit
currentprior to recovery of TER (attributed to chloride ion secretion) (Blikslager, Moeseret
al. 2007). Initially PGs increase chloride flow but over the longer term inhibit the apical
Na+/H+ exchanger (NHE) (Blikslager, Moeser et al. 2007). This has been attributed to
chloride secretion and reduced concentration pulling water through the paracellular route,
reducing its size and hence increasing TER (Blikslager, Moeser et al. 2007). HoweverPI3K
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inhibition does notalter the size of chloride secretion but inhibits TER recovery and normal
mucosa-serosafluxes of mannitol and innulin (Blikslager, Moeseret al. 2007).
1.5.3. Breaking the bondsattachingepithelial cells to the monolayer
The historical concept of cell shedding was that the cells nearest the lumen becameless
adherent to the basement membrane and minor trauma from luminal contents fractured
the weak bonds attaching them (Gibson 2004). There is now evidence of an autonomous
fracture of adhesion molecules within IECs. IECs have been postulated to release proteases
such as urokinase or autolysosomes to remove the adhesion molecules. This seems
feasible given cathepsin B has been demonstrated in cytoplasmic vacuoles of IECs
(Shibahara, Sato et al. 1995; Gibson, Birchall et al. 1998).
1.5.3.1. The Role of Tight Junctions during Shedding
Madarafirst described the formation of TJCs at the basal aspects of the neighboursof a
shedding cell (Madara 1990). He described that TJ elements of the neighbouring cells were
still present apically (with thickening of the terminal web) but peri-junctional micro-villi
were lost and processes were extended alongside the shedding cell (Madara 1990). The
shedding cells were observed to haveproliferation of TJ) elements along the membrane of
the part of the cell still in the plane of its neighbours and the processes beneath the
shedding cells were identified as having TJ elements (Madara 1990). HoweverTJ proteins
have subsequently been demonstrated to be recruited to the apical lateral membrane
resulting in closure of the adjacent paracellular space (Blikslager, Moeser et al. 2007).
Reassembly of the TJ is paramount to restoring barrier function but Madara demonstrated
partial failure of paracellular resistance using penetration of horseradish peroxidase; this
penetrated into the paracellular space surrounding the extruding cells in 19 out of 36
shedding events (none showed complete penetration) (Madara 1990) (Blikslager, Moeser
et al. 2007). Similar studies in our department (discussed in 1.2.5.4.) demonstrated partial
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permeation of Lucifer Yellow associated with gaps in the epithelial monolayer. This
occurred in a minority (3%) of the gaps observed but in 45% of shedding events (Watson,
Chu et al. 2005). Madara believed this partial permeation was due to the TJC reforming
basally. However there is mounting evidence to support their restitution apically
(discussed later). Our department has demonstrated an acellular material filling defects
associated with shedding (see sections 1.2.5.1.-2.) (Madara 1990; Turner 2000; Watson,
Chu et al. 2005).
1.5.4. Recovery of Barrier Function Following Injury
Two mechanismsexist for closure of epithelial defects; the large defects (approximately
greater than 10 epithelial cells lost) necessitate lamellipodia-dependent epithelial
migration and small defects (loss of fewer than 10 epithelial cells) heal by a purse-string
contractureofactin filaments surrounding the defect (Russo, Florian et al. 2005).
1.5.4.1. Recovery of the monolayer following large defects in the monolayer
Recovery of barrier function following injury to the IEC monolayer encompasses the
movementofcells into a defect (restitution) and restoration of TJs and paracellular spaces.
The barrier provided by the IECs is significant but may be overwhelmed by substances
erroneously brought across the apical membranebyfacilitated transport mechanismse.g.
bacterial N-formyl-L-methionyl-L-leucyl-L-phenylalanine or substances which alter the
apical membranes structure e.g. Salmonella typhimurium which has a typeIII secretory
apparatus able to penetrate the apical membrane(Blikslager, Moeseret al. 2007).
Abreu assessedbarrier function of the IEC monolayer following apoptosis using the T84cell
line and induced apoptosis by Fas ligand binding (Abreu, Palladino et al. 2000). This
obviously has a trade off: using the cell line allowed microscopic and immuno-
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histochemical evaluation. However the use of the adenocarcinoma-derived cell line is a
less than perfect model for the human IEC monolayer and the degree of apoptosis
(quantified morphologically by nuclear staining and chromatin condensation) induced was
considerable (50% at 24 hours and 40% at 72 hours) (Abreu, Palladino et al. 2000).
Nevertheless, they demonstrated expression of Fas basolaterally and it induced apoptosis,
reduced TER and increased paracellular flux up to 4 times base-line flux and allowed
passage of molecules up to 3000 Daltons (Abreu, Palladino et al. 2000). In addition he
demonstrated TJs surrounding groups of cells which appeared to be excluding multiple
apoptotic cells and e-cadherin expression basolaterally in apoptotic cells versus laterally in
healthy cells, possibly representing two separate methodsof barrier function restitution
(Abreu, Palladino et al. 2000). Concurrent with these junctional mechanisms of barrier
restoration they also demonstrated spreading of healthy cells with corresponding
reductions in cell height and an increase in cell width to provide a cellular mechanism
(Abreu, Palladino et al. 2000).
Repair of large defects in the epithelial membrane encompasses three elements. Thefirst
is villus contraction. This reduces the surface area and occurs secondary to smooth muscle
contraction (Blikslager, Moeser et al. 2007). The initial contraction is due to enteric nerve
stimulation and immediate but sustained contraction occurs secondary to prostaglandin
release acting on longitudinal muscle. The sustained contraction lasts hours andis locally
regulated (Blikslager, Moeseret al. 2007). IECs have a cytoprotective effect by producing IL-
6, tumour necrosis factor and heat shock proteins and their involvement in woundrepair
appearto be linked to commensal flora (Mumy and McCormick 2005). Administration of
antibiotics to rid the murine intestine of its microflora resulted in failure of the IECs to
producethese vital factors (Mumy and McCormick 2005). The second phase is when IECs
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migrate (restitution) within minutes of a defect occurring; cells adjacent to the defect
extend membraneprojections across the defect and establish focal contacts at the edge
(lamellipodia) secondary to disassembly of microvilli (Blikslager, Moeser et al. 2007).
Lamellipodia are driven by the actin-myosin cytoskeleton (Blikslager, Moeseret al. 2007).
Thefinal phaseis closure of the paracellular space.
Blikslager believes the adherens junction (AJ) is repaired first. This stabilises the TJ and
serves as a regulatory site for recruitment of signalling molecules and TJ proteins
(Blikslager, Moeser et al. 2007). Initially the AJ forms during cell migration due to the
interaction of cytoskeletal proteins (incl. Nectins, B and a catenins and E-cadherin) and
gradually becomes a mature AJ (Blikslager, Moeser et al. 2007). With AJ formation
assembly of the TJ can commence, involving ZO-1 localisation to the apical lateral
membrane(ZO-1is critical to recruitment of integral proteins for the TJ) , JAM, claudin and
occludin recruitment finally resulting in restoration of TER (Blikslager, Moeseret al. 2007).
The key is the focal contacts between basement membrane andrestituting epithelium
(Blikslager, Moeser et al. 2007). Trans-membrane integrins are bound on the cytoplasmic
surface to a plaque of proteins with cytoskeletal filaments (Blikslager, Moeser et al. 2007).
These initiate diverse cellular pathways including focal adhesion kinase (FAK) (Blikslager,
Moeseret al. 2007).
72
Introduction
1.5.4.2. Epithelial Purse-string closure of small epithelial defects
Small defects in the monolayer (fewer than 10IECsin size) close utilising the contracture of
an actin ring which forms at the periphery of the wound. Thetension resulting from this
contracture is distributed across cells in the vicinity of the defect by the AJs (Danjo and
Gipson 1998). Phosphorylation of myosin light chains by MLCK results in actinomyosin
contraction and is consequently a key step in resolution of the defect. Rho kinase (ROCK)
also regulates MLC phosphorylation either by direct phosphorylation or inhibition ofits
phosphatase (Russo, Florian et al. 2005). The wound closure has two distinct phases:
assembly of the actin ring at the wound edge and then its contracture. Russo et al
eloquently demonstrate the temporal activity of the two enzymesin the closure of the
defect using a cell line which expressed a green fluorescent protein linked to B-actin. The
deficiency of using a cell line different to in-vivo studies is resolved to some degree by
identifying similar enzymeactivity in biopsies of human colon (Russo, Florian et al. 2005).
Unfortunately the biopsies were not from healthy individuals but diseased colon (ulcerative
colitis). However subsequent studies on normal intestine have shown similar results
(Bullen, Forrest et al. 2006).
The defect in the artificial monolayer is resolved in 30-45 minutes (Russo, Florian etal.
2005). Figure 16 showsa defect thesize of a single cell. Initially actin is deposited at the
wound edgewithin 2 minutes of the defect occurring, by 8 minutes a ring has formed and
the wound edges have rounded from tension secondary to the ring (Russo, Florian etal.
2005). Beyond 8 minutes the wound reducesin size rapidly with neighbouring cells also
flattening (Russo, Florian et al. 2005). Rhois initially localised to cell junctions prior to cell
loss. Howeverit rapidly localises to the wound edge(with and separate to actin) but when
contracture begins at approximately 8 minutes it has moved to the cytosol (Russo, Florian
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et al. 2005). In contrast ROCK is found randomly in discrete groups prior to the defect
developing, at 2 minutes small quantities are associated with the developing actin ring and
wound edge butat 8 minutesit is present in the cytosol and persists within the actin ring
but is absent at the wound edge (Russo, Florian et al. 2005). Russo demonstrates the
temporal relationship of these enzymes with the elements of the purse-string contracture
by inhibiting ROCK at two points in wound closure. Inhibition of ROCK concurrent with
woundingresulted in actin filamentsfailing to coalesce round the wound edge. The wound
did not contract andfilipodia (not normally seen) were present but failed to close the
defect (Russo, Florian et al. 2005). Inhibition of ROCK at 6 minutes after woundingdid not
alter wound closure. Hence rho and ROCK appearto beinvolved in assembly rather than
contracture of the actinomysin ring. However MLCK and phosphorylated MLC whichis
present in small quantities at the wound edge at 2 minutes increases to nearly
circumferentially cover the ring by 8 minutes. Inhibition of MLCK does not prevent the
actinomyosin ring forming. However woundsfailed to contract (Russo, Florian et al. 2005).
To corroborate this, biopsies from individuals with ulcerative colitis (a condition which
inducescell loss) demonstrated MLC phosphorylation at the marginsofcells neighbouring a
site of cell loss and has been confirmed by subsequent studies on normal small intestine
(Bullen, Forrest et al. 2006).
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Figure 1.16 Diagram showing the temporal relationship of actin deposition and activation
of rho, Rho Kinase (ROCK) and Myosin Light Chain Kinase (MLCK) in woundclosure.
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2.1. Definitions
Caspase Activity: The brown colouration caused by the secondary detection system must
affect the whole of an epithelial cell. Likewise a negative cell demonstrates no
discolouration.
Gap: The defect created in the epithelial monolayerby cell shedding.
Phosphorylated myosin light chain activity: The presence of secondary detection system
activity (brown colouration) nearthe cell membraneofepithelial cells bordering a shedding
event.
Shedding Event: The elevation of a nucleus and corresponding epithelial cell above the
level of its neighbouring cells and their nuclei. It was desirable but not essential to have
evidence of apoptosis (pyknosis or karyolysis of nuclei).
Villus: A protrusion of the epithelial monolayer (must have a visible connection to the
muscularis mucosae) the height of which was three or more times the width and on which
at least 50% ofthe cells were visible as a monolayer.
Zona Occludens-1 Activity: Pin-point secondary detection activity (brown discolouration)
at the apex of the epithelial-epithelial junctions consistent with the site of tight junctions
and a similar activity in the region of a shedding event.
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2.2. Tissue identification and retrieval
2.2.1. Murine tissue
All experiments were performed according to UK Home Office regulations and animals
used in the study weresacrificed humanely using cervical dislocation. Following death the
entire intestine was immediately resected and flushed with 0.9% saline to remove
macroscopic debris.
Immuno-histochemistry: Tissue used for immuno-histochemistry was from a six month old
male wild type mouse bred in the Duncan Building at the University of Liverpool, UK, kept
in standard conditions with 12 hour light/dark regimens and a standard pellet diet with free
access to water sacrificed at 10 am. The intestine was prepared as described above and cut
into 1cm pieces, stacked together within a loop of micropore tape (3M Bracknell, UK) and
cut into 4 smaller bundles of intestine. These bundles were placed in a standard pathology
cassette marked to identify the specimen and immersed in a solution of 10% neutral
buffered formaldehyde (BIOS Europe Ltd, Skelmersdale, UK) for 48 hours prior to paraffin
embedding. All tissue samples placed in a fixative in this study had a minimum volumeof
fixative to sample ratio of 10:1.
Electron Microscopy: Tissue used in electron microscopy was also kept in standard
conditions with 12 hours light/dark regimens with a standard pellet diet. The murine
intestine usedinitially to assess the method for electron microscopy was from a 16 week
old male wild type mouse bred at the Paterson Institute for Cancer Research, Manchester,
UK and sacrificed at 10 am. Animals were kept in standard conditions with 12 hour
light/dark regimens and a standard pellet diet with free access to water.
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Following resection as described above the intestine was laid on labelled reference card
and immersed in 0.9% saline to ensure the tissue remains moist. Making an anti-
mesenteric incision along the length of the intestine it was opened out and the entire
serosal surface waslaid flat on the card. Initially the intestine had been flushed with a
mucolytics solution (1mmol dithiotheotal) for 10 minutes but we found this made no
difference to the preparation and this was subsequently omitted. The card and bowel were
fixed in a 3% solution of glutaraldehyde in Sorensen’s solution for twenty four hours.
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2.2.2. Humantissue
2.2.2.1. Participant identification
Application for ethical approval (Appendix | & Il) was obtained for this study from Liverpool
(Adult) Local Research Ethics Committee (04/Q1505/135). The original approval ran for
one year and an extension was granted on subsequentreapplication. This study required
donation of small or large intestine from human participants undergoing intestinal
resections or those undergoing endoscopic duodenal biopsyaspart of their National Health
Service (NHS) treatment. Potential participants were identified from prospective
gastrointestinal surgery and endoscopy theatre lists at the Royal Liverpool University
Hospital. Participants were contactedprior to their procedurebythe principal investigator
and informed about the study. They were given the opportunity to answer any questions
and received a written information sheet regarding the study (Appendix Ill). After a
minimum of twenty-four hours candidates were contacted again and written consent
(appendix IV) obtained if they were agreeable to entering the study.
2.2.2.2. Endoscopic tissue retrieval
Retrieval of tissue from duodenal biopsies was performed with the consentofparticipants.
Tissue wasretrieved whilst participants underwent a gastroscopy and duodenal biopsy as
part of their NHS treatment. An additional biopsy was taken at the time of the endoscopic
duodenal biopsies. Tissue has a tendency to curl following excision due to contraction of
the muscularis mucosae. In an attempt to reducetissue distortion, biopsies were placed on
blotting paper with muscularis mucosae lying directly on the blotting paper. The blotting
paper and specimen were immediately placed in a 10% buffered formaldehydesolution for
48 hours and following this prepared as paraffin embedded blocks (described below).
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4um slices from each paraffin embedded duodenal biopsy were taken and stained with
haematoxylin and eosin (H&E) as described below. Examination of these sections revealed
small numbersofvilli with no shedding events visible but good tissue preservation. It was
felt that the small numberofvilli obtained with each biopsy and trauma the mucosa
sustained with each biopsy waslikely to yield too small a number of shedding events for
the effort required compared with surgical intestine retrieval and consequently this
methodofretrieval was not pursued.It did however demonstrate coeliac disease, a Clinical
condition which causesvillous atrophy.
Image 1.1 Duodenal biopsy with haematoxylin and eosin stained sections A. normal
mucosaandB.coeliac disease. Note the bluntedvilli. Magnification x10, bar 100m.
 
  
 
 
2.2.2.3. Operative Tissue Retrieval
Recent evidence suggests that shedding cells are loosely attached to the basal lamina of
the villus tip and even a minimum of trauma will result in their loss (Barkla and Gibson
1999). Participants had intestine resected using a standard surgical technique with the
exception that the vessels feeding the specimen were ligated and divided last. This
preserved vascularity to the last possible moment(image 2.2). The date of tissue resection,
age and sex of participants, reason for resection, duration of immersion in formaldehyde
and time to paraffin embedding is shown below (table 2.1).
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All tissue used was distant to the pathological lesion which had necessitated intestinal
resection. Tissue was then immediately placed in a solution of 10% neutral buffered
formaldehyde (BIOS Europe Ltd, Skelmersdale, UK) or a mixture of three parts methanol
and one partacetic acid for fixation. The formaldehyde solution was the standard fixative
but the methanol solution was used in those cases where minimal fixation was required
such as when identifying the basement membrane.
Image 2.2. Image of humancolon being resected. A key facet of our technique is the
ligation and division of vessels (labelled A) supplying the specimen to be performedlast.
This is a deviation from standard surgical practice and maintains vascularity until the
tissue is removed from the participant. The colon(labelled B) can be seen already divided
howeverthe feeding vessels arestill intact.
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Table 2.1. Table of participant age, sex, pathology of resected tissue, ischaemic time to
immersion in formaldehyde and paraffin embedding of specimens.
 
 
  
Specimen 28- 03- 07- 07- 14- 24- 24-
11 12 04 05 04 O6A O68
Sex (F=female, M=male) F F F M F M M
Age (yrs) 76 22 59 68 72 78 39
Condition (Ca = carcinoma, Ad= Ca Ad Ca DD Ca Ca Il
adenoma, DD= diverticular disease
andIl= ileostomy resected following
revision surgery)
Time to immersion in formaldehyde 3 3 4 8 5 2.5 10
(mins)
Time in formaldehyde to processing 77.5 25 27 78 27 24 26
(hours: mins)        
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2.3. Specimenfixation and paraffin embedding
A variety of different techniques of exposure to formaldehyde were used (shown below):
Intestine was incised along the anti-mesenteric border either completely, partially or left
untouched and immersed in formaldehyde. A further specimen sealed at one end using a
ligature and filled with formaldehyde following which the opposite end wasclosed using a
ligature and immersed in formaldehyde. Finally a segment of intestine received a full
length anti-mesenteric slit and was pinned opento a cork board and placed inverted within
formaldehyde. The intestinal segments were immersed in formaldehyde for twenty four to
seventy two hours. Following this they were sliced into 5mm segments and embeddedin
paraffin using a standard automated paraffin embedding process.
Figure 2.1 Different Methodsof Tissue Exposure to Formaldehyde, A: Direct immersion B:
Half length anti-mesenteric slit C: Ligation of intestine and inflation with formaldehydeD:
Full length anti-mesenteric slit E: Anti-mesenteric slit and pinned to cork board
 
  
84
 
Materials and Methods
2.4. Slide preparation andstaining
2.4.1. Slide preparation
4m sections were cut using a microtome,floated on to plain microscopeslides and placed
in an oven at 50°C overnight. Sections from eachslice of the paraffin embedded specimen
were stained with haematoxylin and eosin (described below) and assessed in terms of
preservation and numberof shedding eventsrelative to the numberofvilli present. A low
and high magnification digital image of any potential shedding event was taken.
The optimum method of tissue and shedding event preservation was found to be simple
immersion in formaldehyde. Segments longer than 10cm tended to have poor penetration
of formaldehyde to the middle of segments and consequently if the intestine was longerit
wasdivided into equal lengths. Latterly some samples were placed in a solution 3 parts
methanol and 1 part acetic acid termed modified meth-Carnoys solution for 24 hours prior
to paraffin fixation. Whenfixing in paraffin with modified meth-Carnoys the solution in the
embedding processor must be alcohol not formaldehyde.
2.5. Quantification of the numberof sheddingeventspervillus
All slides performed with all the techniques listed below were viewed under light
microscopy and the numberofvilli present in each tissue section quantified, using the
definition of a villus described previously. All shedding cells (definition above) associated
withvilli were counted. Initially a Professor of Gastroenterology, the principal investigator
and a Consultant Histopathologist reviewed the images and a consensus was agreedas to
whetherthese represented actual shedding events.
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2.6. Serial sections of shedding events
A block from the best preserved intestinal segment with the most shedding events had ten
serial 4um slices taken and stained with haematoxylin and eosin as described above. Each
slide was reviewed and digital images of shedding events taken at low and high power
magnification. The position of each event waslocated on slides before and afterthe slide
with the shedding event. A digital image was obtainedofall slides showing the shedding
event. The investigator, Professor of Gastroenterology and Consultant Histopathologist
reviewed the imagesofthe serial shedding events.
2.7. Quantification of shedding events associated with mucus
4um sections from paraffin embedded blocks were stained with either alcian blue or
periodic acid Schiff. Images of shedding events were obtained and reviewed by
investigator, Professor of Gastroenterology and Consultant Histopathologist. The presence
of either an intense blue colour with the alcian blue stain or a purple colour with periodic
acid Schiff associated with a shedding event wasinterpreted to be a positive result.
2.8. Special stains
 
2.8.1. De-waxing and hydrationof slides EquipmentandReagents
Slides were dewaxed in two separate containers of Paraffin sections on slides
xylene for 3 minutes 30 secondseach, then placed in ,Coplin jars
three containers of 100% ethanolfor thirty secondsin
Xylene
each andfinally rinsed in tap water.   
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2.8.2. Haematoxylin and eosin staining
Slides were dewaxed, rehydrated (described previously)
and immersed in Gill’s haematoxylin (Shandon
Scientific, Runcorn, UK) for five minutes. After an initial
washin cold running water for one minute to remove
the excess haematoxylin, slides were differentiated in
1% acid alcohol for 5 seconds, washed in waterfor a
further minute and blued in Scott’s tap water to
produce a blue nuclear stain. Following a further 1
minute wash in tap water, slides were immersed in
alcoholic eosin for thirty seconds and finally washed for
1-minute in tap water to produce the pink cytoplasmic
component. Using graded ethanol slides were
dehydrated and cleared with xylene (three 30 second
washes- ensuring the oily appearance has left the
slides), mounted with XAM (BDH Merk, Lutterworth,
UK) and cover slipped. The adequately stained section
should look similar to those shownin image 2.1.
 
 
Equipment and Reagents
Dewaxed and_ rehydrated
paraffin embeddedsections.
Coplin jar
Haematoxylin
1% acid alcohol (600mL
distilled water, 1400mL
ethanol, 20 mL Hydrochloric
acid)
Scott’s tap water (40g
magnesium sulphate, 7g
sodium bicarbonate, 2L tap
water and 2 crystals of thymol)
Eosin Y-alcoholic (0.4% eosin
(BDH Merck) and 70% ethanol)
Graded ethanol solutions
Xylene
XAM
Cover slips
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 2.8.3. Alcian blue (AB)
Equipmentand ReagentsDe-waxed and rehydrated slides (described
Dewaxed and_ rehydrated
previously) were washed in distilled water and
paraffin embeddedsections.
stained with 1% alcian blue in 3% acetic acid for 10
minutes. Following a washin running tap waterslides Coplin jar
were stained with neutral red for 30 seconds followed .Haematoxylin
by 1% aqueous neutral red for 30 seconds to 2
; oo, 1% Alcian Blue in 3% aceticminutes. Having been washed again with tap water
. acid pH 2.5slides were dehydrated through graded ethanol,
cleared with xylene (three 30 second washes- 0.2% aqueousneutral red
ensuring the oily appearance hasleft the slides) and
Graded ethanolsolutions
mounted with XAM (BDH Merk, Lutterworth, UK) and
cover slipped. Image 2.3 shows the negative control Xylene
(liver) and the positive control small intestine. Goblet XAM
cells can be seen to contain positively staining mucins
Cover slips   and the glycocalyx (the thin film surrounding the
villus) also stains positively. A cell can be seen leaving the villus tip in the same image.
 
 
 
 
Image 2.3 Alcian blue stained slides, A. liver negative control and B positive control-
humansmall intestine, note the shedding cell (arrow head) and the gobletcells (arrows).
Original magnification x 63, bar 25 um.
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2.8.4. Periodic acid Schiff (PAS)
De-waxed and rehydratedslides (described previously)
were washedin distilled water and treated with periodic
acid for 10 minutes. Following a washin distilled water
slides were treated with Schiff’s reagent for 10 minutes
and washedin running water for 10 minutes to develop
the pink colour. Next they were counter-stained lightly
in haematoxylin for 30 seconds, rinsed in tap water and
differentiated in acid/alcohol. After a further wash with
tap water they were allowed to “blue” in Scott’s tap
water substitute and the process completed by a wash
with tap water. Slides were dehydrated through graded
ethanol, cleared with xylene (three 30 second washes
ensuring the oily appearance has left the slides),
mounted with XAM (BDH Merk, Lutterworth, UK) and
cover slipped. Image 2.3 shows the positive control
(liver). Goblet cells contain the positively staining mucins
and the glycocalyx (the thin film surrounding the villus)
 
 
Equipmentand Reagents
Dewaxed and rehydrated
paraffin embeddedsections.
Coplin jar
Haematoxylin
1% Periodic Acid
Scott’s tap water (for
instructions see 2.8.2)
Schiff’s Reagent
Graded ethanol solutions
Xylene
XAM
Cover slips
can also be seento stain positively. A cell is seen leaving thevillus tip in the same image.
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Image 2.4 Periodic acid Schiff stained slides, A. liver positive control x 40 magnification
and B human small intestine. Note the shedding cell (arrow head) and the gobletcells
(arrows). Magnification x 20, bar 50 um.
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2.10. General principles of immuno-histochemistry
2.10.1. Blocking of endogenous
peroxidase
Paraffin sections to be stained with immuno-
histochemistry using the horseradish peroxidase
enzyme require blocking of the endogenous
peroxidases or the there may appear to be false
 
 
Equipmentand Reagents
De-waxed and
sections on slides
Coplin jars
Methanol-400mls
hydrated
 
activity. Dewaxed and rehydrated slides are immersed in a solution of methanol and
hydrogen peroxide (400mL methanol, 12mL hydrogen peroxide) for 12 minutes.
2.10.2. Antigen retrieval
Fixation and tissue processing may cause cross-linking of proteins necessary for antibody
recognition. Antigen retrieval reverses this process, allowing greater sensitivity of the
antibody. The two methodsof antigen retrieval frequently used are proteolytic enzyme
retrieval and high temperature antigen retrieval.
2.10.2.1. Proteolytic enzymeretrieval
Four hundred mililitres of pre-warmed TBS at 372 C
were placed in a trough with 0.4g of trypsin and 0.4g
of calcium chloride. The chemicals were mixed
immediately prior to use as the typsin’s activity
deteriorates the longer it has been activated. Having
ensured the reagents were dissolved, sections were
immersed in the solution for thirty minutes unless
otherwise stated and kept at 372 C. Following
 
 
Equipmentand Reagents
Re-hydrated and
sections on slides
Coplin jars
Oven
Trypsin- 0.4g
Calcium chloride- 0.4g
TBS pH7.4 — 400ml
blocked
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retrieval sections were washedin running tap water.
2.10.2.2. High temperature antigen retrieval
EDTA and sodium hydroxide were dissolved in 10L of
deionised water (stirred for approximately three
hours) and the pH broughtto 7 with sodium hydroxide
solution. Two litres of EDTA buffer were placed in a
pressure cooker loosely covered with a lid and heated
using a hot plate. Once the solution was boiling
vigorously, the slides in metal racks were lowered into
the liquid using heat resistant gloves. The lid was
sealed and the steam escape valve set at one dot.
Once the pressure indicator had risen, the cooker was
heated for three more minutes. After this the cooker
was removed from the heat and placed in a sink of
cold running tap water. Once the pressure indicator
had fallen, the slides were removed and placed
directly into cold running water (ENSURING THE
SLIDES DID NOT DRY-this would produce a heatartefact).
 
 
Equipment and Reagents
Re-hydrated and blocked
sections on slides
Metal Rackforslides
Pressure cooker
Hot plate
PH sensor
10mM Ethylenediamine-tetra-
acetic acid (EDTA)- 37.2g
Deionised water (10L)
3.2g Sodium Hydroxide
Heat resistant gloves  
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2.10.3. Counter-staining of immuno-
histochemistry
Following application of the primary antibody and
secondary detection system, slides were washed in
distilled water. Having immersed the slides in
haematoxylin for 30 seconds they were washed
thourghly in tap water for 5 minutes and dipped in
acid alcohol twenty times. Following a further wash
with tap water slides were immersed in Scott’s tap
water for 1 minute to blue the nuclei. Slides were
dehydrated through graded ethanol, cleared with
xylene (three 30 second washes- ensuring the oily
appearance had left the slides) and mounted with
XAM (BDH Merk, Lutterworth, UK) and cover slipped.
 
 
Equipmentand Reagents
Slides with primary antibody
and secondary detection
system
Metal Rackforslides
Coplin jars
Haematoxylin
Acid Alcohol
Scott’s tap water
Graded ethanol
Xylene
XAM
Cover slips  
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2.11. Studies using immunohistochemistry
2.11.1. Quantification of apoptosis associated with epithelial
shedding using cleaved caspase-3 (Asp175) antibody (Cell Signaling
Technology, Massachusetts, USA. Catalogue No. #9661)
Slides which had been de-waxed, rehydrated, and blocked underwent high temperature
antigen retrieval (described previously). Following antigen retrieval slides were washed
with de-ionised water. A 1:200 (0.3 tg/ml) solution of cleaved caspase-3 antibodyin ready-
to-use antibody diluent (Catalogue no. S0809, DakoCytomation, Ely, UK) was applied to
slides for 40 minutes at room temperature using a DakoCytomation autostainer. Following
a further wash with de-ionised water the DakoCytomation ChemMate EnVision Detection
kit (Catalogue no. K5007, DakoCytomation, Ely, UK) was applied for 20 minutes at room
temperature. After a final wash slides were counter stained and mounted (described
above). Negative control slides were standard slides with only antibody diluent applied
rather than antibody. Positive control slides were normal human tonsil. Slides were
examined and scored for caspaseactivity in IECs within the monolayer and for the presence
or absence of caspaseactivity in sheddingcells.
 Image2.5 Activated caspase-3
antibody applied to human
tonsil. Apoptotic lymphocytes
(green arrows) and apoptotic
(orange arrows) bodies are
indicated by the dark brown
stain. Original magnification
 
X63, bar 25um.
94
Materials and Methods
2.11.2. Location of the site of tight junctions associated with
intestinal epithelial cell shedding using an antibody against Zona
Occludens-1 (ZO-1)
Slides which had been de-waxed, rehydrated, and blocked underwentproteolytic enzyme
antigen retrieval as described above with the exception that the slides were placed in
trypsin for sixty minutes rather than the thirty minutes. Following antigen retrieval slides
were washed with de-ionised water. A 1 in 100 (2.5 wg/ml) solution of rabbit Zona
Occludens-1 antibody (catalogue no. 61-7300; Zymed Laboratories Inc., San Francisco, CA,
USA) in ready-to-use antibody diluent (Catalogue no. SO809, DakoCytomation, Ely, UK) was
applied to slides for 40 minutes at room temperature using a DakoCytomation autostainer.
Following a wash with de-ionised water the DakoCytomation ChemMate EnVision
Detection kit (Catalogue no. K5007, DakoCytomation, Ely, UK) was applied for 20 minutes
at room temperature. Slides received a final wash and were counter stained and mounted.
Negative control slides were standard slides with only antibody diluent applied rather than
antibody. Positive control slides were normal human intestine. 4um sections were stained
with a Zona Occludens-1 (ZO-1) antibody as described below. Slides were examined and
scored for ZO-1 activity (definition above) near shedding cells. These were divided into
those with activity in the upper or lowerhalf of the gap below the sheddingcell.
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Image 2.6 Human small intestine with rabbit ZO-1 antibody applied. Tight junctions are
demonstrated (small arrows) at the apical borders of IECs and a sheddingcell is evident
at thevillus tip (large arrow). Original magnification X63, bar 25m.
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2.11.3. Investigation of the mechanism of restitution of the epithelial
monolayer following cell shedding using an antibody against
phosphorylated myosin light chains (PMLC)
This technique required freshly cut 4um paraffin embedded tissue sections. Slides which
had been de-waxed, rehydrated, and blocked underwent high temperature antigen
retrieval (described previously). Following antigen retrieval slides were washed with de-
ionised water. A 1:80 (10 ug/ml) solution of antibody against PMLC (Donated by Professor
Turner; University of Chicago) in ready-to-use antibody diluent (Catalogue no. S0809,
DakoCytomation, Ely, UK) was applied to slides for 40 minutes at room temperature using a
DakoCytomation autostainer. After a wash with de-ionised water the DakoCytomation
ChemMate EnVision Detection kit (Catalogue no. K5007, DakoCytomation, Ely, UK) was
applied for 20 minutes at room temperature. Slides received a final wash and were
 counterstained and mounted
as described previously.
Negative control slides were
standard slides with antibody
diluent applied rather than
antibody. Image 2.6 contains
an endogenous positive  control with myofibroblasts  
 
staining positive.
Image 2.6 Human small intestine with an antibody against PMLC applied. A sheddingcell
is indicated by the large arrow and immunoreactivity is evident lateral to it (small black
arrow). Myofibroblasts, an endogenous control (green arrows) are seen beneath the
basement membrane, Original magnification X63, bar 25um.
97
Materials and Methods
2.11.4. Quantification of the association of shedding events with a
blood vessel using a monoclonal mouse anti-human CD34 class II
clone QBEnd 10 antibody (catalogue no. M 7165; DakoCytomation,
Ely, UK)
Slides which had been de-waxed, rehydrated, and blocked underwent high temperature
antigen retrieval (described previously). Following antigen retrieval slides were washed
with de-ionised water. A 1:50 (1ug/mL) solution of monoclonal mouse anti-human CD34
class Il clone QBEnd 10 antibody in general antibody diluent (Catalogue no. S0809,
DakoCytomation,Ely, UK) was applied to slides for 40 minutes at room temperature using a
DakoCytomation autostainer. Following a wash with de-ionised water the DakoCytomation
ChemMate EnVision Detection kit (Catalogue no. K5007, DakoCytomation, Ely, UK) was
applied for 20 minutes at room temperature. Finally slides received a further wash, were
counterstained and mounted (described previously). Negative control slides were standard
slides with only antibody diluent applied rather than antibody. Tonsil was used as a
positive control as it contains a large numberofeasily identifiable blood vessels.
A circle (diameter 1.5 cell lengths) centred on the assumed location of the nucleus of the
shedding cell prior to being shed was drawn on thedigital image and the area within the
circle examined for evidence of CD34 activity. As a control a cell 10 cell positions distant to
the shedding event either left or right was similarly examined and compared with thecell
undergoing shedding.
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Image 2.7 Human tonsil with an antibody against CD34 (endothelial marker) applied.
Blood vessels are positively stained, a few of which are highlighted by the arrows.
Original magnification X63, bar 25m.
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2.11.5. Quantification of the association of Shedding Events with
Lymphocytes using an antibody against CD45
Slides which had been de-waxed, rehydrated, and blocked underwent high temperature
antigen retrieval (described previously). Following antigen retrieval slides were washed
with de-ionised water. A 1:2000 (0.16ug/mL) solution of monoclonal mouse anti-human
CD45 clones 2b11 + PD7/26 antibody (catalogue no. M0701; DakoCytomation, Ely, UK) ina
5% solution of bovine serum albumin (Bovine albumin fraction V BDM prod 4415547) was
applied to slides for 40 minutes at room temperature using a DAKO autostainer. Following
a wash with de-ionised water the DakoCytomation ChemMate EnVision Detection kit
(Catalogue no. K5007, DakoCytomation, Ely, UK) was applied for 20 minutes at room
temperature. Finally slides received a further wash, were counterstained and mounted as
described previously. Negative control slides were standard slides with only antibody
diluent applied rather than antibody. Tonsil was used as a positive control due to thelarge
numberof leucocytes within the tissue;asillustrated in image 2.8.
Shedding events were located on slides stained with CD45 and digital images obtained. A
circle (diameter 1.5 cell lengths) centred on the assumedlocation of the nucleus of the
shedding cell prior to being shed was drawnonthedigital image and the area within the
circle examined for evidence of CD45activity. As a control a cell 10 cell positions distant to
the shedding event either left or right was similarly examined and compared with thecell
undergoing shedding.
100
Materials and Methods
 
Image 2.8 Human tonsil with an antibody against CD45 (common leucocyte antigen)
applied. The tonsil is tightly packed with leucocytes and they can be seenstaining
positively. Original magnification X63, bar 25um.
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2.11.6. Quantification of the association of shedding events with
macrophages/monocytes using monoclonal mouse anti-human
CD68 clone PG-M1 antibody (catalogue No. M_ 0876;
DakoCytomation,Ely, UK)
Slides which had been de-waxed, rehydrated, and blocked underwent high temperature
antigen retrieval (described previously). Following antigen retrieval slides were washed
with de-ionised water. A 1:200 (0.625ug/mL) solution of monoclonal mouse anti-human
CD68 clone PG-M1 antibody in general antibody diluent (Catalogue no. S0809,
DakoCytomation,Ely, UK) wasapplied to slides for 40 minutes at room temperatureusing a
DakoCytomation autostainer. Following a wash with de-ionised water the DakoCytomation
ChemMate EnVision Detection kit (Catalogue no. K5007, DakoCytomation, Ely, UK) was
applied for 20 minutes at room temperature. Following which slides received a further
wash and were counterstained and mounted as described previously. Negative control
slides were standard slides with antibody diluent applied rather than antibody. Tonsil was
used as a positive controlas it contains a large number of monocytes and macrophages.
Sections stained with CD68 (monocyte/macrophage marker) were examined, shedding
events located and digital images obtained. A circle (diameter 1.5 cell lengths) centred on
the assumedlocation of the nucleus of the shedding cell prior to being shed was drawn on
the digital image and the area within the circle examined for evidence of CD68activity. As
a control a cell 10 cell positions distant to the shedding event either left or right was
similarly examined and compared with the cell undergoing shedding.
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Image 2.9 Humantonsil with an antibody against CD68 (monocyte/macophage marker)
applied. The tonsil has numerous macrophages whichstain positively (black arrows).
Original magnification X63, bar 25um.
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2.12. Immuno-fluorescence
2.12.1. Investigation of the relationship of apoptosis with cell
shedding using double staining with antibodies against cleaved
caspase-3 and cleaved cytokeratin 18
To further investigate the relationship of shedding and apoptosis two markers of apoptosis
were used: cleaved caspase-3 (Asp175) (Cell Signalling Technology, Massachusetts, USA.
Catalogue No. #9661) and cleaved cytokeratin 18 antibody, clone M3028 (Catalogue no.
2140349; Roche Applied Sciences, Penzberg, Germany). Serial 21m sections were double
stained for immuno-fluorescence, shedding eventsidentified and correlated to the position
on other serial sections. The double stained slide was compared with thosestained single
for the same antibodies.
Four 3um serial sections were cut from paraffin blocks. Sections were de-waxed and
rehydrated followed by high temperature antigen retrieval (described previously).
Following a wash with de-ionised water manual staining was undertaken in a flat-bed
incubation tray. Primary antibodies were applied for 60 min following which sections were
washed in TBS and incubated for 60 min with a mixture of two fluorescently labelled
secondary antibodies: FITC-labelled horse anti-mouse IgG (dilution 1:50-30 mg/ml)
(Catalogue no. FlI-2000; Vector Laboratories, Peterborough, UK) and TRITC-labelled swine
anti-rabbit immunoglobulins (dilution 1:50-25 mg/ml (Catalogue no. RO156;
DakoCytomation, Ely, UK). Sections were washed in TBS and mounted in aqueous mounting
medium containing DAPI (Catalogue no. H-1200; Vector Laboratories, Peterborough, UK).
Negative controls were performed using antibody diluent in place of antibody. The
following primary antibodies were applied singly and concurrently as a mixture to serial
sections: rabbit anti-cleaved caspase-3 antiserum (dilution 1:50-1.2 mg/ml) (catalogue no.
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#9661; Cell Signalling Technology, MA, USA): mouseanti-cleaved cytokeratin 18 antibody,
clone M3028(dilution 1:50-0.66 mg/ml) (Catalogue no. 2140349; Roche Applied Sciences,
Penzberg, Germany).
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2.13. Scanning electron microscopy
2.13.1. Tissue preparation for electron microscopy
All specimens (human and murine) were fixed in 3% glutaraldehyde (Agar Scientific,
Stansted, England) in Sorensen’s solution for 24 hours. Fixed specimens were transferred
to a Petri dish and washed in Sorensen’s solution three times. During washes the tissue
size was reduced by dissection with a scalpel into 2mm squares (in the case of human
intestine the mucosa dissected from the muscle layers) and placed in labelled glassvials.
The Sorensen’s solution was then exchanged for 1 % Osmium tetra-oxide (Agar Scientific,
Stansted, England) in Sorensen’s solution and left for 1 hour. Following this tissue was
washed three times in Sorensen’s solution for 5 minutes and dehydrated with immersions
through graded ethanol (30%, 50%, 70%, 95%, 95%, 100%, 100% and 100%).
Next samples were successively immersed in four pots of 100% arkone (Arcton 112,ICI
Chemicals, Runcorn, UK) for 5 minutes then dried using a critical point dryer (E3000 Series
Critical Point Drying Apparatus, Polaron, New Haven, UK). In the critical point dryer the
sample wascooled to 8°C, pressurised and the arkone exchangedforliquid carbon dioxide.
The liquid carbon dioxide was exchangedten times (ensuring the sample remains covered
withliquid at all times) and following the last change the specimenwasleft for 5 minutes.
The temperature of the liquid CO, is then raised to 40°C (critical point is 31°C) to dry and
following this the pressure was slowly released. Samples were coated in a platinum-
palladium alloy using an Edwards Auto 306 coating unit (Edwards Instruments, UK) and
mounted for electron microscopy. Specimens were examined with a cryo-pumped vacuum
system and were examinedat 30 kV in a Hitachi $5200field emission lens scanning electron
microscope (feSEM).
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3.1. Over-view of the methods and criteria used to identify
shedding events
The optimum methodoftissue retrieval and preservation was assessed andis described in
the materials and methods chapter. The key facets are maintaining tissue vascularity for
the maximum possible time, ideally ligating the vascular pedicle immediately prior to
excision. Segments of intestine should be short (approximately 10cm) and immediately
immersedin fixative.
Initial assessment consisted of reviewing H&E stained sections for adequacy of
preservation and subsequently the presence of shedding events. Digital micrographs of
proposed shedding events were reviewed by the investigator, a Consultant
Histopathologist and Professor of Gastroenterology. Thecriteria initially used to define a
shedding event were-lECs visible as a monolayer of which a single cells nucleus was
orientated beyond the apical membrane boundaryof neighbouring cells. The sheddingcell
was identified rising above its fellows, detaching from them to be later shed into the
intestinal lumen. It became apparent that the glycocalyx was absent above these shedding
cells.
We observed shedding events with more prominent apical membranes than their
neighbours which in the later stages of shedding developed condensation of the nuclear
chromatin and became fragmented before the cell detached from the monolayerto be lost
into the lumen of the bowel. The cytoplasm does not obviously fragment and the cell
appears to be shed largely intact. Beneath the shedding cell there is an area which stains
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positively for eosin and does not contain a nucleus. These zones appear to be the
histological equivalent of the epithelial gaps described previously by our department and
observed by confocal microscopy in the living mouse intestine but more recently viewed
with confocal endoscopy in the human intestine (Watson, Chu et al. 2005; Kiesslich, Goetz
et al. 2007).
For the purpose of this study villi were defined as a protrusion from the muscularis
mucosae(in perfectly preserved tissue) the height of which was greater than three times
the width with no more than 50% ofthe villus cross cut. It is important to ensure perfect
preservation as shedding events are delicate and the damage caused by necrosis or from
poor preservation or trauma may disrupt them.
Cross cutting of the villus occurs when the plane of the microtomefalls across two or more
cells on the monolayer, thus sectioning them obliquely and creating the appearance of
more than onelayerofcells (see figure 1 on following page). This is common whenthe
edge ofa villus is sectioned and meansthat the cells are impossible to assess in terms of
shedding (figure 1 slide A). In figure 1 slide B the section passes through the centre of the
villus giving an accurate representation of the villus where as with slide C the section has
passed throughthe curveofthe villus, although there are no apparentcrosscuts, thevillus
appearsshorter thanin reality due to the two dimensional view obtained from the section.
The majority of villi examined have crosscuts present. However it was only deemed
significant if over 50% of the villus was cross cut. The number of shedding events were
counted and expressedrelative to the numberofvillus sections viewed.
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Figure 3.1. The image left contains a shedding event (centre) with cross cut areas of the
villi outlined in green (original magnification X63). The diagram to the rightillustrates
howtheplaneof section relative to the curvatureofthevillus results in cross cutting and
artificially reduced villus length. In slide A the plane of section crosses the edge of the
villus. Thus four cells are sectioned at the apical aspect of the villus giving the
appearance of multiple layers of cells in the monolayer. Slide B is a modelof the perfect
slide and in slide C the section has passed through the curve ofthe villus such that the
villus appears to be in twopieces.
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3.1.1, Frequency and stages of shedding in the human small intestine
In the 14 417villus sections examined 771 cells were in the process of being shed. When
images of effete human small intestinal epithelial cells in the process of shedding were
viewed, they appearedto havefive distinct stages discussed below.
3.1.1.1. Stage 1
The glycocalyx is absent on the surface of the cell about to be shed andtheapical portion
of its cell membrane develops a more rounded appearance(illustrated in figure 3.2). The
basal aspects of neighbouring cells extend beneath the effete cell. The effete cell’s nucleus
movesapically. Howeverthe basal limit of its nucleusis still below the most apical limit of
neighbouring cells nuclei. The apical membrane of the shedding cell is level with those of
its neighbours. This rise in the level of the nucleus may be due to break down of the
anchoring proteins at the base of the cell or pressure from neighboring cells causing the
cell to be pushed apically. The majority of cells at this stage show no morphological
features of apoptosis. Howeverin a minority the nucleus is deformed and pyknotic.
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Figure 3.2. Haematoxylin and eosin stained sections of shedding events from human
small intestine; the images A’ and B’ are magnified views of the area in the boxes.
Images A and B each showcells in an early stage of shedding. The glycocalyx (arrows)is
absent over the shedding cell and its nucleus has risen above those of neighbouring
nuclei but its basal border lies below the upperlimits of neighbouring nuclei. In image A
the nucleus appears similar morphologically to its fellows where as image B the nucleusis
shrunken and pyknotic. Original magnification of both image sets X6, bar=25um.
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3.1.1.2. Stage 2
In the second stage of shedding(illustrated in figure 3.3) the apical portion of the cell has
moved beyond thelevel of its neighbours and the nucleus has risen such that the lower
border is now beyondtheapical border of neighboring nuclei and typically level with the
glycocalyx of neighbouring cells. The edges of neighbouringcells still tightly adjoin the
shedding cell. Despite the close proximity of the neighbouring cells the movementof the
apical portion could signify breakdownofthe tight junction complexes thus allowing the
apical portion of the cell to move beyond the heightof its fellows. The majority ofcells
show morphological features of apoptosis. However a minority demonstrate late features
of apoptosis.
Figure 3.3. Haematoxylin and Eosin stained sections of shedding events from human
small intestine; images A, B, C, D, E and their magnified views(indicated by ‘) show cells
in the second stage of shedding. The inferior aspect of the shedding cell’s nucleus is
higher than the superior aspect of all neighbouring nuclei. Images C and D have nuclei
which are deformed and appear apoptotic and image E has a pyknotic heavily
fragmented nucleus. Original magnification of both image sets X6, bar=25m
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3.1.1.3. Stage 3
The third stage of shedding involves loss of contact with neighbouring cells which can be
individually or in groups. The cell remains in contact with neighbourspartially and thereis
some contact with the basement membraneillustrated below in figure 3.4. The junctional
proteins have been disrupted by this point and the majority of cells exhibit morphological
features of apoptosis. However clefts that appear between the shedding cell and its
neighboursare rarely seen to extend completely along the paracellular border. There is a
potential site of weakness developing along this border.
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 Figure 3.4. Haematoxylin and Eosin
stained sections of shedding events
from human small intestine; images
A, B, C, D, E and F with magnified
views (indicated by ‘) show cells in
the third stage of shedding. The
apoptotic cell breaks contact with
neighbouring cells. Breaks in the
monolayer are visible laterally
indicating disruption of the tight
junctions and_ potentially the  epithelial barrier. However the
basal portion of the cell is still
attached. Image F shows twocells
on neighbouring villi in the third
stage of shedding. Original
magnification X63, bar 25um. 
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3.1.1.4. Stage 4
In the fourth stage of shedding, the attachments to neighbouring cells remaining in the
monolayer have broken andthecell is attached by a thin basal portion to the basement
membrane. The sheddingcell is tethered to the basement membrane with an appearance
similar to a kite and nearly all cells are morphologically apoptotic. Relatively large clefts
appear betweenthe shedding cell and its neighbours with the majorityfilled basally by the
basal portion of neighbouring cells. Howeverin isolated events (figure 3.5) a break in the
continuity of the monolayer is seen, filled with an eosinophilic material that could be
plugging potential sites of weakness in the monolayer. The scarcity of these events may be
due to the thickness of 441m sections causing overlapping of cells in the immediatevicinity
of the shedding event to give the appearance of them covering the defect.
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Figure 3.5. Haematoxylin and Eosin stained sections of shedding events from human
small intestine; images A, B, C, D, E and their magnified views (indicated by’) show cells in
the fourth stage of shedding. The apoptotic cell has broken contact with neighbouring
cells and is only attached by a tapering attachment to the basement membrane. Image A
the defect below the sheddingcellis filled with an eosinophilic material (circle). Original
magnification X63, bar 25um.
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3.1.1.5. Stage 5
In the fifth stage of shedding the cell has been shed; it has lost contact with the basement
membraneand a defect exists between neighbouring nuclei which may befilled with the
same eosinophilic staining material mentioned above. Previous work performed in our
department (see section 1.25) has demonstrated acellular discontinuities in the murine
intestine. This appears to be the same phenomenonoccurring in the human intestine.
Figure 2.6. Haematoxylin and Eosin stained sections of shedding events from human
small intestine; images A, B, C, D, E and their magnified views (indicated’) show thefifth
stage of shedding; the shed cell has left a defect (circled in blue) which contains
eosinophilic material. Image A has a cell is in the process of being shed and twocells
distant to it, there is a gap in the nuclei the size of a cell, the glycocalyx is absent above
indicating a site of previous shedding. Original magnification X63, bar 25um.
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3.1.2. Serial 44m sections through a shedding event in the human
small intestine
We performed 4um serial sections on human small intestine prepared as discussed
previously. The shedding events were identified on individual slides and then correlated to
the corresponding site on theslide prior to and following the shedding event. This was
performed using low power magnification to find the more easily identifiable macroscopic
features of the section with which to correlate the immediate area of the shedding event.
Then using high power magnification with major microscopic features we localised the
exact site of the shedding event correlating microscopic anatomyto identify thesite.
Comparing the serial sections it is easier to imagine the three dimensional structure of the
shedding event and is an improvement on the use of a single 44m section mounted on a
slide. One difficulty of using conventional histology to evaluate events in tissue is its two
dimensional nature. Any event occurs in four dimensions (X, Y, Z and time). The four
micron section is a projection viewed by the microscope and consequently no idea of
topography within the Z axis of the section can be seen but when viewedin serial sections
this can be intimated. The problem is compoundedby the orientation of the cell: unlessit
is orientated in the plane of the section it may lie over two or three sections and henceit
can be hard to interpret if a shedding eventis occurring.
Figure 7 shows a typical shedding event from the human small intestine, sub-image A
showsa fracture on theleft aspect of the shedding cell. When viewedin isolation this may
have been interpreted as an artefact. However in conjunction with image B it can be
confidently identified as a shedding event with a pyknotic nucleus. Image B fortunately
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demonstrates the true nature of the shedding event and the cell can be confidently
described as having lost contact with the basement membrane. Without the other images
it would be impossible to definitely say if the shedding event wasstill in contact with the
basement membrane(this could have been on the images A and C). Image C would have
been discounted a potential fracture as the apoptic apical fragment shows no connection
with the gap present.
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3.1.3. Scanning electron microscopy of small intestinal shedding
events
Scanning electron microscopy (SEM) gives a 3 dimensional topographical image of the
luminal surface of intestine on which shedding events can be seen. The specimenis coated
in a thin layer of metal ions which then reflect a focus beam of electrons on to a
phosphorised screen. The layer of mucus found on the mucosal surface, which normally
protectsit, could potentially have impeded visualisation of shedding cells. Hence wetried
using a variety of mucolytics in addition to standard preparation techniques and discovered
that the standard preparation protocol for scanning electron microscopy provided more
than adequate clearance of mucusfor near perfect visualisation of thevilli.
Regular globular protrusions from the monolayerwere seen andidentified as gobletcells in
the process of releasing mucus (figure 3.8). SEM of the human small intestine also
demonstrated defects in the monolayer (figure 3.9), the size of an epithelial cell and
located in the apical third of the villus. We were concerned that the defects were
potentially empty goblets cells devoid of mucus. However the mouth of a goblet cell
producing mucusis consistently smaller than that of a cell. A minority of cells on thevillus
had elongated microvilli (figure 3.10) and as discussed earlier this indicates these cells are
effete and will leave the monolayerin the near future.
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Figure 3.10. Scanning electron micrographs of the human small intestine demonstrating
cells with elongated microvilli (inside red box) and a magnified image of the red box
inserted (right).
 
3.2. Effete epithelial cells within the colon
A crypt section was defined as an indentation towards the muscularis mucosae the length
of which was three or more times the width with no more than 50% ofthe crypt crosscut.
Wereviewed 4096 crypt sections and identified 101 effete cells. These were photographed
and subsequently divided into groups dependent on the apparent modality of effete cell
loss; if these effete cells were shed or if there was evidenceof in-situ apoptosis without
subsequentshedding.
3.2.1. Histological assessmentofeffete cell loss within the colon
3.2.1.1. Effete cell shedding within the colon
A proportion of cells appear to undergo shedding in a mannersimilar to that described in
the small intestine. The nucleus of the effete cell rises above the height of its neighbours,
the cell breaks contact with neighbouring cells to be attached by the basal portion of the
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cell and is then lost to the lumen (figure 3.11). Interestingly the nucleus appears to show
morphological features of apoptosis at an earlier stage than seen in the small intestine: all
shedding cells in figure 3.11 appear apoptotic. The loss of effete cells also appears to occur
in specific areas of the surface of the colon where occasionally more than oneeffete cell
can be seen (figure 3.11 images L and M) and a showerof apoptotic bodies are seen in the
intestine in figure 3.11 image F.
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Figure 3.11. Images of colonic epithelial cells in the process of being shed. Theoriginal
image is shownleft and a magnified section of the original (black boxed area) is shown to
the right. Images A-B showeffete cells with the now morphologically apoptotic nucleus
rising above the height of neighboring cells nuclei. Images B-D show clefts appearing on
the lateral borders of the shedding cell with clefts becoming increasingly obvious in B-M.
Images F-M show effete cells attached only by their most basal portions, the
neighbouring cells always meet beneath the effete cell so the basement membraneis
never exposed and notein all the imagesit is rare to see apoptotic debris beneath the
shedding cell (apoptotic debris visible separate to shedding cells on slides E and J) .
Images L and M showareas of multiple effete cell loss; in slide M the second effete cellis
distant to the shedding event (blue circle) where as in slide L they are neighbours.
Original magnification x 63, bar is 25m.
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3.2.1.2. In situ Apoptosis within the colon
Effete colonic epithelial cells were also noted to exhibit late features of apoptosis without
any evidence of detachment from the basement membrane. Similar to cell shedding, the
normally regularly spaced nuclei were absent in the region of the effete cell with visible
apoptotic debris consistent with the loss of a single epithelial cell. The remaining cell was
neverthe same height as surroundingcells potentially as a result of incomplete cell loss.
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Figure 3.12. Images A-D are human colon stained with haematoxylin and eosin. They
show breaks in the continuity of the epithelial monolayer with apoptotic debris
(indicated by arrows) scattered within the basement membrane. A magnified area of the
original (black boxed area) is shownto the right (indicated by ‘). Original magnification x
63, bar = 25um.
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3.2.2. Serial 444m sections of a humancolonic cell shedding
Attempting to resolve the issue of the mode of shedding occurring within the colon, we
performed serial 44m sections of human colon, located shedding events on a section and
then found the corresponding site on sections prior to and following it. As in the small
intestine this goes some distanceto alleviating the two dimensional nature of a section.
Howeverit is by no meansperfectandisstill only a snap-shotin time.
Figure 17is a series of 4m sections through a human colonic shedding event. The images
cover a distance of 20m and combined they demonstrate the cell being shed well
howeverin isolation they may bedifficult to interpret with images A, B, D and E being
easily dismissed by the uneducated eye and without supporting evidence. This may be a
reason why shedding events are under reportedin the literature. The main bodyof thecell
can be seenat a height well abovethat ofits fellows, its nucleus is apoptotic, interestingly
in the basement membraneandin cells next to it apoptotic bodies can be seen. It is not
clear if the apoptotic material is within the neighbouring cells or within the paracellular
space.
This series demonstrates cell shedding does occur from the human colon. However itis still
not possible to say which mechanism predominates.
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Figure 3.13. Serial 44m H&E stained sections of a colonic epithelial cell shedding.
Magnified views of the area in the black box indicated by ‘. Original magnification X63,
bar= 25um.
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4.1. Discontinuities in the monolayerare not gobletcells
A potential cause of the gaps seen in the epithelial monolayer would be mistakenly
identifying mucuspresent in goblet cells as the defects. Consequently slides were stained
with alcian blue and periodic acid Schiff which stain for acid and alkaline mucins. Twenty
shedding events were observedin the small intestine. None of these had mucin present at
their basal aspects. Figure 4.1 shows shedding events stained with periodic acid Schiff in
box A and alcian blue in box B. The goblet cells are endogenous controls and stain
positively (black arrows). The magnified views (right boxes) of the shedding events
highlight an absence of mucus in the area below shedding events and the glycocalyx
(arrowed)is absent over the sheddingcell.
In the colon much fewer shedding events were witnessed with only 7 demonstrated. None
of these demonstrated mucusbasally associated with the shedding event.
Within the small intestine discontinuities associated with shedding events are not due to
mis-identification of goblet cells as demonstrated by the absence of mucusin the shedding
events observed. In the colon the results would seem to concur. However the small
number of shedding events observed means more study is needed before a definitive
conclusion can be made.
A concern was the potential mucolytic effect of fixatives resulting in apparent false
negative results; we do not believe this has had any effect or it was minimal as the
glycocalyx was well preserved and mucuswaspresentbothin goblets and on the surface of
the intestine.
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Figure 4.1. Shedding events in the human small (image sets A and B)and large (image set
C) intestine stained with periodic acid Schiff in image set A and C. Image set B contains
images stained with alcian blue. Boxespresentin the left image indicate the magnified
area on the right of the box. Black arrows highlight goblet cells; green arrows
demonstrate the shedding epithelial cell and the arrow head highlights the glycocalyx
evident in the magnified views of image sets A and B. Original magnification X63,
bar=25um.
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4,2. Shedding events are not associated with leucocytes
As discussed earlier the mechanism of shedding is not known. Leucocytes have been
proposed as messengers inducing shedding events, potentially involved in the demise and
subsequent removal of senescent epithelial cells. We looked at shedding events in the
human small intestine using immuno-histochemistry with the antibody against CD45,
leucocyte commonantigen.
In the human small intestine we observed 109 shedding events of which 61 (56%) were
associated with a leucocyte (within one nucleus distance of the shedding cell). A non-
shedding epithelial cell was chosen five cells distant to compare the shedding events with.
This kept the non-shedding equivalent near the villus tip which may be important regarding
the frequency of leucocytes encountered. 132 (60%) of the 218 non-sheddingcells
contained a leucocyte within one nucleus distance of the cell. Thus the non-shedding
shedding cells were marginally more frequently associated with leucocytes compared to
shedding cells. Thus there is no evidence to support the belief leucocytes are associated
with epithelial cell loss from the human small intestine.
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Figure 4.2. Immuno-histochemistry performed with an antibody against CD45 (leucocyte
common antigen) and haematoxylin counterstain. Image A is human tonsil (positive
control) and Images B-F is from human small intestine with shedding events indicated by
arrows. Images B, C and F contain leucocytes near the shedding event (indicated by
brown pigmentation) where as images D and E havenostaining in the region of the
shedding event. Original magnification X63, bar=25um.
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4.1.2. Shedding events are not associated with macrophages
Macrophages have been documented in the guinea pig (discussed earlier) performing a
significant role in the removal of effete epithelial cell by phagocytosis. Weidentified
shedding events in the human small intestine and using immuno-histochemistry with the
antibody against CD68, a macrophage marker compared the association of macrophages
with shedding and non-shedding epithelial cells near the villus tip using the same method
described earlier for identify non-shedding epithelial equivalents .
In the human small intestine we observed 64 shedding events of which 29 (45%) were
associated with a macrophage (within one nucleus distance of the shedding cell). 53 (41%)
of the 128 non-shedding cells contained a macrophage within one nucleus distance of the
cell. Thus the non-shedding cells were marginally less frequently associated with
macrophages compared to shedding cells. However macrophages occur frequently in the
lamina propria and it is not usual for a macrophageto lie adjacent to a cell. We have also
shownin chapter 3 intact epithelial cells are shed from the human small intestine whichis
in direct opposition to the mechanism of cell shedding proposed by Iwanaga (Han, lwanaga
et al. 1993). There is no evidence to support the belief macrophages are associated with or
take part in epithelial cell loss from the human small intestine.
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Figure 4.3. Immuno-histochemistry performed with an antibody against CD68 and
haematoxylin counterstain. Image A is humantonsil (positive control); the presence of
macrophagesis indicated by the brownstain. Images B-F are from human small intestine
with shedding events indicated by arrows. Images B and C contain leucocytes near the
shedding event (indicated by brown pigmentation) where as images D, E and F have no
staining within one nucleus radius of the shedding event. Original magnification X63,
bar=25um.
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4.4, Shedding eventsare not associated with bloodvessels
A variety of authors have postulated the presence of shedding messengersor the lack of
anti-shedding signals inducing cell shedding (e.g. Netrin-1). Regardless of the messenger
the key feature would be the proximity of the shedding event to blood vessels if a
haematogenously disseminated messenger was the cause. Using CD34 (an endothelial
marker), we assessed the distance of shedding events from blood vessels in the small
intestine.
As described previously, shedding events were compared with a control, non-sheddingcells
5 cells distant to the shedding event. Shedding events were within 1 cell nucleus radius of
the blood vessels in 43/47 (91%) shedding events compared to 84/92 (91%) control non-
shedding cells. The identical and high frequency of shedding events and non-sheddingcells
to blood vessels (figure 4.4 images A-E) highlights the intense vascularity of the villus tip
and the proximity of blood vesselsto all cells on the villus. Image F in figure 4.4 is one of a
minority of instances where blood vessels were not immediately adjacent to a blood vessel.
The data would suggest a haematogenously disseminated messenger is not the cause of
the cell shedding.
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Figure 4.4.  Immuno-histochemistry performed with an antibody against CD34
(endothelial marker) and haematoxylin counterstain. Images A-F are from human small
intestine with shedding events indicated by arrow heads. Images A-E contain blood
vessels within 1 cell nucleus of the shedding event (indicated by brown pigmentation)
and image is the relatively rare case where no blood vessel wasin the vicinity of the
shedding event. Image E superbly demonstrates the anatomy of the vascular arcade in
the villus tip and its site immediately beneath the monolayer. Original magnification
X63, bar = 25um.
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5. Restoration of the epithelial monolayerafter shedding
As discussed in the introduction, two distinct theories exist regarding the restitution of the
tight junctions following the loss of effete epithelial cell from the intestinal epithelial
monolayer. The key difference between the two theories concernsthe site at which tight
junctions return. Madara believes the tight junctions re-form basally whereas Turner
demonstrates tight junctional elements returning apically.
Welooked at two aspects of tight junction formation after epithelial cell shedding; the site
of tight junction proteins (Zonula Occludens-1) and the use of phosphorylated myosin light
chains in association with tight junction formation.
5.1. The association of zonula occludens -1 (ZO-1) with
shedding events
ZO-1 is a key protein necessary for tight junction formation and was discussed earlier.
Using an antibody against the protein we assessed the site of tight junction formation
during effete cell loss. We demonstrated formation of apical ZO-1 complexes during effete
cell loss in 41/42 shedding events (image 5.1 A) and in only one shedding event were the
ZO-1 complexes located basally (image 5.1B). This demonstrates the formation of tight
junctions after cell shedding occurs apically and supports Turner’s proposed method of
restitution of epithelial barrier function.
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Image 5.1 Location of Zonula Occludens -1 (ZO-1) during epithelial shedding from the
human small intestine. Immuno-staining with monoclonal antibody against ZO-1,
counterstained with haematoxylin, highlights the tight junctions (arrows) which are
located apically in the vast majority (41/42) of shedding cells (*), as shown in image A. In
a minority of shedding events (1/42) the tight junction was located basally as in image B.
Original magnification X63, bar = 25um.
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5.2. Myosin Light Chain Phosphorylation is associated with epithelial
cell loss from the small intestine
The method proposedby Turnerofepithelial barrier restitution following shedding involves
a contracture of the tight junctions surrounding the cell which has been lost. Using an
antibody against phosphorylated myosin light chains donated by Professor Turner’s group
we correlated myosin light chain phosphorylation with epithelial cell shedding. 25 of 46
shedding events studied demonstrated phosphorylation of myosin light chains in the area
immediately adjacent to the shedding event. Given the time course of initial actin
deposition (within two minutes) progressing to phosphorylation and contracture within
eight minutes, approximately 75% of events would be expected to be positive. Our finding
corroborates the method proposed by Turner by the presence of phosphorylated myosin
light chains but also the time course of the event given 54% of shedding events were
positive.
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Image 5.2 Location of phosphorylated myosin light chains during epithelial shedding from
the human small intestine. Images A-D with the magnified view of the area in the black
box (marked ’) are of intestine stained with a monoclonal antibody against
phosphorylated myosin light chains (arrows) which highlights its presence in the
epithelial cells adjacent to the shedding cell(*). Note the myofibroblasts within the
lamina propria also take up the antibody. 25 of 46 shedding events studied
demonstrated phosphorylation of myosin light chains in the area immediately adjacent
to the shedding event. Counterstained with haematoxylin, original magnification X63
and bar 25um.
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6. Apoptosis of humanintestinal epithelial cells
The chronological sequence of shedding and apoptosis is yet to be demonstrated. As
discussed earlier epithelial cells detached from the basement membrane undergo
apoptosis, termed anoikis. However its relationship with shedding has yet to be
demonstrated. We looked at two markers of late apoptosis; cleaved cytokeratin 18 and
caspase 3 and their presence in epithelial cells associated with intestinal epithelial cell
shedding.
6.1. Cleaved Caspase -3
Using a monoclonal antibody against this late marker of apoptosis we looked at shedding
events and epithelia in continuity with the monolayer. We defined a caspase positive cell
as a cell in the epithelial monolayer which exhibited immune-reactivity throughout its
cytoplasm. Weinitially looked at a sample of 865 villus sections in which 944 cells stained
positively for caspase activity. There were a total of 342 shedding events with 341 of these
staining positively for caspase activity and 245 being at a late stage of shedding and 97
being in an early stage of shedding. Of the 944 caspase positive cells 709 were isolated
cells and there were 116 groups of caspase positive cells with at least one additional (9
groups of 3 and 1 groupof 5) immuno-reactive cell within three cells of it and 79 groupsof
caspase positive cells had a positive neighbour (7 groups of 3 and 1 groupof5).
This data suggests that apoptosis is a frequent event at the villus tip in the human small
intestine (1.09 cells per villus section). The high proportion of cells (25%) within a close
proximity (three cells) of another cell immuno-reactive to caspase-3 and those
neighbouring (16.9%) caspase-3 positive cells indicates this is potentially a process affecting
the numberofcells near the villus tip.
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Image 6.1 Immuno-staining of human small intestine with a monoclonal antibody against
cleaved caspase-3 and counterstained with haematoxylin. The boxed area from the left
image is magnified (marked with a ‘on the right). Images A and A’ show positively
staining cell in the late stage of shedding. Images B and B’ show a positively staining IECs
at an early stage of shedding. Images C and C’ show cell in the process of shedding
(arrow head) with a cell which stained positively for caspase activity but remained within
the epithelial monolayer and exhibited no macroscopic features of apoptosis. Original
magnification X63, bar 25um.
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6.2. Double staining with antibodies against cleaved caspase-3 and
cleaved cyto-keratin 18
Various cell types other than epithelial cells, such as lymphocytes, macrophages and
fibroblasts are known to occupy the monolayer or the area adjacent to it. We were
concerned that the apoptotic cells we demonstrated could be apoptotic cells of a non-
epithelial type and consequently examined human small intestine stained with an antibody
against cleaved cyto-keratin 18. Cytokeratin 18 is only present in epithelial cells, thus
allowing exclusion of non-epithelial cells and is cleaved late in apoptosis similar to caspase-
3.
We performed double staining immuno-fluorescence with antibodies against cleaved
caspase-3 and cleaved cyto-keratin 18 on human small intestine and identified 69 shedding
cells. Of these shedding events, 45 stained for both caspase-3 and M30. 19 sheddingcells
werepositive for M30 but negative for caspase-3. Conversely, five cells were positive for
caspase-3 and negative for M30. Notably all cells in the process of shedding stained for a
marker of late apoptosis although not all stained for both. However, there was no
statistical difference in the proportion of cells positive for either caspase-3 or M30. An
incidental finding noted with this technique was that some shedding cells were observed
on the shaft, rather than the tip, of the villus.
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7.1. Demonstration of epithelial cell shedding from the human
small intestine
Microscopy has existed for over 400 years and we have had theability to study epithelial
cell shedding from the human intestine for the last 100 years. Yet there are relatively few
studies regarding this common physiological event and the method and rate of cell
sheddingis still uncertain (Shibahara, Sato et al. 1995; Gibson 2004; Bullen, Forrest et al.
2006). A variety of different methodsof cell shedding have been documented in numerous
species of mammal including the guinea pig, seal and reindeer (see Introduction section
1.22). However in this study we observed only the extrusion of entire cells which
occasionally fragmented in the process of shedding. This is not compatible with the
methods, proposed by Iwanaga in the guinea pig model, of basal phagocytosis with loss of
an apical cap or that described by Myklebust and Mayhew whichinvolvescell shrinkage
and division centrally prior to loss of the apical fragment (Han, lwanaga et al. 1993; Han,
Iwanagaet al. 1993; lwanaga, Han et al. 1993; lwanaga T. 1994; Ilwanaga 1995; Takahashi-
Iwanaga, Iwanaga et al. 1995; Suzuki, Mori et al. 1997; Myklebust and Mayhew 1998;
Mayhew, Myklebust et al. 1999) (Mayhew, Myklebust et al. 1998; Myklebust and Mayhew
1998). A necrosis method of shedding has been postulated but | feel this is unlikely to
occur in the human small intestine given that we see large numbersof cells in the latter
stages of apoptosis in the monolayer.
Our group found that study of epithelial shedding from the human intestine required a
minimum of ischaemic time prior to the specimen being immersed in adequate fixative
(approximately 1:20 ratio) and minimal trauma to the specimen. This may be whyprevious
studies have proved difficult; the surgical technique for resection of the intestine would
normally involve devascularisation of the intestine to be resected at an early stage.
157
Discussion
Specimens are frequently received in the laboratory in insufficient fixative or have been
stored such that the specimenis not in contact with fixative; to ensure complete immersion
specimens were weighted downbylaying hand towels on the specimen when immersed in
fixative. We also found that opening the specimen reduced the numberof shedding events
demonstrated, presumably as a consequenceof the shear forces on these nowfragile cells.
In addition the modality of microscopy is not the ideal method to study shedding as this
four dimensional event (x, y, z and time) is seen in only two planes. We overcamethis to
some degree by using serial sections which enabled the observerto visualise a more three
dimensional structure of shedding. Howeverthis does not allow an accurate assessmentof
shedding rates and requires some extrapolation which| will discusslater.
Wefound 771 epithelial cells being shed in the human small intestine out of 14 417 villus
sections examined. This indicates sheddingis a relatively frequent event and is consistent
with current literature. It is difficult to ascertain the duration of shedding in the human
small intestine but using the figure of 1400 cells being lost per villus per 24 hours
approximately 1 cell is lost per villus per minute (Potten and Loeffler 1990). Given we
found on average approximately 3 shedding cells per villus (average numberof cells shed
per villus section X pie X diameter of the villus/width section X 2) examined this implies
sheddingis a relatively quick event occurring over approximately 3 minutes. Watson found
shedding and restitution of the defect took approximately 60 minutes in the murine
intestine and Russo comments of a similar time of 45 minutes for an artificial defect (the
size of one cell in) in a cultured monolayer to resolve (Russo, Florian et al. 2005; Watson,
Chu et al. 2005). If these figures are accurate then a much greater numberof defects
should be seen relative to shedding events, defects should out number shedding events
10:1. Our experience was that defects in the monolayer were rarely seen. The defects
158
Discussion
have been showntobefilled with an eosinophilic material in the murine intestine (Watson,
Chuet al. 2005). The defects may have been missed due to their appearance being similar
to an IEC, defects being small or sectioned so the defect appeared smaller.
7.2. Scanning Electron Microscopy of epithelial shedding in the
human small intestine
We used Scanning Electron Microscopy (SEM) to overcome the problem of two
dimensional views obtained with conventional microscopy discussed earlier. This provides
a surface view of the villus with superb resolution. Consistent with lwanaga’s findings in
the guinea pig we saw elongated microvilli on distinct areas of the villus, ranging from 1 to
three cells in size suggesting they area also an early feature of cell shedding. It was not
possible to correlate these events to a cell number duetodifficulties in accurately counting
the numberof cells per villus. Unfortunately the inability to view and label cytoplasmic
elements of the cell with SEM in addition to the lack of information regarding the time
shedding occurs over limited its further use.
The limitation of microscopy requiring dead and fixed tissue is the obviouslimiting factor.
In murine studies confocal microscopy proved immensely helpful and allows a true four
dimensional assessment of shedding. At the time of this research confocal endoscopy was
unavailable. However following its completion, confocal endoscopy has allowed more
detailed study of the human intestine with the use of acriflavine to differentiate between
goblet cells and shedding events.
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7.3. Association of shedding events with non-epithelial cells
The initiation of epithelial cell shedding in the small intestine has been linked to
haematogenously transmitted messengers such as Netrin-1 (Mazelin, Bernet et al. 2004).
Wefound no association with blood vessels but instead demonstrated that thevillus is an
extremely vascular area with most cells near the villus tip in close proximity to a blood
vessel, as might be expected given its role in nutrient absorption. Another postulated
mechanism to initiate cell shedding utilises lymphocytes to induce either necrosis or
apoptosis by interacting directly with the effete cell. We demonstrated no association of
shedding cells with lymphocytes and hence weconcludethatit is unlikely lymphocytes are
responsible for the initiation of cell shedding. However, a large proportion (602 of 944) of
cells in the monolayer demonstrated immuno-histochemical evidence of late apoptosis
whilst still in the monolayer (discussed later). With no morphological features of apoptosis,
it is conceivable that temporally we may have been examiningthe effete cell too long after
its stimulation for shedding. The increased frequency (37 vs. 46%) of leucocytesfive cells
distant to the shedding event would support this theory as they may have moved away
from the apical cell to initiate another. Further experiments would be desirable using
double staining techniques for caspase-3 and CD45.
No association was demonstrated with macrophage, given whole cells were seen being
shed there is no evidence to support a modelof apical fragment shedding as described by
Iwanaga nor do macrophages appearto beinitiators of cell shedding (Iwanaga, Han etal.
1593).
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7.4. Restitution of the epithelial barrier function following cell
shedding
A variety of theories exist regarding tight junction restitution after their disruption through
the process of cell shedding. Madara described lamellipodia extending beneath shedcells
to create a tight junction which subsequently movesapically analogousto a zipper (Madara
1990). Myklebust and Mayhew describe tight junctions forming through the middle of the
shedding cell which subsequently induces its loss (Mayhew, Myklebust et al. 1998;
Myklebust and Mayhew 1998; Mayhew, Myklebust et al. 1999). Turner describes a purse
string contracture of neighbouring tight junctions reducing the diameter of the defect; this
may occur independently or combined with the model proposed by Watsonof an acellular
material filling the defect left by the shedding cell (Turner 2000; Watson, Chu et al. 2005).
We demonstrated the formation of tight junctions in the apical portion of neighbouring
cells during shedding using an antibody against zonula occludens-1, a major tight junction
protein. This indicated that Turner’s method of restitution may be correct. Turner
describes contracture of the tight junction using myosin light chain kinase phosphorylated
the protein (see introduction section 1.5.4.2). In a second experiment, using an antibody
against phosphorylated myosin light chains we demonstrated approximately half (25/46)
the shedding events having evidence of myosin light chain phosphorylation. This is
consistent with Turner’s data which documents twophasesin contracture; assembly of an
actin ring initially followed by contracture of the myosin light chains. Both experiments
support the theory of purse-string contracture. However Russo, who documented the
temporal arrangement of these events, commentsactin rapidly builds up after 2 minutes
and that contracture begins at about 8 minutes and is resolved in 30-45 minutes. This
leaves a window of approximately 8 minutes with norestriction of flow between lumen
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and basement membrane.This is a fraction of the time the shedding event occurs over but
implies Watson’s model of shedding may be occurring simultaneously.
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7.5. The relationship of cell shedding with apoptosis
As discussed earlier the chronological sequence of shedding and apoptosis is yet to be
demonstrated. Epithelial cells detached from the basement membrane undergo apoptosis,
a process termed anoikis. Howeverits relationship with shedding is not clear. We looked
at two markers of late apoptosis; cleaved cytokeratin 18 and caspase 3 and their presence
in epithelial associated with intestinal epithelial cell shedding.
From the earlier histological results, in 14 417 villus sections examined 771 cells were
identified in the process of shedding (5.35% of villus sections). This figure is small in
comparison to the 944 cells with caspase-3 activity out of 865 villus sections examined:
1.09 cells in late apoptosis per villus section. Potten famously quantified the numberof
cells lost per villus per 24 hours as approximately 1400 in the mouse. There were a number
of assumptions:that a villus is circular (approximately), that we accurately assess the whole
villus for shedding events and shedding is completed in 15 minutes then the quantity of
shed cells per 24 hoursis calculated by:
Cells shed per villus section X pie X (diameterof the villus/width section) X 2 (for each edge
scored) X 96 (4 shed cells per hour for 24 hours)
Thus using the equation above 81 cells would be shed per 24 hoursif the data from the
haematoxylin and eosin stained microscopy is used. If the apoptotic cells are substituted
for the shedding cells this equates to 1643 cells per villus per 24 hours. The dilemmais
where these apoptotic cells go; are they all shed? If so it would appear that sheddingis
shorter and follows apoptosis.
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8.1 Future developments for observing intestinal cell shedding
Observing cell shedding in fixed tissue has a numberof flaws, the trauma and ischaemia
necessary to removethetissue, the contracture of tissue caused by dehydration from the
fixatives and the inability to observe the eventin as the tissue has been ‘frozen in time’ due
to the fixation. These limitations were overcome by Creamer who used microscopes to
view canineintestine in anaesthetised animals (Creamer, Shorter et al. 1961). However the
images wereof poor quality. This technique has been refined by more recent authors such
as Watson whoused a confocal microscope to obtain optical sections at multiple levels in
the murine intestine and used a heated water bath to maintain an environment closer to
the peritoneal cavity. This is the optimum modality, to observe shedding in vivo but was
obviously not possible in the human intestine. Since completion of my work confocal
endomicroscopy has been developed and workhas continued in the department using it to
observe shedding to the large and small intestine(Kiesslich, Goetz et al. 2007). Theinitial
work waslimited to 17 individuals who did not demonstrate any pathology on endoscopy.
The initial study of 17 individuals was a good size however studies on moreindividuals
would improve the validity of the data. There is also a potential to view human villi for
protracted periods of time using confocal endomicrosopyvia an ileostomy, should a willing
volunteerbe found.
The humancolon wasbriefly examined in my work and no clear modality of shedding was
demonstrated in contrast to the work on the small intestine. The confocal endomicroscopy
identified sites of cell loss but could not determine the mode by which they were lost. Thus
despite the limitations of using fixed tissue further examination of human colonusing light
microscopy to observe shedding events is necessary. Performing serial sections provides a
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wealth of information and allows a more accurate 3-D interpretation of the sheddingcell.
Consequentlyit is vital further serial sections are performed on human colonic tissue.
The defects created in the epithelial monolayer by cell shedding were less frequent than
expected (see Discussion section 7.1). Further work identifying the glycocalyx (absent at
sites of cell shedding) perhaps using wheat germ lectins would identify and quantify the
numberof defects present in the monolayer. The constituents of the material filling the
defect in the monolayer have not been explored. It seems likely these would be composed
of basement membrane constituents. Immuno-histochemistry for collagen and heparin
sulphate may help to elucidate this. Further studies focused on the basement membrane
at sites of shedding would be beneficial, in particular assessing the thickness of the
basement membraneatsite of epithelial loss and if this is thinned associated with shedding
events.
Finally we have deliberately not looked at shedding in diseased bowel howeverthereis the
obvious question of whether shedding occurs in the in the same mannerin conditions such
as inflammatory bowel disease andis it involved in its pathogenesis.
8.2. Future developmentsfor the association of shedding events
with non-epithelial cells
The studies performed on blood vessels, lymphocytes and macrophages failed to
demonstrate any association with cell shedding in the small intestine. We deliberately
restricted our work to the small intestine due to time restraints. This work should be
repeated in the colon. Wefailed to look at myofibroblasts in association with cell shedding.
It seems unlikely these cells induced shedding however the eosinophilic material filling
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defects in the monolayer must be produced by a cell type and myofibroblasts are a likely
suspect.
8.4. Further developments in restitution of the epithelial
barrier function following cell shedding
Again our work focused on the small intestine and it should be repeated in human colonic
tissue. Real time imaging of intestine with confocal endomicroscopy will allow
documentationofthe restitution of the monolayer.
8.5. Future developments regarding the relationship of cell
shedding with apoptosis
The studies we performed on the small intestine require repeating in the colon. Further
work using earlier markers of apoptosis would be helpful (eg. Caspase-9) to determine the
time course of apoptosis in the intestine. It would also be interesting to understand the
relationship of anchoring molecules such as the CAM’s with epithelial apoptosis; double
staining with caspase-3 and a CAM antibody could demonstrate if apoptosis induces their
loss or vice versa.
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LIVERPOOL (ADULT) RESEARCH ETHICS
COMMITTEE APPLICATION FORM
 
For Ethics Committee use only NUMDE?: ...... eee cece eee eee ees Date received:
Outcome: ...... cece eeee eee eee eee Applicant informed: .................   INSTRUCTIONS:Please complete this form in typescript. Select Yes/No options as appropriate. It is essential that
this form is completed fully and the relevant enclosures are received if the study is to receive proper scrutiny by the
Ethics Committee. Please refer to the Guidance Notes when completing the form.
CHECKLIST: The following checklist must be completed. Please indicate if the following have been enclosed by
selecting Yes/No/Notapplicable option below.
Not
Yes No Applicable
17 copies of the application form (double-sided if possible) L U O
2 copies ofthe protocol U L L
17 copies of the patient information sheet Q L L
17 copies ofthe patient consent form L O O
17 copies of the GP Letter L O L
17 copies of advertisements/posters LJ LU L
17 copies of Questionnaire* |] Finalised |_| Not yet finalised LJinformation
Fee O O Q
(cheque for £500 made payable to Central Liverpool PCT— commercially sponsored studies only)
2 copies of manufacturer’s data sheetforall drugs O O L
1 copy of the Clinical Investigator’s Brochure Q O O
2 copies of the manufacturer’s indemnity L O L
2 copies of CTX/CTL/DDX O U QO
Annexe A** O O O
Annexe B*** Q L L
Annexe CH U O Q
2 copies of CV (max. 2 pages) O Q O
= Please indicate if not yetfinalised. Include an interview schedule if used.
ae If the study involves the use of a medicinal product or medical device.
ea If the study includes the use of ionising or non-ionising radiation, radioactive substances or X rays
H Forresearch in general practice.
Please return your completed application to: Mrs K Simons, Administrator, Liverpool Research Ethics
Committee, Hamilton House, 24 Pall Mall, Liverpool, L3 6AL. Tel: 0151 285 2097
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 SECTION 1 Details of applicant(s)
1. Shorttitle of project (in not more than 6 words)
Histological examination ofhuman bowel
Fulltitle
A histological study of human small and large bowel mucosa
Summary ofpractical benefits/improvements in patient care which are envisaged
Cells of the mammalian intestinal epithelium migrate from the crypt to the villus, where they are shedinto the
intestinal lumen. Wereport a previously unidentified mechanism that enables abundantcell shedding to occur
without breach of the epithelial barrier. /n vivo observations with confocal and two-photon microscopyreveal
that loss of cells from the murineintestinal villus epithelium is accompanied by compensatory replacement
with an extracellular substance that sustains epithelial impermeability against luminal macromolecules.
Results suggest that targeting of epithelial barrier function by drugs and pathogens mayinclude more than
regulation of the tight junction and apical membrane impermeability. In this project we wish to confirm that the
findings we have madein mice are also found in humans.
Results have implications for drug discovery, whereprediction of intestinal absorption is a major goal during
the developmentof oral medicines. Intestinal epithelial cell culture models have been popular tools in the
study of drug absorption. Results have sometimesfailed to extrapolate to in vivo absorption in man,potentially
becausein vitro models cannotreplicate this biological function. Results could also be important because
pathologies of plugging the cell-free zone could play a majorrole in inflammatory andinfective intestinal
disease where permeation of luminal antigens, toxins or organismsoccurs.
 
2. Applicant(all correspondencewill be sent to this address unless otherwise indicated)
Surname: Watson Forename: Alistair Title:Professor
Present appointment of applicant: Professor of Medicine
Qualifications:M.D. F.R.C.P.
Address:Dept of Medicine, 5" FLOOR UCD, The Duncan Building, RLUH, Daubly St, Liverpool L69 3GA
Tel: 0151 706 4074 Fax: 0151 706 5802 Out of hourstel:
Email Address:Alastair.Watson@liv.ac.uk
Please note that a briefCV ofhead applicant must be attached with proposal(ifone has not been
submittedin the last 12 months). Please indicate relevant qualifications.03/06/068/C(A) was approved on 11 in
August 2003
 
3. Other workers and departments/institutions involved (please supply names and addresses)
Timothy Bullen Research Registrar Royal Liverpool University Hospital
Fiona Campbell Consultant Histopathologist Royal Liverpool University Hospital
Michael Hershman Consultant Colorectal Surgeon Royal Liverpool University Hospital
Kate Johnston Research Nurse Royal Liverpool University Hospital
170
Appendix 1
4. Signatureof relevant bodies
The information supplied in this application form is to the best of my knowledge and belief accurate. I have
read the Guidance Notes and clearly understand my obligations and therights of the subject, particularly with
regard to obtaining freely-given informed consent. I undertake to carry out the work in accordance with the
principles of the Declaration of Helsinki (South Africa October 1996).
Signature of applicant ...............ccceceececceceeeeceeeneeeeeeneceeneneeeeneesDate .........cceeeceeeeceeneeeeeeeeeeees
Signature ofHead of Department/Supervisor/Principal in General Practice
with overall responsibility
fOF thE: POJECt sascesweeseeer emeaesseseeeseeeeeeeers vaeereneoey enema ee esenaesDate vesorreerarcereemerey wesemens
Name and Title in'capitals: sic sssevaszsevsesaans ec engeeeetanesecrvevenncescsweasenuewis teea ga seeearREET
Lamfully awareofthe details ofthis project and happyforit to continue as outlinedhere.
Signature(s) of relevant Clinical Director(s) where study is being conducted/Medical Director(s)
signing on behalf of Trust(s) involved (where appropriate)
Namie anid, Tithe in. Capitals: —...:5..0.rneeessoosindcsieiielnsle sib.sib ssiisaibate ala i sbuedelbi ch sh a SAUTER SBN ENE UIREER areeMENT
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 SECTION 2 Details of project
This section must be completed. Two copies of the protocol should be supplied, butit is not sufficient to complete
questionsbyreferring to the protocol.
5. Aimsandobjectives of project (i.e. whatis the intentionofthe project ?)
AIM:We demonstrated the previously undocumented feature ofcellfree zones on intestinalvilli oftransgenic mice
(discussedin question 6), we wish to proceed to demonstration ofthisfeature in the human gastro-intestinaltract. We
will obtain samplesofintestinefrom patients attendingfor a right hemicolectomy orfrom small bowel biopsies takenfor
the investigation ofiron deficient anaemia. Samples will befrom three male and threefemale patientsfor each procedure
with a total oftwelve patients being involved.
Study end points: Histological examinationofall twelve samplesofintestine.
6. Scientific background of study {Committee members, who do notreceive afull protocoleach, use this
section to decide ifthe researchis significant, valid and novel — See also Guidance Notes]
Theintestinal epithelium presents a permeability barrier to the luminal contents that prevents undesirable
solutes, microorganisms and luminal antigens from entering the body. However, it remains mysterious how
the intestinal barrier is sustained during the high rate of cellular turnover that is normally observed in the
epithelium. Epithelial cells of the mammalian small intestine arise from stem cells at the base of the crypt and
migrate up to the villus where they are shed (7). In the mouse, ~1400 cells are shed from eachvillus per 24
hours (7). Regulation of the tight junctional assembly between adjacentepithelial cells is a well-established
mechanism controlling passive absorption and is implicated in the pathogenesis of Crohn’s disease and
response to numerousintestinal pathogens (2-5). Other mechanisms mayalso be important, but informationis
limited because the mechanism ofcell shedding is poorly understood.
Wehavelimited insight into mechanismsofcell shedding or the maintenanceof barrier function duringcell
shedding, because questions have only been addressedusingfixed tissue, cells collected from the intestinal
lumen,or cell culture models. Confocal reflectance, used to identify physical structures that reflect laser light
(6), has reported that this apparently cytoplasm-free zone contained someother non-fluorescent(yet
reflective) material. We have demonstrated that the cytoplasm-free zones are the same diameter as an
epithelial cell (10 ym) and can beclearly distinguished from folds in the epithelium (which are larger than
individual cells and present a distorted epithelial border).
Experiments have confirmed that gaps in the annular ring of nuclei occurred that were coincident with lack of
cytoplasmic or nuclear DNAstaining but that such spaces contained reflective material. Results also
confirmed that the reflective material does not contain remnants of cytosol. Staining with the membrane dye
Dil demonstrated that discontinuities in the apical brush border membrane occurred whennuclei were absent,
despite continued presenceofreflective material. We concluded from these observations using 6 different
markers that the small intestinal villus epithelium of the living mouseis not a continuous epithelium, but rather
is interrupted bycell-free zones defined by the coincident loss of apical brush border membrane, cytosol, and
nucleus. We consequently wish to demonstrate this in the human gastrointestinal tract
C. S. Potten, M. Loeffler, Development 110, 1001-20 (1990).
E. J. Irvine, J. K. Marshall, Gastroenterology 119, 1740-4 (2000).
M. L. Hermiston, J. |. Gordon, Science 270, 1203-1207 (1995).
J. Berkes, V. K. Viswanathan, S. D. Savkovic, G. Hecht, Gut 52, 439-51 (2003).
S. P. Colgan et al., J Immunol 153, 2122-9 (Sep 1, 1994).
S. Chu, S. Tanaka, J. D. Kaunitz, M. H. Montrose, J Clin Invest 103, 605-12 (1999).Q
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7. Brief outline of project (i.e. what do youintend to do ?)
The project will be divided into two parts, the first will concern obtaining samplesofintestine from right
hemicolectomy specimensand the second will involve examining samples of proximal small bowel obtained during
the investigation of iron deficient anaemia. In each group wewill recruit three male and three female patients thus
achieving a total of twelve patients. Both parts of the study will run concurrently.
Patients in the first part will be recruited from patients undergoing elective right hemicolectomy under Mr Hershman for
Crohn’s disease or colorectal carcinoma. Having been informedofthe study patients will be consented for surgery on
the standard hospital consent form and a consentform specific to the study (enclosed). Surgery will be no different to the
normal procedurebut the proximalanddistal margins of the specimenare sent immediately to the pathology department
for examination.
In the secondpart of the study patients whoare attending for gastroscopy and small bowelbiopsyforinvestigation of
iron deficient anaemia under Professor Watson arerecruited to the study. They will be informed and consented for the
study prior to attending for endoscopy. The gastroscopy will be performed as normal hospital protocol exceptthat small
bowelbiopsy is performed with Key Medsingle use “jumbo”forceps . Biopsy specimensare then taken immediately to
the pathology laboratory.
 
8. Study design (e.g. cohort, case control)
Exploratory pilot study
9. (i) Howwasthesize of the study determined ?
Thisis a pilot study in which the emphasis is on the development of the techniqueto visualise cell shedding and
the resultant gaps. From discussion wefeel that 12 patients in total will be adequate for technique development.If
the project is successful we shall undertake a second study to determine the effect of mucosal disease on thecell
shedding process. We shall apply for ethical approval of such a study under separate cover.
(ii) Wasthere formalstatistical input into the overall study design?
L] Yes X No
If Yes, please give nameofadviser:
(iii) What methodofanalysis will be used: Histology
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10. Doesthe studyfall into anyof the following categories ?
Pilot X Yes [} No
Multi-centre study L] Yes LINo
Student project L) yes LINo
If this study is to be conducted at centre(s) other than that named in Question 11, please complete
the following:
(i) Whichcentres are involved ? (please include addresses) N/A
(ii) Which Local Research Ethics Committees have been approached and whatis the
outcometo date ? N/A
(iii) Whowill have overall responsibility for the study ?
(iv) Whohascontrol of the data generated ?
11. Wherewill the study take place and in whatsetting ?
Royal Liverpool University Hospital: operating theatres, endoscopy department and pathology labs
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12. Is any payment being made, or actively being sought bythe investigator or department/unit in respect
of this study (include research grants) ?
L} Yes XNo
If Yes, complete the section below; if No, go to Question 13
(i) Is the payment:
(a) A block grant L] Yes LINo
If Yes, give details, including amount & source of funding Dos sven eerie
Name of funding body/sponsor wwe: ssvensssucasvars vaxurs crews wasavaceanadesieesdeenesnns
(b) Based on numberofsubjects recruited Ll yes LINo
If Yes, give name of funding body/sponsor..............ccccceceeeeeeeee eee eeu eee eeueeuseeeeuseuess
If paymentis based on numberofsubjects recruited (per capita/payment),
state total sum payable for each subject completing the study
Eivsaeernnnanianes
State numberofsubjects agreed forcentrenamedinQIL eae eeeeeeeeeeeee
Will patients have their travel costs paid ? L} Yes LINo
If more than one UKcentreis involved, state total number
ofsubjectstobe recruited ceteris
(iii) Is the payment madein orderto:
If Yes, state sum
(a) Pay a salary(ies) LJ) Yes LINo Eee
(b) Fund equipment LJ Yes LINo Lives cousmysvanne
(c) To support further departmental research L} Yes LINo Loe
(d) Other(state) L] Yes LINo Lecccceeeeeeeee
(iii) Whowill have control of the funds ? (e.g. Charitable Trust etc)
(iv) Doesthe investigator(s) have anydirect personal involvement
(e.g. financial, shareholding,etc.) in the sponsoring organisation ?
(If Yes, give details) L] Yes LINo
(v) Will all the costs incurred by the institution be covered by L] yes LINo
the grant/sponsorship ?
13. If the project is to be carried out in a Trust has the R & D Lead X Yes LJNo LINA
in the Trust been notified of the project ? If No/NA,give reasons.
14. Schedule
Proposedstarting date: 1 November 2003 Proposed duration: 12 months
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 SECTION 3 Recruitment of subjects  
15.
Patients will be selected from elective patients under going anelective right hemicolectomy under Mr Hershman
How will the patients or subjects in the study be selected, approached and recruited; whatinclusion and
exclusion criteria will be used ? State ifthey are the subject oftherapeutic or non-therapeutic research.
and patients of Professor Watson undergoing endoscopy. Theprinciplesof the study will be explained to
candidatesandif they are willing enrolled.
 
16. How manysubjects will be recruited and of what age group ?
12 subjects age 18-65, 6 male and 6 female
 
17. Howwill the control group (if used) be selected, approached andrecruited; what inclusion and exclusion
criteria will be used ? Type N/4if no controls
N/A
18. How manycontrols will be recruited and of what age group ? Type \/4 if no controls
N/A
19. Are the subjects or control included in this study involved in any other research investigation at the
present time ?
No L] Yes xX No
If Yes, please give details
20. Will healthy volunteers be used ? L] Yes X No
If Yes, complete details below. If No, go to Question 21.
(i) Whatis their relationship to the investigator ?
(ii) Will they receive any paymentand, if so, what is the source ofthe funding ? L} yes LINo
If Yes, give details of payment per subject.
Applicants must undertaketo explain to volunteers that the researcher will contact their GP to
ask about any drug therapyand that they must inform the researcherif they consult another doctor
during the study, and thatthis doctor will be informedof this study.
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 SECTION 4 Consent 
21. Is written consent to be obtained ? xX Yes L]No
If Yes, please attach a copy of the consent form to be used.
(Please see our standard consent form in the Guidance Notes)
If no written consentis to be obtainedis it because one ofthe following methodsof research is employed ?
 
Postal questionnaire L} Yes LINo
Interview L} Yes LINo
Other L] Yes LINo
If Other, please justify.
22. Doesthe study include subjects for whom English is not a first language ?
Ll yes XNo LINA
If Yes, give details of arrangements made;if No,please justify.
This is a pilot study without funding and therefore paymentfor interpreters would notbepractical.
23. Are the subjects or controls in one of the following vulnerable groups?
People with learning difficulties L] yes X No
Other vulnerable groups, e.g. mental illness, dementia Ll Yes X No
If Yes, please complete the details below, otherwise go to Question 24
(i) Whatspecial arrangements have been madeto deal with the issues of consent andassent,
i.e. how and from whom will informed consent/assent be obtained ?
Study will be explainedto the participant and wriiten consent obtained
(ii) In what way,if any, can the proposed study be expected to benefit the individual patient/subject
on whomit is performed ?
It will not benefit the patient.
 
24. Will the patient/subject be given a written information sheet or letter ? X Yes L] No
(Please see Guidance Notes on suggestedformat)
Note: The Patient Information Sheet/Letter must be separatefrom the Consent Form
If Yes, please attach a copy to each application form. If No, please justify.
NOTE:If you,as investigator, are not responsible for the overall care of the subject, you must
ensure that the Clinician responsible is given a copy of the Patient Information Sheet and signed
Consent Form (for any patient/subject under the care of a Consultant at an NHSTrust)
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 SECTION 5 Details of interventions   
25. Does the study involve the use of a medicinal product or medical device ? Ll Yes X No
If Yes, please complete Annexe A,otherwise go to Question 26.
26. Will anyionising or non-ionising radiation, or radioactive substances or X-Rays be administered to a
patient or volunteer ?
| Yes X No
If Yes, please complete AnnexeB,otherwise go to Question 26.
Please ensure that information in Question 15 includes exclusioncriteria with regard to ionising
radiationif appropriate.
 
27. Whatinvestigations and/or interventions will subjects and/or control have over and aboveroutine care ?
Please complete (a) and (b) by selecting YES/NO option as appropriate. If YES, give details
(a)
Self completion questionnaires L] Yes X No
Interviews/interview administered questionnaires [] Yes X No
Video/audio taping [] Yes X No
Physical examination L] Yes X No
Internal physical examination L] Yes XNo
Imaging investigations (not radiation) [] Yes X No
Other investigations not part of normal care L] Yes X No
Additional outpatients attendances L} Yes X No
Longerinpatient stays Ll Yes X No
Local anaesthetic L] Yes X No
General anaesthesia L] Yes X No
Other [] Yes XNo
Details:
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N/A
(b) Blood sampling, biopsies, tissue samples
Yes No Samples Indwelling! Repeated Total
Cannula Puncture Volume
Venepuncture* O xX O O rrml
Arterial* Q xX L Q] Cheeml
(If an indwelling cannulais utilised, please give details of the quantity, site, size of cannula and duration]
Biopsy* X Yes L]No
[If Yes, please give details of the site, size, number, method used and whether local/general anaesthesia]
Only patients that are undergoingeither colonic resection or endoscopy andbiopsyaspartof their normal NHS
treatmentwill invited to participate in the study.
Patient undergoing Right Hemicolectomy under general anaesthesia will have 2.5 - 5cm of the proximal anddistal
endsof the specimen sent to pathology.
Patients undergoing small bowel biopsyas partof an investigation of iron deficiency anaemia will have an
additional biopsy of 5mm taken using endoscopy forceps undersedation.
Othertissue/ Body sample* Ll Yes XNo If Yes, please give details
*If Yes, will samples be retained beyond the end of the study for testing for other factors beyond thatin
this study ? X Yes L|No Weshall retain tissue blocks and
Slides for additional staining.
If Yes, will the samples be anonymised ? X Yes L|No
If No, please justify
If additional investigationsor tests are involved with revenue consequencesfor the NHS,all of the relevant
head(s) of department(s) must be contacted.
Signature of Head of Department............... 0c cccecee eee cee eee cee ee ee seen enenees Date .......cece neces
Namein capitals 2.20.0... 0c cece cece ee ceeeeeeeeeeeeeenenes POSIION oo... eee ee cece ects cee eee eee eeeneeee enna eee enes
Please provide further signatures, if appropriate.
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 SECTION 6 Risks and ethical problems 
28. Are there are ethical problemsor considerations that the investigators consider to be important or
difficult with the proposed study ?No
L] Yes xX No
If Yes, please give details:
(i) Is it possible that the trial medication will not be available at the end of the trial ?
N/A [l yes [INo XNA
(ii) If Yes, is this madeclearin the patient information sheet ? Ll Yes LINo
If No, give reasons:
 
29. Are there any potential hazardsto subjects or patients ? Yes X Yes LINo
If Yes, please give details, and give the likelihood and details of precautions taken to meet them, and
arrangements to deal with adverse events and overdoses, including reporting to the relevant authorities
For the patients undergoing surgery there will be no additional hazard overthose of right hemicolectomy.
Forthe patients undergoing endoscopythey will undergo one single additional biopsy. There is a very small chance of
bleeding or perforation. This is madeclear in the patient informationsheet.
 
30. Is this study likely to cause discomfort or distress to subjects/patients ? No [] Yes XNo
If Yes, estimate the degree andlikelihood of discomfort or distress entailed.
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31. Will information be given to the patient’s General Practitioner (especially if a drug is to be given or an
invasive procedureis undertaken) ?
No LI Yes X No
If Yes, please enclose a copy of the GP information sheet/letter
If No, please justify
The information from the study biopsies is anonymous.
Weare not looking for a pathological entity, we are looking for structures not previously documented in medical
literature of a healthy person.
If the studyis on patients underthe care of a Consultant at an NHSTrust, has the consentofall
consultants whosepatients are involved in this research been obtained ?
Only patients of the consultants in the study will be used.
xX Yes |] No
If the study is in general practice, has the consentofall the partners been obtained Ll] yes LINo
Where available, please enclose an information sheetfor consultants or GPS
 
32. If, during the course of the study, an unexpected butclinically significant result is found, what course
of action will you take ? Please givefull details.
This will not occuras all patients will be undergoing histological diagnosis anyway as part oftheir NHS treatment.
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 SECTION 7 Indemnity and confidentiality
Productliability and consumerprotectionlegislation make the supplier and producer (manufacturer) or any person
changingthe nature ofa substance, e.g. by dilution, strictly liablefor any harm resultingfrom a consumer’s (subject or
patient) use ofthe product.
33. (i) If you are not a memberofstaff of an NHS Trust or Health Authority what arrangements have
been madeto provide indemnification and/or compensationin the eventof a claim by, or on
behalfof, a subject for negligent harm ? N/A
(ii) What arrangements have been madeto provide indemnification and/or compensation in
the event of a claim by, or on behalf of, a subject for non-negligent harm ?
 
N/A
Ifthe study is commercially-sponsored, please supply two copies ofthe Indemnity Form.
(iii) Will a medical student be involved directly in the project ? No Ll] Yes XNo
34. Has a manufacturer provided any equipment or medical devices ? N/A Ll yes LINo XNA
If Yes, what arrangements have been made with the manufacturerto provide indemnity ? Please enclose
two copies ofany appropriate documentation.
35. (i) Hasthe relevant Data Protection Officer been notified of the study? xX Yes No
Amanda Penketh : 0151 706 3558
(ii) If No, give reasons:
 
182
Appendix 1
 
 
 
36. Will the patient’s medical records be examined ? (] Yes XNo
If Yes, will informationrelevant to this study only be extracted ? L} Yes LINo
If extra information is extracted, please justify.
What, if any, additional steps have been taken to safeguard confidentiality of personal records ?
37. Will the study includethe use of anyofthe following ?
Audio/video tape recording ? L] Yes XNo
Observation of patients ? CL] Yes X No
If Yes to either,
(a) Howare confidentiality and anonymity to be ensured ?
(b) Whatarrangements have been madeto obtain consent ?
(c) Howlongwill the tapes be kept, where will they be stored and what will happen to them at the
end ofthe study ?
Please note that audio tapes should be transcribed and destroyed within 6 weeks. Ifaudio tapes are
to be kept longerthan 6 weeks, please justify.
38. Will medical records be examinedbyresearch worker(s) outside the employmentof the NHS ?
L] Yes XNo
If Yes, it is the responsibility of the principal investigator to ensure that research workers understand
that they must:
(i) undertake neverto divulge information about patients or research subjects, recorded or otherwise, to
anyone without the authority of the Consultant/GP under whosecarethe patientis;
(ii) also understand that the names, addresses and places of work of patients or research subjects are
confidential and mustnotbe divulged.
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PROTOCOLTITLE:
An investigation of the shedding of epithelia from human small and large
bowel mucosa.
Chief Investigator (or Principal)
Name: Professor AJM Watson
Address: Dept of Medicine, 5th FLOOR UCD, The Duncan Building, RLUH, Daubly
St, Liverpool L69 3GA
Telephone:0151 709 4074
Fax:0151 709 5802
Email: Alastair.Watson@liv.ac.uk
Nameand addressof Co-Investigator(s), Statistician, Laboratories
etc
Name: Mr Timothy Bullen
Address:Royal Liverpool University Hospital, Prescott Rd, Liverpool. L7 8XP
Telephone:0151 706 2000
Fax: 0151 794 6825
Email: t.bullen@liv.ac.uk
Name:Dr Fiona.Campbell
Address: RoyalLiverpool University Hospital, Prescott Rd, Liverpool. L7 8XP
Telephone:0151 706 2000
Fax:0151 794 6825
Email: Fiona.Campbell@rlbuht.nhs.uk
Name: Mr MJ Hershman
Address: Royal Liverpool University Hospital, Prescott Rd, Liverpool. L7 8XP
Telephone:0151 706 2000
Fax:
Email: michael.Hershman@rlbuht.nhs.uk
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Background
The intestinal epithelium presents a permeability barrier to the luminal contents that
prevents undesirable solutes, microorganisms and luminal antigens from entering
the body. However, it remains mysterious how theintestinal barrier is sustained
during the high rate of cellular turnover that is normally observed in the epithelium.
Epithelial cells of the mammalian small intestine arise from stem cells at the base of
the crypt and migrate up to the villus where they are shed (1). In the mouse, ~1400
cells are shed from each villus per 24 hours (1). Regulation of the tight junctional
assembly between adjacent epithelial cells is a well-established mechanism
controlling passive absorption and is implicated in the pathogenesis of Crohn's
disease and response to numerousintestinal pathogens (2-5). Other mechanisms
may also be important, but information is limited because the mechanism of cell
shedding is poorly understood.
We have limited insight into mechanisms of cell shedding or the maintenance of
barrier function during cell shedding, because questions have only been addressed
using fixed tissue, cells collected from the intestinal lumen, or cell culture models.
Confocal reflectance, used to identify physical structures that reflect laser light (6),
has reported that this apparently cytoplasm-free zone contained some other non-
fluorescent (yet reflective) material. We have demonstrated that the cytoplasm-free
zones are the same diameter as an epithelial cell (10 um) and can be clearly
distinguished from folds in the epithelium (which are larger than individual cells and
present a distorted epithelial border).
Experiments have confirmed that gaps in the annular ring of nuclei occurred that
were coincident with lack of cytoplasmic or nuclear DNA staining but that such
spaces contained reflective material. Results also confirmed that the reflective
material does not contain remnants of cytosol. Staining with the membrane dyeDil
demonstrated that discontinuities in the apical brush border membrane occurred
when nuclei were absent, despite continued presence of reflective material. We
concluded from these observations using 6 different markers that the small intestinal
villus epithelium of the living mouse is not a continuous epithelium, but rather is
interrupted by cell-free zones defined by the coincident loss of apical brush border
membrane, cytosol, and nucleus.
1.C. S. Potten, M. Loeffler, Development 110, 1001-20 (1990).
2.E.J. Irvine, J. K. Marshall, Gastroenterology 119, 1740-4 (2000).
3.M. L. Hermiston, J. |. Gordon, Science 270, 1203-1207 (1995).
4.J. Berkes, V. K. Viswanathan, S. D. Savkovic, G. Hecht, Gut 52, 439-51 (2003).
5.S. P. Colgan et al., J Immunol 153, 2122-9 (Sep 1, 1994).
6.S. Chu, S. Tanaka, J. D. Kaunitz, M. H. Montrose, J Clin Invest 103, 605-12
(1999).
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2 Trial Objectives, Design and Statistics
2.1. Trial Objectives
Epithelial cells lining the surface of human bowel have been demonstrated to leave
gaps whenshed,the size of the cell. Previous studies within this department have
demonstrated in the mouse model that these gaps are not composed of cellular
material and provide an impenetrable barrier. In the human model we have shown
these gaps are not goblet cells and are not composed of mucus. Wehavealso
shownthese cells are apoptotic when shed and 20%of gaps on thevillus tip are
associated with cells which have begun a cascade which results in cell death.
Ourintention is to further investigate these gaps in the continuity of intestinal
epithelial cell s by performing electron microscopy studies of human bowel to show
these gapsin greater depth and quantify them more accurately. In addition we wish
to perform immuno-histochemistry to find to the composition of these gaps.
Inaddition we would also wish to perform further studies such as polymerase chain
reaction.
2.2 Trial Design
The study will look at tissue from participant’s specimens obtained at surgery. The
specimens will be used for immuno-histochemistry, electron microscopy or
polymerasechain reaction.
 
Study Design
Consultants Operating Lists are
reviewed and suitable patients are
approached on admission to enter the
Type: Pilot study study.   
Numberof Patients: Thirty |
Consented 1-2 days following initialStudy Summary: discussion & prior to operation.
|
Specimen of resected bowelcollected
from theatre and bowel not required for
histopathological examination place in
preservative and takenfor investigation
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2.3 Trial Statistics
The study aims to document a phenomena occurring in the normal human bowel
and consequently does not require statistical comparison.
3 Trial Medication
None
3 Selection and Withdrawal of Subjects
3.1 Inclusion Criteria
Anyindividual having a bowel resection by Mr MJ Hershman, Mr P Carter or Mr P
Rooney.
Individuals must be overthe age of 16.
Individuals must be able to comprehend English.
3.2 Exclusion Criteria
Under age 16.
Unable to comprehendthe implications of the study.
3.3 Withdrawal of Subjects
Participants withdrawing from the study will not have their bowelcollected or used in
the study.
3.4 Concomitant Medication
This is not relevant in the present study
3.5 Subject Compliance.
This is not relevant in the present study
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4 Assessmentof Efficacy
4.1 Efficacy Parameters
4.1.1 Primary Efficacy Parameters
The visualisation and quantification of gaps in the epithelial continuity of the
intestine using immuno-histochemistry and electron microscopy.
4.1.2 Secondary Efficacy Parameters
Assessment of the composition of the gaps in the continuity of the intestinal
epithelia.
4.2 Proceduresfor Assessing Efficacy Parameters
Immunohistochemmistry, electron microscopy and polymerasechain reaction.
5 Assessmentof Safety
This is not relevant in the present study as there is no intervention with participant
we will ask consent to use tissue which is removed as part of their normal NHS
treatment and which would normally be incinerated.
5.1 Specification, Timing and Recording of Safety Parameters.
5.2 Procedures for Recording and Adverse Events
This is not relevant in the present study- Tissue collected is that not required by the
pathology department for assessmentandis surplus.
6. Direct Access to Source Data and Documents
No patient information is accessedin the study.
7 Ethics
Central Liverpool Ethics Committee
8 Quality Assurance, Data Handling, Publication Policy and
Finance
The data obtained from the study is for an MD andwill be kept for five years. All
tissue obtained is anonymised and no patient information is obtained.
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Liverpool (Adult) Local Research Ethics Committee
Hamilton House
24 Pall Mall
Liverpool
L3 6AL
Telephone: 0151 285 2097
Facsimile: 0151 236 4493
Email: kathy.simons@centralliverpoolpct.nhs.uk
21 December 2004
Private and Confidential
Professor AJM Watson
Professor of Medicine
The University of Liverpool
5th Floor UCD
The Duncan Building
Daulby Street
Liverpool
L69 3GA
Dear Prof Watson
Full title of study: Aninvestigation of the shedding of epithelia from human small
andlarge bowel mucosa.
REC reference number: 04/Q1505/135
Thankyou for your letter of 17 December 2004, responding to the Committee’s requestfor
further information on the above research and submitting revised documentation.
Thefurther information has been considered on behalf of the Committee by the Chair.
Confirmation of ethical opinion
On behalf of the Committee, | am pleased to confirm a favourable ethical opinion for the
above researchon the basis described in the application form, protocol and supporting
documentation as revised.
The favourable opinion applies to the research sites listed on the attached form. Confirmation
of approvalfor othersites listed in the application will be issued as soon aslocal assessors
have confirmed that they have no objection.
| would like to confirm the favourable opinion applies to the first phase of the study only and a
resubmission will be required for the PCR part of your project.
Conditions of approval
The favourable opinion is given provided that you comply with the conditions set out in the
attached document. You are advised to study the conditions carefully.
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Approved documents
Thefinal list of documents reviewed and approved by the Committee is as
 
 
follows:
DocumentType: Version: Dated: Date
Received:
Application 3.0 10/11/2004 11/11/2004
Protocol 1 31/10/2004 11/11/2004
Participant Information Sheet 7 30/10/2004 11/11/2004
Participant Consent Form 3 09/11/2004 11/11/2004
Response to Request for} Patient Information 17/12/2004 17/12/2004
Further Information Sheet, Version 8    
Management approval
The study should not commence at any NHSsite until the local Principal
Investigator has obtained final management approval from the R&D
Departmentfor the relevant NHS care organisation.
Membership of the Committee
The members of the Ethics Committee who werepresentat the meeting are
listed on the attached sheet.
Notification of other bodies
The Committee Administratorwill notify the research sponsorthat the study
has a favourable ethical opinion.
Statement of compliance
The Committee is constituted in accordance with the Governance
Arrangements for Research Ethics Committees (July 2001) and complies
fully with the Standard Operating Procedures for Research Ethics
Committees in the UK.
 | 04/Q1505/135 Please quote this numberonall correspondence
With the Committee’s best wishesfor the successofthis project,
Yours sincerely
Dr Tej Purewal
Chair
Enclosures List of names and professions of members who were present
at the meeting and those who submitted written comments
Standard approval conditions
Site approval form (SF1)
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List of names and professions of members who were present at the meeting
and those who submitted written comments
Dr Tej Purewal
Consultant Diabetes/Endocrinology
Mr Roy Farquharson
Consultant in Obstetrics & Gynaecology
Dr Pip Fisher
GP
Dr Alan Fryer
Consultant Geneticist
Mrs Pauline Rowe
Lay Member
Ms Rebecca Smyth
Research Midwife
Ms Samantha Vernon
Lay Member
Professor Greg Wilkinson
Consultant Psychiatrist
Mrs Dorothy Zack-Williams
Health Visitor
In Attendance
Mrs Kathy Simons
Administrator
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RESEARCH IN HUMAN SUBJECTS OTHERTHANCLINICAL TRIALS OF
INVESTIGATIONAL MEDICINAL PRODUCTS
Standard conditions of approval by Research Ethics Committees
1. Further communications with the Research Ethics Committee
1.1 Further communications during the research with the Research Ethics
Committee that gave the favourable ethical opinion (hereafter referred to in this
document as “the Committee”) are the personal responsibility of the Chief
Investigator.
Commencementof the research
2.1 It is assumed that the research will commence within 12 months of the date
of the favourable ethical opinion.
2.2 In the case of research requiring site-specific assessment (SSA) the
research may not commenceatanysite until the Committee has notified the
Chief Investigator that the favourable ethical opinion is extendedto the site.
2.3 The research may not commence at any NHSsite until the local Principal
Investigator (PI) or research collaborator has obtained management
approvalfrom the relevant NHS care organisation.
2.4 Should the research not commence within 12 months, the Chief Investigator
should give a written explanation for the delay. It is open to the Committee
to allow a further period of 12 months within which the research must
commence.
2.5 Should the research not commencewithin 24 months, the favourable opinion
will be suspended and the application would need to be re-submitted for
ethical review.
3. Duration of ethical approval
3.1 The favourable ethical opinion for the research applies for the expected
duration of the research as specified in the application form. If it is proposed
to extend the duration of the study, this should be submitted for approval as
a substantial amendment.
4. Progress reports
4.1 Research Ethics Committees are required to monitor research with a
favourable opinion. The Chief Investigator should submit a progress report
to the Committee 12 months after the date on which the favourable opinion
was given. Annual progress reports should be submitted thereafter.
4.2 Progress reports should be in the format prescribed by COREC and
published on the website (see www.corec.org.uk).
4.3 The Chief Investigator may be requested to attend a meeting of the
Committee or Sub-Committee to discuss the progress of the research.
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5.2
5.3
5.4
6.2
6.3
6.4
72
Amendments
If it is proposed to make a substantial amendment to the research, the Chief
Investigator should submit a notice of amendment to the Committee.
A substantial amendment is any amendmentto the terms of the application
for ethical review, or to the protocol or other supporting documentation
approved by the Committee,that is likely to affect to a significant degree:
(a) the safety or physical or mental integrity of the trial participants
the scientific value of the trial
the conduct or managementofthetrial.
Notices of amendment should be in the format prescribed by COREC and
published on the website, and should be personally signed by the Chief
Investigator.
A substantial anendment should not be implemented until a favourable
ethical opinion has been given by the Committee, unless the changes to the
research are urgent safety measures (see section 7). The Committee is
required to give an opinion within 35 days of the date of receiving a valid
notice of amendment.
Amendmentsthat are not substantial amendments (“minor amendments”)
may be madeat any time and do not needto benotified to the Committee.
Changesto sites (studies requiring site-specific assessmentonly)
Where it is proposed to include a new site in the research, there is no
requirementto submit a notice of amendment form to the Committee. Part C
of the application form together with the local Principal Investigator’s CV
should be submitted to the relevant LREC for site-specific assessment
(SSA).
Similarly, where it is proposed to make important changes in the
managementofa site (in particular, the appointment of a new PI), a notice of
amendmentform is not required. A revised Part C for the site (together with
the CV for the new PI if applicable) should be submitted to the relevant
LREC for SSA.
The relevant LRECwill notify the Committee whether there is any objection
to the newsite or Principal Investigator. The Committee will notify the Chief
Investigator of its opinion within 35 days of receipt of the valid application for
SSA.
For studies designated by the Committee as having “no local investigators”,
there is no requirementto notify the Committee of the inclusion of newsites.
Urgent safety measures
The sponsoror the Chief Investigator, or the local Principal Investigator at a
trial site, may take appropriate urgent safety measures in order to protect
researchparticipants against any immediate hazard to their health or safety.
The Committee must be notified within three days that such measures have
been taken, the reasons whyandthe planfor further action.
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8.2
8.3
8.4
9.1
9.2
9.3
10.
10.1
11.
12.
12.1
Serious Adverse Events
Any Serious Adverse Event (SAE) occurring to a research subject must be
promptly notified to the Committee where it is considered possible that the
event resulted from their participation in the research. An SAE is an
untoward occurrence that:
(a results in death
(b is life-threatening
results in persistent or significant disability or incapacity
consists of a congenital anomaly’ or birth defect
f) is otherwise considered medically significant by the investigator.
)
)
(c) requires hospitalisation or prolongation of existing hospitalisation
))
d
e
—_
~—
~
~
~
Reports of SAEs should be provided to the Committee within 15 days of the
Chief Investigator becoming aware of the event, in the format prescribed by
CORECand published on the website.
The Chief Investigator may be requested to attend a meeting of the
Committee or Sub-Committee to discuss any concerns about the health or
safety of research subjects.
Reports should not be sent to other RECsin the case of multi-site studies.
Conclusion or early termination of the research
The Chief Investigator should notify the Committee in writing that the
research has ended within 90 days of its conclusion. The conclusion of the
research is defined as the final date or event specified in the protocol, not
the completion of data analysis or publication of the results.
If the research is terminated early, the Chief Investigator should notify the
Committee within 15 days of the date of termination. An explanation of the
reasonsfor early termination should be given.
Reports of conclusion or early termination should be submitted in the form
prescribed by COREC and published on the website.
Final report
A summary of the final report on the research should be provided to the
Committee within 12 months of the conclusion of the study.
Review of ethical opinion
The Committee may review its opinion at any timein the light of any relevant
information it receives.
The Chief Investigator may at any time request that the Committee reviews
its opinion, or seek advice from the Committee on any ethical issue relating
to the research.
Breach of approval conditions
Failure to comply with these conditions may lead to suspension or
termination of the favourable ethical opinion by the Committee.
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The Royal Liverpool and
Broadgreen University Hospitals
NHS Trust
Royal Liverpool University Hospital
Prescott St
Liverpool
L7 8XP
Tel:0151 706 2000
Fax: 0151 706 5806
PATIENT INFORMATION SHEET: GASTROSCOPYBIOPSY
AUGUST31 2003
PILOT STUDY: HISTOLOGICAL EXAMINATION OF HUMAN BOWEL
This is a study being conducted by Professor A. Watson, Mr M.J. Hershman and Dr
F. Campbell, Mr T. Bullen and Miss K. Johnston at the Royal Liverpool University
Hospital. We wish to look closely at the cells lining the bowel in humans. Forthis
purpose we wish to take a sample of bowel at the procedure you are about to
undergo.
Study Procedures
If you decide to take part your participation in the study will take place during your
planned gastroscopy. This is a camera test to look at the stomach and small bowel.
During the gastroscopy a sample ofthe lining of the bowelis sent to a doctorin the
laboratory to look at it under a microscope. The sample is 4mm (1/6 of an inch) in
size and painless whentaken.
Risks of Study Procedures
At the time of the Gastroscopy there is a small chance (<0.1%) that damage could
occur to the bowel, such as bleeding or of making a small hole (perforation) which
would require further treatment or surgery. The risks are small and the
endoscopists are medically qualified and have been fully trained and are careful
operators.
Confidentiality
Your participation in the study, should you decide to take part, will be treated as
confidential.
YourRight to ask Questions and/or to Withdraw from the Study
You have the right to ask any questions concerning the potential and/or known
hazards of this study at any time. You will be informed of any significant new
information pertaining to your safety.
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Permission
The trial has Royal Liverpool University Hospital Trust and Liverpool Local
Research Ethics Committee approval.
Voluntary Participation
Your participation in this research study is voluntary, and you may discontinue your
participation in the study at any time. You are entitled to receive a signed copy of
this form.
If you agree: Instead of one sample of bowel being taken we would take two. The
sample would go to the same doctorin the laboratory but have special dyes placed
onit.
If you decline: Wewill take only one sample. Being in the study is voluntary and
we understand if you do not wish to participate. It will not affect the investigation
and yourtreatmentif you decline, norwill it affect your relationship with the medical
and nursingstaff.
If you wish to know more: We will be happy to discuss any questions you may
have regarding this study. Please ring 0151 706 4194 Kate Johnston Research
Nurseor via e-mail at docbullen@hotmail.com.
Thankyoufor reading this.
Version 3 19.10.03
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The Royal Liverpool and ae
Broadgreen University Hospitals
NHS Trust
PATIENT INFORMATION SHEET
PILOT STUDY: HISTOLOGICAL EXAMINATION OF HUMAN BOWEL
This is a study being conducted by Mr T. Bullen, Mr P Carter, Mr P Rooney, Mr M.J.
Hershman, Dr F. Campbell, Dr M. Pritchard and Professor A. Watson at the Royal
Liverpool University Hospital. We wish to look closely at the cells lining the bowelin
humans. For this purpose we wish to take a sample of bowelat the procedure you
are about to undergo.
Study Procedures
If you decide to take part in the study will use some of the bowel removed during
your planned surgery.All tissue removed in theatre is sent to a doctor (pathologist)
in the hospital to look at more closely. With your permission a small portion of the
bowelwill be sent to a different doctor in the laboratory to perform tests on the cells
lining the bowel.
Risks of Study Procedures
Thereis no risk other than that explained for you planned surgery.
Confidentiality
Your participation in the study, should you decide to take part, will be treated as
confidential.
Your Right to ask Questions and/or to Withdraw from the Study
You have the right to ask any questions concerning the potential and/or known
hazards of this study at any time. You will be informed of any significant new
information pertaining to your safety.
Permission
Thetrial has Royal Liverpool University Hospital Trust and Local Research Ethics
Committee approval.
Voluntary Participation
Your participation in this research study is voluntary, and you may discontinue your
participation in the study at any time. You are entitled to receive a signed copy of
this form.
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If you agree: Part of the bowel being removed would be sent a doctor in the
laboratory and would have tests performed on it. There is no added risk to the
operation from beingin this study.
If you decline: Being in the study is voluntary and we understandif you do not wish
to participate. It will not affect your treatment if you decline, nor will it affect your
relationship with the medical and nursing staff.
If you wish to know more: Wewill be happy to discuss any questions you may
have regarding this study. Please ring 0151 794 6865 Timothy Bullen Surgical
ResearchFellow oralternatively via e-mail at docbullen@hotmail.com.
Thankyoufor readingthis.
Version 6 30.10.04
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The Royal Liverpool and Ae
Broadgreen University Hospitals
NHS Trust
Patient Consent Form: Version 2 — 18t November 2004.
Study No:
PILOT STUDY: HISTOLOGICAL EXAMINATION OF HUMAN BOWEL
INFORMED CONSENT STATEMENT
This is a study being conducted by Professor A. Watson, Mr P Carter, Mr P Rooney,
Mr MJ Hershman, Dr F Campbell, Dr M Pritchard and Mr T. Bullen. Contact on
0151 794 6865
RoyalLiverpool University Hospital, Prescott St, Liverpool, L7 8XP
 PATIENT’S STUDY NUMBER: | | | |
|, (Full name - printed) have read and understand
all the preceding information describing this clinical research study, and all my
questions have been answered to mysatisfaction. | voluntarily consent to give
samples of the tumour removed previously for the above study.
Date:
 Signature of Patient
Signature of Investigator: Date:
This document must be placedin the patient's medicalfiles.
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